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Abstract
As technology advances, so does the quality of treatment offered to cancer patients. Proton
therapy, and more specifically proton pencil beam scanning, is currently at the forefront of
radiation therapy. Pencil beam scanning offers excellent tumor dose control as well as sur
rounding organs at risk sparing. Current treatment planning, however, is performed on a static
image acquired before treatment. Naturally, this is not a proper representation of the actual
patient on a daily basis. Thus, there is a need for adaptive radiation therapy, such as read
justing a given treatment plan based on the patient’s daily setup or a moving tumor location.
In order to perform adaptive treatment delivery, appropriate imaging as well as an extremely
fast, yet accurate, dose computation engine is needed.
GEANT4 Monte Carlo simulations were performed in order to assess the imaging capabili
ties and limitations of a proton radiography detector, comparing them to conventional X-ray
imaging. In parallel, a small form factor proton radiography system was designed based on
available technologies. Thus, photonic bandgap fibers, a CMOS active pixel sensor, and Bi
cron scintillating fibers were evaluated for proton imaging purposes.
The requisites and limitations of treatment planning for proton pencil beam scanning were
further defined, from the acquisition of the treatment planning software’s beam model to the
methodologies and treatment robustness. Based on this work, a simplified Monte Carlo al
gorithm was designed and implemented on the CPU architecture. This computation engine,
GMC, was validated against physical observables and then compared to the treatment plan

ning software dose calculation, as well as a ”full” Monte Carlo recomputation.
Proton radiography showed poor spatial resolution but excellent density resolution when com 
pared to X-ray radiography. This density resolution can be of importance when attempting to
perform tumor tracking. The lower imaging dose associated with proton radiography is also
of interest, especially in pediatric patients. Moreover, the use of a unique beam’s eye view
could slightly improve the accuracy of treatment delivery. Photonic bangap fibers, as well as
the specific CMOS active pixel sensor used in this work, did not yield promising results for
proton imaging. Conversely, Bicron scintillating fibers proved to be suitable for the design of
a proton radiography system, as both the individual particle’s position and energy could be
acquired.
The treatment planning software's beam model is very simple, as compared to other modal
ities. However, the planning stage presented a few limitations, such as a lack of robustness
analysis and issues related to spot placement. It was shown that both of these issues could
be addressed with the use of a fast, yet accurate, dose computation engine. GMC was suc
cessfully implemented on the CPU architecture, and compared extremely well against actual
pre-treatment QA measurements. The comparisons against the current algorithm of the treat
ment planning software and the full Monte Carlo engine matched the expectations for such
an algorithm.
The complementing work on proton imaging and fast dose computation algorithm lays a solid
foundation to materializing pencil beam scanning adaptive radiotherapy. Future work will fo
cus on generating the necessary synergy between the two systems in order to implement the
tools in the clinical setting.
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Chapter 1

Introduction
External beam radiation therapy generally aims at controlling tumor tissue growth using highenergy rays. Diverse modalities are available but all have the same intent: maximizing the
amount of dose received by the tumor while minimizing the dose to the surrounding healthy
tissue. Through the use of its finite range in tissue, proton radiotherapy offers excellent oppor
tunities at fulfilling this goal. As costs decrease and technology advances, so does the quality
of radiation treatments. One such example is proton pencil beam scanning (PBS).// Proton
therapy treatments in a clinical setting began in the U.K. in 1989 at the Clatterbridge Cancer
Centre. At the time, cost and technology only permitted the treatment of eye patients due to
the relatively low energy of the beam (62 MeV). As time passed, it became possible to treat
deep/large tumors using double-scattering technology, a 3D conformal proton therapy tech
nique with results comparable to photon IMRT treatments (St Clair et al., M ock et al., Trofimov
et al. [14, 15, 16]). The first treatment of a patient with PBS followed in 1996 at the Paul
Sherrer Institute in Switzerland; however, it was not until 2008 that PBS become truly avail
able in a clinical setting. Through the use of intensity modulation, PBS offers excellent tumor
dose conformality along with notable organs at risk sparing. Thus, PBS is quickly becoming
a modality of choice for new radiotherapy centers.
In spite of the fact that PBS is at the forefront of radiotherapy, numerous challenges remain.
One challenge is the adaptation of a radiation therapy treatment plan. This adaptation could
occur based on a patient ’s daily setup position or ’’online” through the use of tumor tracking.
The continuous expansion of computing power and speed plays a key factor in the achieve
ment of this skill. PBS adaptive radiotherapy requires novel imaging capabilities, such as
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proton imaging, in order to efficiently position the patient and recompute the intended treat
ment plan dose. This recalculation must be practically instantaneous yet accurate, so the
treatment can be adapted without any delay.
This thesis aims to build the basis for proton pencil beam scanning adaptive radiotherapy.
Proton therapy mechanism and current workflows are presented in chapter 2. Chapters 3
and 4 investigate the possibilities and limitations of a clinically viable proton radiography imag
ing system. PBS treatment planning requisites and the development of a simplified Monte
Carlo dose algorithm are the focus of the work presented in chapters 5 and 6.

1.1
1.1.1

Aims and objectives
Proton imaging characteristics, limitations, and feasibility

Current proton centers mostly rely on orthogonal X-ray imaging for patient setup verifications.
This imaging modality may result in a relatively large, undesired dose to the patient, especially
in pediatric patients (Miglioretti et al. [17]). As this thesis will show, X-ray imaging is quite
possibly not the optimal modality for certain tumor sites. Because of this, there is a need for
proton imaging which could be used at the time of patient setup. Additionally, the possibility of
using tumor tracking with proton imaging could result in the online adaptation of the treatment
plan, hence ensure the treatment is truly delivered as intended.
Research question:

What are the imaging capabilities of a small form factor, clinically viable proton
radiography detector?

Chapter 3 presents various work using Monte Carlo simulations in order to demonstrate the
theoretical possibilities of a clinically viable proton radiography system.

1.1.2

Design of a proton radiography detector

All current solutions for proton radiography detectors rely on a range telescope-like device in
order to acquire the proton range/energy information (Schneider and Pedroni [18], Schneider
and Pedroni [19], Schneider etal. [3], Sauli [20], Pemleretal. [4], Johnson etal. [21], Talamonti
et al. [22], Sipala et al. [23]). While such systems could be used to produce proton images,
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the range telescope is impractical for clinical use due to its rather bulky design.
Research question:

What technologies are available in order to build a small form factor, clinically viable
proton radiography detector?

Subsequent to the simulation work realized on proton radiography imaging, chapter 4 shows
the different designs and empirical work performed in order to build a clinically viable proton
radiography system.

1.1.3

Proton pencil beam scanning planning

Proton pencil beam scanning is currently the most promising radiation treatment modality. The
use of intensity modulation as well as the finite range provided by the individual Bragg peaks
can result in highly conformal target coverage, along with great organs at risk sparing. It is,
however, a new modality, and as such, there is still limited experience or proper guidelines for
treatment planning.
Research question:

What are the current methodologies and limitations of proton pencil beam scan
ning treatment planning?

Chapter 5 presents the requisites as well as the current treatment planning methodologies
used at Massachusetts General Hospital for proton pencil beam scanning delivery. The limi
tations and uncertainties of these methodologies are also discussed.

1.1.4

Fast MC dose algorithm

The current clinical practice for proton treatment planning relies on dose computations using a
pencil beam algorithm (PBA). PBA are analytical dose computation engines that presents the
advantage of speed and relatively good accuracy. In the presence of large heterogeneities,
however, these PBA engines tend to fall apart and large discrepancies may be observed
(Schaffner et al., Grassberger et al. [13, 24]). Conversely, full Monte Carlo dose computations
engine are far more accurate but present a large overhead and result in clinically unacceptable
computation time. Not only does PBA suffer from these inaccuracies but, when it comes to
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adaptive radiotherapy, its dose calculation speed remains inadequate as the whole process
must occur within seconds.
Research question:
Could the current clinical PBA dose computation engine for proton therapy be
replaced with a faster yet more accurate MC algorithm?

Chapter 6 presents the implementation of a fast yet accurate Monte Carlo dose algorithm for
proton therapy treatment planning.

1.2

Contributions and Publications

The principal contributions discussed in this thesis resulted in the following publications and
presentations:

• C hapter 3: Proton Radiography: feasibility studies.
The work presented in chapter 3 has been published in numerous articles {Depauw
et al. [25], Depauw and Seco [26], Depauw et al. [27]), and presented at multiples con
ferences (Depauw et al. [28], Depauw et al. [29]).
Additionally, co-authored work has been published (Seco and Depauw [30], Seco etal. [31],
P o lfet al. [32], ? [? ]), and presented at various conferences (Seco and Depauw [33],
Dias et al. [34], Seco et al. [35], Seco et al. [36], Spadea et al. [37], Spadea et al. [38]).
• C hapter 4: Proton Radiography: experimental realization.
The experimental work described in chapter 4 resulted in a couple of papers (Polf
et al. [32] and Seco and Depauw [30]), as well as presented at various conferences (De
pauw and Seco [39], Depauw and Seco [40], Seco and Depauw [33], Goulet et al. [41],
Koybasi et al. [42]). An invited talk was also given at the University of Wollongong (De
pauw [43]).
• C hapter 5: Proton pencil beam scanning planning.
The PBS planning methodologies presented in chapter 5, as well as their results, have
been published and presented in numerous places. Multiple manuscripts were also
awaiting submission at the time of writing. Specifically, the PMRT example was recently
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accepted for publication in the Red Journal (Depauw et al. [44]).
Co-authored work has been published in Kooy et al. [45], Clasie et al. [11], Dowdell
etal. [46], Carabe etal. [47], and Butterworth etal. [48], as well as presented at various
conferences {Clasie et al. [49], Clasie et al. [50], Dowdell et al. [51], Rochet et al. [52],
Carabe-Fernandez et al. [53], McGarry et al. [54]).
• C hapter 6: Fast MC dose algorithm.
The work in chapter 6 is yet to be published, but was partially presented at the Interna
tional Conference on the Use of Computers in Radiation Therapy (Depauw et al. [55]),
and published in their proceedings (Depauw et al. [56]).
Numerous submissions shall follow this thesis work, including future work on the algo
rithm ’s validation and speed improvements.
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Chapter 2

Contemporary proton pencil beam
scanning
2.1

Introduction

Proton beams were first suggested for medical use by Wilson [57], leading to the treatment
of the first cancer patient in 1954 at Lawrence Berkley Laboratory (Lawrence [58]). The
first patients were treated using a cross-firing technique utilizing the plateau region of the
beam. The advantages of the Bragg peak (figure 2.9) over conventional radiotherapy, how
ever, quickly became clear. Thus, the Harvard Cyclotron Laboratory (HCL), together with the
Massachusetts General Hospital (MGH), focused on the use of the Bragg peak for cancer
therapy in the 1960s (Lawrence [59]). Early on, proton therapy was only administered through
such collaboration efforts in physics research facility. The first hospital-based proton therapy
center was initiated at the Clatterbridge Centre for Oncology in the U,K., followed in 1990 by
the first U.S.-based center in Loma Linda (Slater et al. [60]). Only two additional U.S.-based
centers were opened over the course of the following decade, including MGH ’s Francis H
Burr proton center (Particle Therapy Co-Operative Group [61]). Since 2001, however, eleven
additional centers have treated patients, and ten more are under-construction, solely in the
U.S. (Particle Therapy Co-Operative Group, Particle Therapy Co-Operative Group [61, 62]).
Largely assisted through recent improvements in accelerators and delivery techniques, this in
crease in treating proton centers highlights the great interest in proton therapy due to protons ’
promising physical characteristics. Historically, only passive scattering delivery techniques
were available. Such techniques present intrinsic limitations which prohibit the full use of pro
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ton therapy ’s theoretical benefits over conventional radiotherapy. More recently, pencil beam
scanning (PBS) delivery techniques have emerged in hospital environments. Thus, both MGH
and M.D. Anderson treated their first patients using this technique in 2008. PBS allows for
high tumor conformality along with great organs at risk (OAR) sparing.
The physical properties of proton pencil beam scanning are described below, as well as the
current state-of-the-art in PBS technology. The current workflow and limitations of PBS adap
tive radiotherapy are further highlighted.

2.2

Proton therapy

Unless specified, the information presented in this section was derived from De Laney and
Kooy [63], Attix [64], or Paganetti [2].

2.2.1

Physical interactions

Protons mainly interact with matter in two distinct ways: electromagnetic interactions and nu
clear interactions. All protons undergo many electromagnetic interactions which are mostly
nonelastic (kinetic energy loss and particles states unchanged). These electromagnetic inter
actions occur with either atomic electrons or atom nuclei. Conversely, only a fraction of the
incident protons will undergo nuclear interactions.
In the case of electromagnetic interactions with atomic electrons (figure 2.1(a)), the proton
transfers part of its momentum to the electron. The electron gets ejected and becomes a socalled ^-electron that will ionize the medium. As the proton loses momentum, it transfers more
and more energy during each interaction with an electron as it remains for a longer period of
time within the electron ’s vicinity. As later discussed, this gives rise to the characteristic Bragg
peak (figure 2.2). Although the proton transfers only very little energy during these collisions, it
will come to a rest due to the large number of interactions. The proton scattering is negligible
during such interactions.
A proton generally loses negligible energy during an electromagnetic interaction with an atomic
nucleus (elastic interactions) but scatters with a small angle. This interaction is presented in
figure 2.1(b). Although the proton ’s local deflection is small, an increasing angular spread of
the protons is observed at depth due to the large number of these interactions (figure 2.4).
This angular spread phenomenon is commonly referred to as ”multiple Coulomb scattering”
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Figure 2.1: Electromagnetic interactions between an incident proton (green) and (a) an atomic electron
(blue) or (b) an atomic nucleus (yellow and green). These interactions result in either a transfer of
momentum (energy loss) to the electron (a), or a slight scatter (b).

(MCS).
As previously discussed, the energy of the incident proton decreases as the energy locally
deposited (dE) increases due to the increasing time the proton remains within the electron’s
vicinity. As a consequence, a proton of a given incident energy comes to rest at a known depth
that depends on the medium’s density. This depth is known as its ” range” . A monoenergetic
proton beam is thus characterized by its depth dose distribution, the so-called ” Bragg peak” .
An example of a pristine Bragg peak is given in figure 2.2 for an incident proton beam with
an energy of 170 MeV. Although not a fully understood process, there is a very small build-up
observed at the entrance of the peak which is believed to arise from in-air nuclear interactions
prior to the water. The curve highlights the initial slight increase in dose deposited (dX), called
the ’’plateau region” , followed by the peak as dE increases as a power law function [65]. The
physical range R 80 of a monoenergetic beam corresponds to the depth at which 50 % of the
incident protons have stopped, and is defined as the distal 80 % mark on the depth dose
curve. The range of each proton varies slightly due to statistical fluctuations in the number
of interactions the proton undergoes. This phenomenon is known as range straggling and
results in an increase in the width of the peak. Within the clinical therapeutic range (30 MeV
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to 250 MeV), range straggling equates to « 1.2 % of the nominal range across materials of
various densities.
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Figure 2.2: Depth dose distribution of a 170 MeV proton beam known as the "Bragg peak”.

A Spread-Out Bragg peak (SOBP) can be generated by overlapping Bragg peaks from protons
of various energies. A SOBP is characterized by its range R 90 (defined as the distal 90 % mark
on the depth dose curve) and its modulation (defined as the proximal 98 % mark on the depth
dose curve). Figure 2.3 shows an example of an SOBP along with the weighted individual
Bragg peaks that it is composed of. Although the SOBP is a very important concept in a
scattered proton delivery system, it is less relevant to PBS delivery techniques due to the
three dimensional intensity modulation feature, as later discussed.
Laterally, the MCS component of the beam results in a near-Gaussian angular distribution.
The numerous atomic interactions that occur within a medium result in a small displacement
of the protons which slowly increases the width of the cross section of a unidirectional beam

2- Contemporary proton pencil beam scanning ~ N. Depauw, PhD thesis, 2014 - CMRP, UOW

9

Depth
Figure 2.3: A spread-Out Bragg peak (thick line) generated from a composition of individual pristine
Bragg peaks (thin lines). The solid squares represent the proximal and distal 90 % of the curve, deter
mining the range and modulation of the beam; the empty square highlights different points along the
curve between the proximal 70 % and distal 10 %. This figure was produced using Gottschalk [1]
at the macroscopic level. This angle can be measured at a given depth as highlighted in figure
2.4(a). Furthermore, this scattering angle rapidly increases as the momentum of the protons
rapidly diminishes at the end of range. This is illustrated in figure 2.4(b), which shows the
relative increase in MCS as a function of depth over range.
Additionally, a fraction of the incident protons undergo head-on collisions with the nucleus of
an atom. Although these nuclear interactions may be elestic, they are generally nonelastic and
result in the generation of two secondary particles as illustrated in figure 2.5. One of these
secondaries is the original incident proton, while the other is a fragment of the nucleus. This
nuclear fragment can consist of a simple nucleon (proton or neutron), or could be a larger
particle such as an alpha particle. It was shown through Monte Carlo simulations that, in
57 % of nuclear interactions, the nuclear fragment was a proton. In such an instance it is
then impossible to tell which secondary particle is the original proton. The energy of these
secondary particles greatly varies and is dictated by the amount of momentum transfered
during the collision between the proton and the atomic nucleus. These secondaries present a
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Figure 2.4: (a) Scattering angle 60 due to the multiple Coulomb scattering of the protons; 60 is ruled
by a normal distribution which can be measured as a displacement x 0 (sigma) at an arbitrary distance
T; (b) Multiple Coulomb scattering as a function of depth over incident range.

relatively high energy compared to ^-electrons, and their dose therefore cannot be considered
locally deposited. The range of these secondaries is typically within 1 to 2 cm. Furthermore,
these interactions typically result in large angle scattering ranging anywhere between 0 and
90 °.
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Figure 2.5: Nuclear interactions of an incident proton (green) with an atomic nucleus (yellow and
green). In this instance, the incident proton transfered some of its momentum to a nuclear proton
which got ejected.

Figure 2.6 shows the probability of nonelastic nuclear interactions in water based on incident
proton range in water (i.e energy). The probability of a nuclear interaction for a particle with a
given proton range (energy) is 1 %/g.cm2 (Janni [ 66]).
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Figure 2.6: Nonelastic nuclear interaction probability as a function of incident proton range in water,
courtesy of Paganetti [2].
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2.2.2
2.2.2.1

Beam delivery
S ca ttering

A narrow beam is broadened through a range modulator wheel and scattering foils in order
to generate a broad Gaussian distribution. In the case of double scattering, the Gaussian
distribution is flattened through the use of a bell-shaped second scatterer which results in a
larger area of uniform fluence. A collimator, generally an aperture made of high-Z material,
is then tailored to eliminate the undesired dose outside of the target. The incident energy of
the narrow beam is simultaneously modified through a modulation wheel. The modulation
wheel presents steps of various thicknesses and rotates at a high speed. This results in
the generation of a SOBP which is delivered multiple times per second. Downstream of the
collimation device, a range compensator is used in order to conform the distal dose distribution
to the target volume. While this results in good distal conformality, this also results in larger
proximal dose as the full modulation of the SOBP must be delivered throughout the entire
target volume. A schematic of a double scattering system is given in figure 2.7.

Figure 2.7: Schematic of a double scattering delivery system: a narrow incident proton beam is
scattered twice while the energy of the beam is modulated through a range modulator; the resultant
uniform central dose distribution is then collimated and compensated in order to deliver a uniform
SOBP that will conform laterally and distally to the target volume.

2.2.2.2

Scanning

In scanning systems, the narrow incident proton beam is magnetically scanned throughout
the target volume using dipoles. In the case of uniform scanning, a single scatterer is used to
first broaden the field and deliver a uniform dose that is then collimated similarly to a scattered
delivery system. In pencil beam scanning (PBS) mode, the narrow field is displaced later
ally such that it conformally shapes to the tumor at each depth. The beam’s energy is then
modulated directly at the output of the accelerator in order to deliver layers (slices) at depth
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throughout the target volume. Additionally, the beam's intensity is modulated throughout the
delivery resulting in fully conformal three dimensional dose distributions. The quality of the
dose distribution is characterized by the machine parameters such as the range of available
energies and the size of the beam. While collimators and range compensators are not re
quired in PBS to obtain good target conformality, they still might be relevant with a machine
presenting a larger spot size. A machine with a smaller incident beam, on the other hand,
would directly achieve optimal lateral and distal tumor conformality. A smaller spot also per
mits highly discreet intensity modulation within the target volume, thus allowing for efficient
sparing of OAR abutting the target volume. For instance, a hole can be generated within the
dose distribution in order to spare the spinal cord in the case that it is located in the middle
of the target volume. One solution to reduce the beam size is to utilize a pair of quadrupoles
positioned upstream of the scanning magnets, followed by a vacuum chamber. In order to
ensure that the delivery is correctly performed, the beam’s position, size, and intensity are
checked online using ionization chambers (IC). The schematic of a PBS delivery system is
presented in figure 2.8.
Vacuum

Figure 2.8: Schematic of a pencil beam scanning delivery system: a narrow incident beam with a
given energy is magnetically scanned laterally to conform to the target volume; the energy of the beam
is then altered upstream in order to deliver subsequent layers. This technique results in high target
conformality laterally, distally, proximally, as well as within the target volume through the use of intensity
modulation.

2.2.3

Clinical advantages

Figure 2.9 compares a 15 MV dose distribution versus a proton SOBP field. The theoretical
advantages of protons are quite obvious. The lower entrance dose as well as the lack of exit
dose with protons can result in a much greater target conformality along with better OAR spar-
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Figure 2.9: Depth dose distributions of a SOBP proton beam, as compared to a 15 MV photon beam,
both adequately covering the tumor.

ing. Thus, the main benefit of proton therapy usually resides in the significantly lower integral
dose as compared to photons (Purdy [67]).
Intensity modulated radiation therapy (IMRT) or volumetric modulated arc therapy (VMAT) also
offers high target conformality using photons. In some cases, these techniques offer simi
lar treatment quality as passively scattered protons (Trofimov et al. [16]). This highlights the
limitation of the clinical advantages of proton therapy over conventional therapy. These are,
however, invalid comparisons. Indeed, IMRT and VMAT techniques are state-of-the-art in
photon therapy, whereas passively scattered proton techniques represent the basics of pro
ton therapy. Conversely, proton PBS techniques allow for far greater conformality of the dose
around as well as within the target volume. Recent studies by Zhang et al. [ 68] and Van de
Water et al. [69] highlight the greater treatment quality expected from PBS as compared to
IMRT and VMAT.
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2.3
2.3.1

Setup Imaging
Current clinical workflow

A CT scan of the patient is acquired prior to treatment for planning purposes. Digitally recon
structed radiographs (DRR) are then generated for setup purposes based on the CT and the
beam isocenter(s) used for treatment planning. The patient is subsequently setup and treated
based on these images.
The conventional proton setup process at MGH and most other proton facilities consists of
the following steps:
1. The patient is positioned based on tattoos priorly inked at the time of CT.
2. Orthogonal X-rays are taken at a specified cardinal angle.
3. The couch is moved in accordance to the DRR priorly submitted, resulting in a precise
placement of the patient at the treatment isocenter.
4. A final ” beamline” X-ray is acquired at the treatment gantry angle in order to confirm the
accuracy of the treatment position.
This aforementioned workflow presents a number of pitfalls. The CT scan is a map of Hounsfield
units (HU) corresponding to the difference in X-rays absorption of the different tissues through
out the body. This HU map must then be converted to proton relative stopping power ratios
(RSP) for appropriate dose computation using protons [70]. This conversion carries a certain
error due to the quality of the CT reconstruction; this, in turn, contributes to range uncer
tainties in the proton treatment (Espana and Paganetti, Paganetti [71, 72]). Furthermore, the
in-room setup process currently relies on the use of an X-ray unit that is independent to the
therapeutic proton beam. Since the imaging and therapeutic beams do not share the exact
same isocenter, a systematic shift could potentially exist between the two unit’s beam’s eye
view (BEV).
A proton computed tomography (pCT) imaging system, on the other hand, would directly gen
erate RSP maps. The range uncertainties associated with the pCT scan would therefore be
significantly smaller compared to the current CT scan. Additionally, an in-room proton radio
graphy setup system would suppress the aforementioned potential BEV discrepancy. Other
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potential advantages of proton imaging technology are the reduced imaging dose and the
tumor tracking capabilities.

2.3.2

Proton radiography and computed tomography

The advantages of proton imaging, both radiography (PR) and computed tomography (pCT),
were explored in the late 1970s (Hanson, Hanson, Steward, Kramer et al. [73, 74, 75, 76]).
Their work highlighted the dose reduction with regards to conventional photon imaging as well
as the intrinsic problem of limited spatial resolution due to proton scattering (MCS). Neverthe
less, this intrinsic spatial resolution limitation was only quantified in the 1990s by a group at
the Paul-Scherrer-Institute (PSI) (Schneider and Pedroni [18]). The group further developed
the idea of proton radiography as a tool for quality control in proton therapy (Schneider and
Pedroni [19]) and, eventually, produced the first actual proton radiograph of an animal (a dog)
(Schneider et al. [3]). This first animal radiograph is shown in figure 2.10.

Figure 2.10: First actual proton radiograph of an animal patient (dog) by Schneider et al. [3]: (a) setup,
(b) reconstructed radiograph based on a backprojection algorithm after 100 iterations.

The poor spatial resolution of proton imaging in comparison to conventional X-ray radiography
is quite obvious in this first radiograph. Although, not truly identifiable in this radiograph, the
density resolution is higher for proton radiography than photon imaging. This greater density
resolution is a strength of proton imaging as it can result in clearer edge detection in certain
tumor sites (Schulte et al. [77]). The detector used to produce this radiograph was based on
the work by Pemler et al. [4]. This radiography detector consisted of two scintillating fibers’s
hodoscopes and a range telescope. The hodoscopes, placed in the front and back of the
patient, were used in order to track the position of individual particles. The range telescope
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is a large water equivalent column in which the residual Bragg peak is recorded, and the
residual range R80 beyond the patient computed. This range telescope, not easily discernible
in the setup photograph of the experiment (figure 2.10(a)), is bulky and not ideal. A schematic
of the design of Pemler’s detector is presented in figure 2.11. The computed R 80 can then
be subtracted to the incident beam range in order to obtain a map of water-equivalent path
length.

Figure 2.11: The original design of the proton radiography detector system built at PSI, courtesy of
(Pemler et al. [4]).

The incident proton energy is much higher for proton imaging (ideally maximal) compared to
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the typical therapeutic range. The extended energy permits the placement of the Bragg peak
beyond the patient and therefore produces images using only the plateau region of the beam.
This results in a significant reduction of the amount of dose delivered to the patient.
The protons do not travel in a straight line due to MCS within the patient. Thus, the simple
acquisition of the individual particle’s position is not enough to ensure an acceptable image
quality. The directional information for each particle would also need to be acquired in or
der to obtain greater image quality. One solution would be to pair the position acquisition
devices with a second set (such as the hodoscopes); the direction vectors could then be
reconstructed from the two positional information. This was also proposed by Coutrakon
et al. [78]. The added information could therefore be used to implement more advanced re
construction techniques such as the most likely path formalism (MLP), proposed by Schneider
and Pedroni [18]. The MLP technique intends to estimate the proton trajectory in a patient,
and therefore more accurately estimate the range degradation. This technique was later im
proved by Li et al. [5] and Schulte et al. [79]. Nevertheless, one important limitation to the MLP
technique is that it considers the patient as a uniform medium.
The generation of pCT images would also be possible by rotating a proton imaging device
mounted on a treatment gantry, such as the one proposed by Pemler et al. [4]. It was later
shown that an appropriate pCT image quality could be obtained using a conventional back
projection reconstruction algorithm along with MLP techniques (Li et al., Ryu et al. [5, 80]).
Figure 2.12 shows various reconstruction techniques that were investigated through Monte
Carlo simulations by Li et al. [5]: straight line path (SLP), most-likely path (MLP), and cubic
spline path (CSP).
Various improvements have been proposed for either PR or pCT devices based on the orig
inal design at PSI. Thus, more recent imaging devices used different technologies such as
scintillating tiles (hodoscopes), gas electron multipliers (GEM) detectors, and silicon strip de
tectors (Sauli, Johnson et al., Talamonti et al., Sipala et al. [20, 21, 22, 23]). Whether they are
intended for radiography or for pCT purpose, all of these detectors present a range telescope
of some sort in order to acquire the energy information of the individual particles. The range
telescope-like device renders the entire system bulkier and less practical for clinical use. Thus,
a simpler device, in a smaller form factor, would be valuable. A more compact proton radio
graphy system would also open the door to a therapeutic pCT system. Such a device could
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Figure 2.12: a) Phantom used forpCT reconstruction algorithm consisting of an outer shell with bone
density (1), a water inner filling (2), and strips of either air (black) or bone (white) at different densities; b)
Monte Carlo simulation of pCT reconstruction of the phantom using different reconstruction algorithm,
courtesy of Li et al. [5].

then be used to obtain accurate proton RSP maps of the patient, which would ensure proper
dose calculation accuracy.
A clinical proton imaging system would reduce uncertainties linked to possible discrepancies
between the imaging BEV and the therapeutic BEV, while offering a largely reduced imaging
dose to the patient. Moreover, proton imaging could be used for online tracking of the tumor
during dose delivery by modulating the energy of the beam at the output of the accelerator at a
very high speed. With the continuously improving technologies and speed, the system could
also update the trajectory of the protons automatically to follow the target, hence reducing the
treatment margins.

2.4
2.4.1

Adaptive radiotherapy
Current clinical workflow & TPS

The word ’’adaptive” presents various meanings as related to radiotherapy. People commonly
consider a specific subset of ideas or tools when referring to adaptive treatment. The general
definition, however, refers to the overall processes used to alter a given patient treatment
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based on an unexpected situation. This situation may arise from a plethora of causes. For
instance, anatomical changes in the patient may be detected over the course of treatment
during setup imaging; these changes in anatomy might grant the need for replanning. Such a
situation arises relatively frequently for certain tumor sites, in head & neck patients for example
for which the tumor might initially be present in an anatomical cavity and later recede out
of it due to radiotherapy. Another unexpected situation may be the early termination of a
patient’s treatment for medical or personal reasons. There is only little work associated in this
latter situation from a physics or dosimetric’s point of view. Typically, only the paperwork and
patient record would have to be modified in order to reflect the treatment received. Such a
situation is therefore not of real interest in this work. On the other hand, there are various steps
associated with adapting a patient’s treatment in the case that replanning seems necessary
due to anatomical changes:

1. A new CT scan must be promptly acquired, which involves finding space in the CT room
schedule.
2. Contours might have to be transfered from the original planning CT to the newly acquired
CT through deformable registration.
3. Fixing the transfered contours and/or recontouring would be necessary.
4. If the difference in tumor tissues and soft tissues surrounding the tumor is small between
the two registered CT, it might be useful to proceed to a deformable registration of the
original dose and assess the discrepancies. This step would be performed for time
saving purposes only; the ideal situation would be to recompute the original plan based
on the field(s)’s fluences onto the new scan.
5. The quality of the original plan recomputed onto the new CT must then be assessed in
order to confirm or rebut the need for replanning.
6. If replanning was deemed necessary, an entire treatment plan, including the paperwork
and QA steps, would have to be generated in haste.

The patient might have to be put on a treatment break in order to correctly complete these
steps and ensure the planned treatment is delivered. The aforementioned replanning process
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must be hurried due to the quick turn around required to ensure the appropriate biological
response is received. Thus, mistakes can easily occur.
Although not all cases of adaptive radiotherapy are this work intensive, replanning is regularly
necessary. Thus, the adaptive radiotherapy workflow should optimally be seamless. In the
ideal situation, the patient would be setup using an advanced setup imaging system, such
as cone-beam CT, with some additional software features. The imaging system could auto
matically recompute the intended treatment plan onto the daily image and decide, based on
parameters set by the physician, whether the daily treatment is appropriate or not. If the treat
ment was deemed inappropriate, the system would automatically adjust the fluence maps
from the original plan so that the correct treatment was to be delivered. This process would
have to be performed within a few minutes in order to not delay the machine schedule nor
compromise the patient’s comfort who would be laying on the table.
Such a system is currently unavailable due to the present state-of-the-art in proton algorithm
computation speed and the lack of advanced imaging. The current version of Astroid, the TPS
at MGH, can only be used for simple treatment planning purposes. Each treatment plan is
uncorrelated from one another, and there is no direct link to the actual patient’s treatment. In
the case of replanning, individual plans must be re-weighted (currently in an external software)
so that the actual delivered treatment appears in the patient’s record. In the aforementioned
optimal scenario, the treatment received would automatically match the initial intended treat
ment, as the imaging system would automatically recompute/adapt the daily treatment.
The adaptation of the treatment based on the tumor motion is another form of adaptive radio
therapy. Such adaptability would only be possible through online imaging and tumor tracking.
A proton imaging system with fast energy switching in combination with a fast recompuation software could then adjust the fluence map on the fly, so that the beam coincides with
the target at all times. In the current workflow, this issue must be mitigated through added
margins and robustness analysis; this is viable for a passively scattered beam, but might be
problematic in PBS due to interplay effects arising from the motion of both the beam and the
tumor.

2.4.2

Monte Carlo Verification

Proton radiotherapy centers currently use a pencil beam algorithm (PBA) for dose calculations.
At MGH, the PBA is based on the work by Hong etal. [81]. The advantages of such algorithms
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are their high computation speed capabilities and relatively good accuracy. In the presence
of large heterogeneities, however, the lack of lateral equilibrium results in calculation errors as
high as 10 % {Grassberger et al. [24]). The uncertainties can be partially mitigated through the
use of added range and modulation margins based on the planner’s experience.
In order to obtain accurate dose distributions, it is thus necessary to turn towards Monte
Carlo computations. Figure 2.13 shows the model of MGH’s proton double scattering nozzle
generated in GEANT4, a Monte Carlo toolkit {Agostinelli et al., Allison et al. [82, 83]), based
on the constructor’s blueprint. This simulation setup permits the accurate recomputation of
patient treatment plans at MGH {Paganetti et al., Paganetti et al. [ 6, 84]). Unfortunately, single
particle tracking is very lengthy and such GEANT4 calculations present a large overhead.
Furthermore, such implementation is difficult to put in place, with not all proton centers having
the ability to obtain such resources.

N o z z le d e l i v e r i n g b e a m

Snout

P a tie n t

Figure 2.13: MGH’s proton double scattering nozzle model in GEANT4 Monte Carlo toolkit (Paganetti
et al. [6]).

A clinical treatment plan is usually generated through multiple optimizations and at times
through multiple beam calculations {change in gantry angle or range shifter). Thus, com 
putation speed is key and Monte Carlo algorithms such as the one presented here are not
appropriate for clinical use. The relatively good accuracy of the PBA is thus the trade off for
speed. In specific cases, such as patients with large anatomic heterogeneities or large het
erogeneities in beam fluence, the patient’s intended treatment plan can be recomputed with
the Monte Carlo algorithm as a verification step. In the unlikely case that the discrepancies
between the Monte Carlo and the PBA calculations are too large, a new plan must be gener
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ated from the outset which might result in a delay in the start of the patient’s treatment.
A fast yet accurate dose computation engine, possibly based on Monte Carlo kernels or sim
plified Monte Carlo calculations, would be useful in order to optimize time and plan quality in
the clinical setting.

2.5

Conclusion

Proton pencil beam scanning is at the forefront of the radio therapeutic treatments that can
currently be offered. Nevertheless, the technology is in its infancy, with substantial room for
improvement. More advanced daily imaging is needed in order to ensure better treatment de
livery. More specifically, proton imaging could not only limit the issues linked to uncorrelated
imaging and therapeutic beam's eye views, but also result in a significant reduction in imaging
dose. Proton computed tomography would also permit the reduction of uncertainties in pro
ton dose calculations. Drastically faster proton dose computation engines are also required
in order to significantly improve the current treatment planning workflow and accuracy. The
combination of both features, advanced imaging and fast computation engine, would lead
to optimal proton PBS adaptive radiotherapy. Daily treatment plan adaptation to account for
setup errors and anatomical changes, as well as an online adaptation of the beam position
to follow the target, would then become possible. The following work therefore suggests a
solution for proton radiography using meshes of scintillating fibers without a range telescope,
as well as a fast oversimplified Monte Carlo dose engine for proton dose calculations. The
small size of the radiography system would render it more suitable for clinical use, with further
development possibly resulting in pCT. The suggested dose engine would track individual par
ticles, thus making it drastically more accurate against tissue heterogeneities than the current
pencil beam algorithms. Moreover, the highly parallelizable properties of the dose algorithm
would make it suitable for portage to the GPU architecture, thus opening the door to online
recomputations.
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Chapter 3

Proton Radiography: feasibility
studies
3.1

Introduction

Proton radiography was first investigated as a radiologic tool in the late 1970’s and early 1980’s
{Steward and Koehler, Hanson etal. [85, 86]), but was unsuccessful to keep up with the growth
of its cheaper alternative, X-ray radiography. The latter is now the common diagnostic and
setup imaging tool in the clinic. Nevertheless, the recent rise in the number of proton therapy
centers around the world is leading to a renewed interest in proton imaging. The use of proton
radiography in the clinic for daily set-up could present several advantages: a lesser imaging
dose to the patient than with conventional imaging {Depauw and Seco [26]), a single beam ’s
eye view {BEV) for both patient imaging and treatment, and a reduced amount of hardware
required in the treatment head. The use of a single beam ’s eye view ensures that there is no
possible discrepancy between the imaging isocenter and the therapeutic beam isocenter, and
in turn reduce the amount of quality assurance {QA) needed for the machine.
Moreover, the use of more advanced proton imaging such as proton computed tomography
{pCT), would result in a significantly more accurate knowledge of the proton stopping power
ratios in patient. This could further lead to a reduction in range uncertainties which would
translate into smaller treatment margins. It should be noted that, unlike conventional X-ray
radiographs which are simple fluence maps, proton radiographs carry some information about
the absorbed range in the patient and could potentially help reduce the range uncertainties as
well.
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The main disadvantage of proton radiography, compared to X-ray radiography, is its poor
intrinsic spatial resolution, as shown by Schneider and Pedroni [18]. Nevertheless, its higher
sensitivity to density variations would possibly present tumor localization advantages in specific
tumor sites {Depauw et al., Depauw and Seco [25, 26]). The sensitivity of proton radiography
to small density variations, as well as its theoretical use in the clinic, are being studied in this
work using Monte Carlo simulations. It should be noted that this work is based on ’’perfect”
detectors so that results do not suffer from any bias due to the current detector technology. 1

3.2
3.2.1

Proton radiography versus X-ray radiography
Simulations setup

This study was performed using the Monte Carlo toolkit GEANT4 version 9.2.p01 {Agostinelli
etal. [82]) with the physics settings described by Jarlskog and Paganetti [87]. Scanned proton
pencil beams {monochromatic and unidirectional) {PBS) were considered for this study and
set to different energies: 200, 300, 400, and 490 MeV. A double scattered beam {MGH DS)
at MGH’s highest deliverable energy {235 MeV) was also evaluated. The latter was gener
ated using the work by Paganetti et al. [6] in which the entire MGH nozzle was implemented,
including scatterers and the rotating range modulating wheel. In this case, the wheel was po
sitioned at its thinnest step, resulting in the narrowest energy spectrum at nozzle exit, with a
peak at 220 MeV. Furthermore, monoenergetic and unidirectional gamma X-ray beams were
simulated for comparison purposes. These consisted of 50 and 100 keV beams, as well as
1 and 2 MeV beams, imitating non-divergent planar sources of kV diagnostic X-rays and MV
therapeutic X-rays, respectively.
All beams were simulated covering a homogeneous 40 cm wide square area. It should be
noted that due to the absence of multiple Coulomb scattering in the X-ray beams, simulating
non-divergent fields slightly bias the results in favors of the X-ray beams. Likewise, the ab
sence of energy spectra {monoenergetic beams) causes a bias towards the X-ray results.
For each primary particle, energy, Cartesian coordinates, and direction cosines were then
recorded 1 cm in front of the phantom. Similar information was gathered for both primary and
1This work was published in numerous articles {Depauw et al. [25], Depauw and Seco [26], Seco and De
pauw [30], Seco et al. [31], Depauw et al. [27], Polf et al. [32], ? [? ]), and presented at various conferences
{Depauw et al. [28], Seco and Depauw [33], Depauw et al. [29], Dias et al. [34], Seco et al. [35], Seco et al. [36],
Spadea et al. [37], Spadea et al. [38]).
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secondary particles in a plane 1 cm behind the phantom. In order to associate the particles
in the rear plane and their incident parent in the fore plane, a track-ID number was assigned.
This process is shown in figure 3.1{a).
Fore plane

Rear plane

Figure 3.1: (a) Depiction of data required for radiographs reconstruction: incident particle position
(xin, yin, Zin) and direction fa d , and exit particle position (xout, Vent, zout) and direction (faout); P
shows the angle between the entrance and exit positions, A the angle between the entrance direction
and P, and C the one between the exit direction and the entrance direction. (b) Example of a cut in the
output data; in this case the green particle would be kept, the blue would be discarded.

As previously stated, this study does not take into account detector resolution in the image
quality in order to avoid any bias from the state of the art in detector technology.
A phantom was specifically designed for this study in order to compare the sensitivity of pro
tons versus X-rays for radiography purpose. The phantom, as seen in figure 3.2, was im
plemented as a water tank {30 x 30 x 8 cm3 or 30 x 30 x 15 cm3) with cylindrical inserts of
various sizes and material compositions. The composition data from the National Institute
of Standards and Technology {NIST) {Berger [88]) was used to implement air {0.001 g/cm 3),
lung type tissue {0.1-0.2-0.3-0.4-0.5-0.6-0.7-and 0.8 g/cm 3), adipose tissue {0.9 g/cm3), and
soft tissue {1 g/cm 3) inserts. The composition data for higher density bony-material {1.11.2-1.29-1.39-1.49-1.58-1.67-1.77-1.86-and-1.92 g/cm 3) was implemented based on for
mer data compiled from EGSnrc {Kawrakow and Rogers [89]). For each material, a total of
10 cylindrical inserts with similar thickness were modeled with increasing diameter, from 0.88
mm to 20 mm. The simulations were performed a total of 6 times per beam, for 2 water tank
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Figure 3.2: Designed phantom: 30 x 30 x 8 cm3 or 30 x 30 x 15 cm3 water volume filled with rows of
21 different materials with densities ranging from 0.001 g/cm 3 (Air - #1) to 1.92 g/cm 3 (Bony material
- #21). This figure was obtained using the GEANT4 visualization driver WIRED (Donszelmann [7]), and
then colorized with GIMP (GIMP [8]).

thicknesses {8 or 15 cm3) and 3 insert thicknesses {2, 4, and 6 cm).

3.2.2

Image reconstruction

Radiographic images in this work were generated using the Matlab™ 2008b commercial soft
ware {MathWorks [90]). The 40 cm2 area was reconstructed as 1024x1024-pixel images,
roughly corresponding to a 0.4 mm/px resolution. It should be noted that each radiograph’s
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quality was improved by the proper handling of their window and level, i.e. scaling of the gray
values in the images to efficiently use the color map {256 shades of gray).
X-ray radiographs are simple “fluence maps”: in each pixel, the imaged value is the number
of particles going through that specific pixel. The fore plane particle information was there
fore not used during this reconstruction process; instead, radiographs were generated from
a pixelated histogram of the output data {rear plane). A 2° angular cut in the output data was
performed in order to improved the image quality, mimicking an anti-scatter grid on an actual
X-ray system. The actual anti-scatter grid consists of a plate with narrow parallel slits. These
slits stop the bulk of the scattered component of the primary X-ray beam, only allowing for the
parallel component to pass through and reach the imaging panel.
Conversely, proton radiographs carry more information; they are “range/energy maps” : in
each pixel, the imaged value is the mean absorbed range Rabs, which corresponds to the
range in water of the mean energy loss E abs of all the particles going through that pixel. For
each particle, the energy loss is computed as the subtraction of the exiting energy {rear plane)
to the entering energy {fore plane), with the help of the track-ID number. The report 49 from
the International Commission on Radiation Units and Measurements {ICRU) {Allisy et al. [10])
was used to determined Rabs from E abs.
It should be noted that not all types of proton imaging detectors would be able to perform
such reconstruction since they do not all present the capacity to either get the incident parti
cles’ data or link this incident data to the output data. This study, however, was supporting a
project using a proton stopping power {dE) detector which would have such capabilities.
As discussed in Chapter 2, different reconstruction techniques exist for proton imaging. Com
plex algorithms such as “the most likely path“ tend to be more accurate since the protons do
not travel in a straight line within the patient. These techniques, however, rely on a homo
geneous medium which have yet to be validated in the patient. For this reason, this work
considered the reconstruction in the middle of a virtual straight line between the entrance
coordinates and the exit coordinates.
In order to reasonably compare the proton to the X-ray radiographs, it was necessary to have
both modalities on a similar ground. It was therefore decided to produce images based on
an approximate equivalent imaging dose, i.e. absorbed dose to the phantom. An estimation
of the absorbed dose was thence performed for each modality. Five million protons and fifty

3- Proton Radiography: feasibility studies ~ N. Depauw, PhD thesis, 2014 - CMRP, UOW

29

Figure 3.3: Normalized dose distributions for 100 keV X-rays and various proton energies. The filled
area under the curve corresponds to the normalized dose delivered during radiography for a 15 cm
thick phantom.

million X-rays were simulated through 30 x 30 x 8 cm3 or 30 x 30 x 15 cm3 water tanks, with
the integral energy deposited recorded. It was then possible to derive a relationship between
modalities to obtain equivalent simulations for different energies. For instance, fifty million 100
keV photons deliver the same absorbed dose to the 15 cm thick phantom as approximately
thirty thousand 200 MeV protons, or fifty-five thousand 490 MeV protons. As seen in figure
3.3, the large difference in the number of particles needed for protons vs X-rays is mainly
due to their respective dose deposition curve; in fact, the protons exit the phantom within the
plateau region, hence depositing most of their energy beyond it. The radiographic simulations,
based on twenty million histories, represent an absorbed dose of approximately 0.002 mGy
for a 200 MeV proton beam.

3.2.3

Effect of secondary protons

As previously discussed, protons sometimes undergo a head-on collision with an atomic nu
cleus in the medium they traverse (see section 2.2.1). These nuclear interactions result in the
primary particle transferring a large portion of its energy to a proton in the nucleus. This results
in the ejection of both particles with a large scattering angle. The energy of these particles is
unpredictable and does not carry the range information desired in proton imaging. Thus, this
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represents noise in the output image. In order to study the effect of such noise and how to
mitigate it, multiple radiographs were generated for each phantom set-up condition: one for
the raw data, one with a cut in the angular spread distribution, one with a cut in the output
energy spectrum, and one with both aforementioned cuts. The angular cut was set to dif
ferent values ranging from 0.1° to 2°, and, for each reconstruction, the best result was kept
for analyses. The energetic cut was set so that the lowest 1% of the cumulative energies
of the output spectrum was suppressed. These cuts corresponded to enhancements that
could easily be implemented in the reconstruction algorithm of an actual proton radiography
detector. An example of this is shown in figure 3.1{b).

Figure 3.4: Reconstructed 490 MeV proton radiographs for (a) primary protons only, (b) primary and
secondary protons, (c) primary protons with angular and energetic cuts, and (d) primary and secondary
protons with angular and energetic cuts. All images were optimized to use the full gray scale, hence
resulting in significant contrast difference.
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Figure 3.4 shows a set of four radiographs generated for a 200 MeV proton PBS beam sim
ulated through a 15 cm thick phantom with 4 cm thick inserts. These radiographs were
reconstructed using the raw data as well as after both energetic and angular cuts; they also
took into account either only primary particles or both primary and secondary particles. Fig
ures 3.4{a) and {b) clearly illustrate the noise created by the secondary protons. Furthermore,
figures 3.4{c) and {d) highlight the possibility to mitigate this significant affect by using the pro
posed cuts. Indeed, the difference image between figure 3.4 {c) and {d) {not shown here by
lack of interest) is close to null in every pixel.
Given this result, it was decided to proceed with realistic radiographs for all analyses thereafter,
i.e. considering both primary and secondary particles, and using both proposed cuts.

3.2.4

Spatial and density resolution

The spatial resolution can be defined as the minimum size {in mm) a region of interest {ROI)
must be in order to be resolved. In this study, the spatial resolution was obtained manually by
plotting profiles through the center of each material row {see figure 3.2) and determining the
smallest observable insert. An example is shown in figure 3.5. This process was performed
using the ImageJ software {Rasband [9]) version 1.42q on a Linux system; no automated
batch script was used, consequently, the entire analysis was performed by a single person in
order to avoid inter-user discrepancies. Additionally, the analyses were ran separately to avoid
bias from previous results. This was done to ensure integrity among results and allowing for
fair comparisons.
It should be noted that the spatial resolution could have been obtained through the determina
tion of modulation transfer functions. Although it would have been theoretically feasible, such
an analysis would have been difficult to perform due to the presence of multiple densities per
image. If performed, each line of inserts with a given density would need to be sliced out of
the image, leaving very limited information for the smaller elements, and thus jeopardizing the
accuracy of the analysis.
The result of this analysis for different beam energies and types is shown in figure 3.6. It can be
noted that a more energetic proton beam results in slightly improved spatial resolution. This is
explained by the relative reduction in multiple Coulomb scattering as the protons travel through
a phantom of similar thickness. Although this result is not clinically significant, there are other
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D is ta n c e (pixels)

Figure 3.5: Plotted profile through the air insert row (p =0.001 g/cm3) of a 490 MeV PBS proton
beam radiograph using the ImageJ software (Rasband [9]) version 1.42q. The spatial resolution can
be determined as the smallest visible insert, # 9 in this instance, hence corresponding to a 1.25mm
spatial resolution.

benefits of using a more energetic beam such as a significant reduction in imaging dose, as
well as the possibility to image larger patients due to the deeper penetration properties of the
beam.
While the MGH double scattered beam (MGH DS) and the 200 MeV proton pencil beam (PBS
200 MeV) present similar initial energies, the latter offers far better spatial resolution. This
can be explained from the the beam generation. Indeed, the MGH DS field was produced
through scattering processes in the nozzle which resulted in a large initial energetic and angular
spreads of the beam at the phantom entrance; the PBS 200 MeV field, on the other hand, was
simulated as purely monochromatic and unidirectional. It should be noted that an actual PBS
beam would present a certain initial angular spread due to its virtual point source. However,
since the location and size of this virtual source are known machine parameters, the presented
results are appropriate. Furthermore, this large initial energetic and angular spread in the MGH
DS beam merely results in a considerably larger number of particles being cut during the
radiograph generation. Considering a much larger number of initial particles would certainly
result in a spatial resolution close to the one observed for the PBS 200 MeV beams.
The spatial resolution for all protons beams is very stable against density, « 2-3 mm for any
densities greater than 0.1 g/cm 3 to water (background). In order to further assess how far
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Figure 3.6: Spatial resolution for radiographs generated with different beams: 200, 300, 400, and 490 MeV scanned proton pencil beams, the MGH
double scattered proton beam (~230 MeV), and 50 keV, 100 keV, 1 MeV, and 2 MeV X-ray beams. These were obtained using comparable absorbed
dose in a 15 cm thick phantom and 4 cm thick inserts.
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materials could be resolved using proton beams, a modified phantom with similar geometry
was ran, but with 21 materials of densities ranging from 0.9 to 1.1 g/cm 3. These materials
presented identical composition based on the striated muscle data published in the ICRU-49
report (Allisy et al. [10]); only their density was modulated. The striated muscle material was
chosen for its density of p =1.04 g/cm 3, similar to the density of most tumors.
The close-up in figure 3.6 highlights the results obtained for this modified phantom. It was
thus found that, in the best case scenario (i.e. the most energetic pencil beam - 490 MeV),
the largest insert (2 cm) could be resolved for any densities greater than 0.02 g/cm 3 to that of
the background. For insert with densities significantly different than that of their background
(in the given case, p < 0.6 g/cm 3 or p >1.5 g/cm 3, i.e. lung and bony tissues versus water),
conventional X-ray radiography shows better spatial resolution (sub-millimeter) than proton
radiography for equivalent imaging dose. This is to be expected due to the intrinsically poor
spatial resolution of proton radiography caused by multiple Coulomb scattering (MCS), as
stated by Schneider and Pedroni [18]. For water density equivalent materials, X-ray operates
poorly, emphasizing the poor density resolution of X-rays versus protons. There is no sub
stantial difference in spatial resolution from using a 50 keV beam versus a 100 keV beam. On
the other hand, switching to a 1 or 2 MeV beam, i.e. similar to a therapeutic beam on a portal
imaging device (PID), translates to a drastic loss in spatial resolution for similar imaging dose. It
is worthy to mention that in a clinical context, both kV and MV X-ray radiography would present
a remarkably better performance (sub-millimeter resolution for kV) for a much broader range
of densities. This discrepancy is explained by the relatively low number of particles simulated
in order to preserve the consistency in imaging dose; an actual imaging X-ray source would
deliver a significantly higher dose, hence a larger number of particles (see section 3.2.2).
The spatial resolution was also studied as a function of the thickness of both the phantom and
material inserts. The results for a 200 MeV proton PBS beam are shown in figure 3.7. The
spatial resolution greatly improves as the material insert’s relative thickness increases. This
is expected due to the increase in interactions with a relatively larger insert. Thus, the best
spatial resolution, 0.9 mm, is observed for an 8 cm thick phantom and 6 cm thick inserts. This
further emphasizes the protons’ sensitivity to density variations.
It might be expected to observe similar spatial resolutions for equivalent phantom/insert thick
nesses ratio. This, however, did not occur; for example an 8 cm thick phantom with 2 cm

3- Proton Radiography: feasibility studies ~ N. Depauw, PhD thesis, 2014 - CMRP, UOW

35

Figure 3.7: Spatial resolution as a function of material density for various thicknesses of phantom and
material inserts: a 8 or 15 cm thick phantom with 2, 4, or 6 cm thick material inserts. The results shown
are fora 200 MeV proton PBS beam. Similarly to the previous results, these were obtained considering
a similar absorbed dose for a given phantom thickness.

thick inserts versus a 15 cm thick phantom with 4 cm thick inserts yielded 0.9-1.8 mm versus
1.8-2.5 mm, respectively. This disparity is due to the difference in MCS contribution while
traveling through the phantom. Indeed, the geometrical aspect of the MCS’s Gaussian distri
bution (see section 2.2.1) will result in a larger spread of the beam while traveling through a
relatively larger medium (as defined in water equivalent depth). For a given relative insert thick
ness, an 8 cm thick phantom therefore results in a smaller spread of the beam than a 15 cm
thick phantom, hence deteriorating the spatial resolution. Similarly, a more energetic beam,
i.e. greater velocity of the protons, results in a smaller spread in the exit plane compared to
a less energetic beam. This further translates to better spatial resolution. This is illustrated in
figure 3.6 with the results for a 490 MeV beam compared to a 200 MeV beam.
The spatial resolution for proton radiography observed in this work was in the order of 1 to 2
mm. This is slightly larger than the 1 mm spatial resolution observed in the literature for stud
ies that used MLP techniques during radiograph reconstruction (Schneider and Pedroni, Li
et al., Schulte et al. [18, 5, 79]). As previously discussed, these MLP techniques were de
veloped for homogeneous phantoms. In largely heterogeneous mediums, such as a patient,
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the accuracy of those techniques have not yet been demonstrated, especially for radiography
(single projection) purpose. For this reason, it was decided to only consider simpler recon
struction techniques. This, however, means that more complex reconstruction algorithms
taking heterogeneities into account - possibly using the diagnostic X-ray planning CT scan could show an improvement in the presented results.

3.2.5

Contrast-to-noise ratio

The contrast-to-noise ratio (CNR) is the most important parameter in radiotherapy imaging. It
essentially represents the difference in signal-to-noise ratio (SNR) between a region of inter
est (ROI) and its surrounding background. In other words, clinically, the CNR quantifies the
ability to distinguish a tumor from its surrounding healthy tissue. The CNR is defined below in
equation 3.1.

Where f is the mean signal value in the region of interest, b is the average background noise,
and <jf,b their respective standard deviations. Due to the low statistics in smaller ROI, the
standard deviation in the ROI a f was substituted by the standard deviation of the background
signal ab; this is appropriate as the latter is a surrogate for the noise in the system as a whole.
CNR was therefore evaluated for each visible cylinder (as defined by the results in the pre
vious section) for various beam energies and type for all studied densities. For consistency
purposes, the ROI size for the first insert (2 cm diameter) was set to a circle of 45 pixels in di
ameter. Each following insert’s ROI was then divided by two (diameter divided by \/2), hence
matching the trend of the insert’s size themselves.
Due to the excessive amount of data, it was not feasible to report CNR values for each mate
rial in all phantom/insert thickness configurations. Thus, we chose to focus on three materials
of distinct densities: air (p =0.001 g/cm 3), a soft tissue with density close to water (p =0.9
g/cm 3), and a higher density bony material (p =1.58 g/cm 3). The analysis was performed for
proton radiographs using all available PBS beams (200 to 490 MeV) for the different phan
tom/insert thickness ratios. The results for a 15 cm thick phantom with 4 cm thick inserts
are shown in figure 3.8. Additionally, the theoretical local contrasts between those three ma
terials and their water background was computed based on the mass stopping powers of
these monoenergetic proton beam as l l / p dEE''

d EdxXd backsround1, as seen in table
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3.1. The mass stopping power data was obtained from NIST (Berger [ 88]). This table high
lights the fact that local contrasts are almost independent of proton energy. Nevertheless,
figure 3.8 shows an improvement in CNR as a function of energy for those tissue equivalent
materials. This is due to 1) the greater number of particles simulated for a higher energetic
beam in order to obtain similar imaging dose, and 2) the larger spreading angle through the
medium of the lesser energetic beam due to MCS, as previously discussed. A more ener
getic beam and/or less material to travel through then translates into less spreading of the
output signal, hence better CNR. Thus, following expectations, CNR increases with a thinner
phantom and/or thicker inserts; this result is not shown here. For any material densities, the
signal in the smaller inserts (< 3 mm) becomes too close to that of the water background and
the CNR rapidly deteriorates. Similarly, CNR are better for densities greatly different than 1
(background).
- f— Reference PBS-200MeV -15 cm phantom - 4 cm inserts
PBS-300MeV
PBS-400MeV
PBS-490MeV

0.001 g/cm3

0.9 g/cm3

1.58 g/cm3

Insert diameter (mm)

Figure 3.8: Contrast-to-noise ratio (CNR) of proton radiographs for 3 different densities (0.001, 0.9,
and 1.58 g/cm3) using various scanned pencil beam energies.
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Table 3.1: Theoretical local contrasts between different materials and water (background) for four proton beam energies (200, 300, 400, and 490 Me V).

A comparison of CNR between a 200 MeV proton PBS radiograph, a kV X-ray radiograph,
and an MV X-ray portal image is shown in figure 3.9. These radiographs were generated with
similar imaging dose. CNR values are very good for protons for low and high density regions
(p < 0.6 g/cm 3 or p >1.5 g/cm 3), better than conventional X-rays. Nevertheless, as previously
discussed, clinical X-ray images would present significantly higher CNR values due to the
higher imaging dose (number of particles). The medium density region (0.6 g/cm 3 < P <1.5
g/cm 3) could not be resolved using X-rays, whereas protons present acceptable CNR values.
This further supports the greater density resolution of proton radiography as compared to
conventional X-ray radiography for a similar absorbed dose. Protons offer better visualization
of density variations and could therefore provide more distinct delimitation of specific tumors’
edges. Analogous to the spatial resolution results, an MV X-ray therapeutic beam results in
far worse CNR than a diagnostic kV unit. Thus, reducing tumor localization compared to kV
imaging.

Figure 3.9: Contrast-to-noise ratio as a function of material density and insert size for radiographs
generated with a 200 MeV proton PBS beam, a pure 100 keV X-ray beam and a pure 2 MeV X-ray
beam, for similar absorbed dose. The hatched area reflects the range of densities for which no insert
could be resolved for the specific modality.
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3.3

Patient studies

Proton radiography, compared to conventional radiography, is promising for clinical use due
to its lower imaging dose and greater density resolution.

Indeed, higher imaging dose in

pediatric patients undergoing conventional X-ray radiography can result in dramatic effects
for the patient, such as abnormal growth or the risk of future malignancies [17]. The use of
proton imaging, however, could help mitigate these effects due to the lower imaging dose.
Furthermore, for patients with moving tumors, proton treatment delivery could be enhanced
using proton radiography as a tool for tumor tracking.
Thus, the following work focuses on patient cases in order to confirm the imaging capabilities
of proton radiography, as well as to look into image guided proton radiation therapy (IGPT)
based on lung and liver cases. This work was complemented by evaluating the use of carbon
ions for patient imaging due to their similar physical properties and further intrinsic imaging
qualities (reduced MCS component compared to protons).

3.3.1

Simulations setup

A stage IIIA non-small cell lung cancer (NSCLC) patient was sought out in order to confirm the
previous results on imaging quality. Additionally, a pediatric case consisting of a 3 1/2 year old
patient who had a whole body CT scan was considered. In order to assess the possibility of
IGPT using direct tumor tracking, the patient cohort was comprised of two adult cases with
lung cancer: a female patient presenting a tumor in the lower region of the right lung with
significant motion amplitude («1 cm), and a male patient with a tumor in the upper region of
the right lung with smaller motion amplitude (^0.5 cm). Finally, a third adult liver case with
fiducial markers was considered in order to investigate IGPT using indirect tumor tracking.
Similarly to the previous phantom study, the Monte Carlo toolkit GEANT4 version 9.2.p01
(Agostinelli et al. [82]) was used with the physics settings described by Jarlskog and Paganetti [87]. Except for the initial NSCLC patient study, scanned pencil beams (monochro
matic and unidirectional) of 230 and 330 MeV protons, as well as 500 MeV/nucleon carbon
ions, were simulated covering a 40 cm2 homogeneous area. For the former NSCLC study,
proton radiographs were simulated with 230 and 490 MeV beams in a 30 cm circular field.
On average, twenty million histories (primary particles) were simulated to produce proton and
carbon ion radiographs. For each patient, CT scans were acquired on a GE LightSpeed QX/i
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with 2.5 mm slices made of 512 x 512 pixels. In the case of the lung and liver patients, 4D
CT data sets comprised of the 10 breathing phases were each considered in order to eval
uate the effect of tumor motion. The CT data was imported into the GEANT4 code through
a Hounsfield unit (HU) to material conversion based on the work first described by Paganetti
etal. [84]. Although this original method described a conversion using 24 distinct tissue defi
nitions with 24 densities, the implementation utilized in this work was based on an improved
conversion using the same 24 tissue definitions but with a total of 4,071 distinct densities.
This conversion therefore allows for accurate computations of particle interactions within the
patient.
The energy, Cartesian coordinates, and direction cosines were recorded for each primary par
ticle crossing a plane 1 cm before the patient, as well as for each primary and secondary ion
crossing a plane 1 cm behind the patient. Atrack-ID registration parameter was used in order
to correctly associate output and input particles. This patient simulation setup is presented in
figure 3.10.

Figure 3.10: Proton radiography patient simulation setup designed in the GEANT4 MC toolkit based
on the patient CT scan converted to material definitions. E0, (x0, y0, z0), and (u0, v0, w0) represent
the initial particle’s energy, position, and directions respectively, while Ei, (xi, y i, zi), and (ui , vi, wi)
represent similar parameters for the exiting particle.

Ion radiographs in this study were reconstructed with an algorithm similar to the one presented
in section 3.2.2. Apart for the initial NSCLC case, pictures in this study were reconstructed as
1024 x 1024 pixel images corresponding to a 0.4 mm/pixel resolution. Energetic and angular
cuts were also applied in order to obtain the most visually appealing images in which tumor
location could be appreciated at its best. For patients with 4D CT data (lung and liver), an ion
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radiograph was produced for each phase of the breathing cycle, and an animated sequence
was subsequently generated in order to fully evaluate the tumor tracking capabilities.
CNR values were computed between the tumor and various surrounding tissues based on
equation 3.1, in order to evaluate the tumor visualization quality. These analyses were per
formed using the ImageJ software (Rasband [9]) version 1.46a, except for the earlier NSCLC
study for which version 1.42q was used.

3.3.2

Lung patients

3.3.2.1

Im age q u a lity

A side by side comparison of an actual kV X-ray CT scout and the simulated proton radio
graphs for the selected NSCLC patient is shown in figure 3.11. It should be noted that, unlike
the previously presented phantom study, no absorbed dose equivalency between X-ray and
protons was performed. The Health Physics Society’s recommendations, as well as inde
pendent studies, suggest that a conventional chest X-ray delivers approximately 0.02 mSv
to a patient (Society, Walter et al. [91, 92]), an order of magnitude larger in comparison with
the simulated radiograph. Thus, this translates into a bias toward the X-ray quality due to
the significantly larger imaging dose. It does not, however, impair these results from drawing
appropriate clinical judgments.

Figure 3.11: (a) Actual kV X-ray scout and simulated (b) 230 MeV and (c) 490 MeV proton PBS beam
radiographs for a selected patient with NSCLC. The numbered squares in b) correspond to the selected
areas for which CNR versus the tumor (region 3) were compared.

Spatial resolution is difficult to quantify in images generated from highly heterogeneous medium
such as patients; it was thus decided to evaluate the spatial resolution only through visual in
spection. The X-ray scout offers a noticeably better spatial resolution, as highlighted by the
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superior edge detection in certain tissues such as the vertebraes and the clavicular bones.
As previously discussed in section 3.2.4, the poor spatial resolution is an intrinsic limitation of
proton radiography due to the MCS component of the beam. Matching expectations, a more
energetic proton beam (490 MeV radiograph compared to 230 MeV image) results in a higher
spatial resolution due to the smaller scattering angle of the beam.
Figure 3.11(b) shows 7 ROI within the lung and bony tissues surrounding the tumor (ROI #3).
CNR between these various background ROI and the tumor were computed. The results are
presented in table 3.2.
actual kV X-ray scout
ROI #

200 MeV proton radiograph

490 MeV proton radiograph

Signal Mean

Std Dev

CNR

Signal Mean

Std Dev

CNR

Signal Mean

Std Dev

CNR

1

42.1

8.2

12.0

69.5

2.2

19.3

64.3

3.7

20.8

2

41.4

7.5

12.6

90.9

4.3

10.6

85.3

8.2

12.6

3

82.1

5.9

-

110.6

3.9

-

124.2

4.0

-

4

58.4

8.0

7.6

57.3

3.1

20.6

52.1

3.8

22.3

5

30.6

4.8

16.6

50.4

2.4

22.4

44.3

3.9

23.1

6

120.0

2.6

15.4

141.2

3.2

15.7

169.9

4.5

17.6

7

133.0

5.8

15.8

214.6

6.1

23.2

231.4

4.7

24.8

Table 3.2: CNR values between different ROI and a tumor background (ROI #3).

The use of protons for lung tumor imaging results in higher CNR than using conventional Xray radiography due to their higher density resolution, and furthermore, at a fraction of the
patient absorbed dose. This confirms our previous findings and signifies a clearer tumor edge
definition in proton radiographs, despite the greater spatial resolution in the X-ray scout image.
This further emphasizes the possibility for using proton imaging for lung patient setup. An
additional benefit, as further discussed in the pediatric case study (see section 3.3.4), is the
use of a unique beam’s eye view for both the imaging beam and the therapeutic beam.
These results led us to further look into the possibility of using proton imaging for direct tumor
tracking in lung cancer patients.
3.3.2.2

D irect tu m o r tra c k in g cap a b ilitie s

Figure 3.12 shows reconstructed sequences of the male lung tumor case for 230 MeV and
330 MeV proton beams, as well as for a 500 MeV/nucleon carbon ion beam.
CNR were also evaluated between the tumor and its direct surrounding tissues, as previously
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Figure 3.12: Reconstructed 4D radiograph sequences through a lung tumor patient breathing cycle
for radiograph with (a) a 230 MeV proton pencil beam, (b) a 330 MeV proton pencil beam, and (c) a
500 MeV/nucleon carbon ion pencil beam. Please note: These sequences must be visualized using
a PDF reader software with sequence display capabilities such as Adobe Acrobat™ in order to fully
appreciate the motion.

described in the static lung study. In this case, the average of values in ROI similar to square 4
and 5 in figure 3.11 was chosen, corresponding to surrounding lung tissue. CNR values were
4.7 dB, 6.1 dB, and 9.3 dB for figure 3.12(a), 3.12(b), and 3.12(c), respectively.
As predicted, the tumor edges are clearly defined on each of these radiographs.

Higher

proton energies not only result in higher spatial resolution due to the relatively lower MCS
effect of the beam, but also result in higher CNR which translates into significant improvement
of tumor edge detectability. Imaging of the tumor could therefore be performed concurrently
to the radiation treatment as long as the accelerator’s output energy can quickly be modulated
accordingly. While this would not apply to current cyclotron-based ion centers, this would be
feasible with a synchrotron-based delivery system. Such system would therefore result in a
proton ”gated” delivery based on direct tumor tracking. The greater tumor edges’ sensitivity
of the more energetic beam transcribes to greater IGPT capabilities, while delivering lower
imaging dose to the patient, and offering the possibility for imaging thicker patients.
A carbon ion beam undergoes much smaller deflection than a proton beam, hence resulting in
drastic imaging improvement. This highlights the excellent opportunity offered by ion beams
for IGPT with direct tumor tracking.
A comparison of 330 MeV proton radiograph sequences generated for both aforementioned
lung patients is shown in figure 3.13.
Computed CNR are 4.9 and 6.1 for radiograph 3.13(a) and 3.13(b), respectively. The differ-
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Figure 3.13: Reconstructed 4D radiograph sequences for two lung cancer patients: (a) a female case
and (b) a male case. These radiographs were generated based on 330 MeV proton beam simulations.
The tumor edges are clearly defined, and the tumor center position is shown by an ”X” mark. The
tumor motion amplitude is further highlighted with the lines. Please note: These sequences must be
visualized using a PDF reader software with sequence display capabilities such as Adobe Acrobat™ in
order to fully appreciate the motion.

ence in CNR, as well as overall visual quality, is easily explained by the differences in patient
anatomy. Patient (a) is a large female presenting a large breast which contributes to a signifi
cant deterioration in the proton beam; conversely, patient (b) is a slender male which translates
to greater imaging capabilities due to MCS. This discrepancy further highlights the advantage
of using a more energetic beam which would not deteriorate through various patient anatomy
as significantly as observed in this study. Although the tum or’s amplitude of motion, size, and
location varies greatly among these two cases, both images result in clear tumor delineation
and clear appreciation of tumor motion (^0.5 cm in the female case and «1 cm in the male
case). Thus, direct tumor tracking could be used for IGPT in a large cohort of lung cancer
patients with distinct tumor specifications. The large difference in tissue density between the
tumor and its surrounding tissues in the case of lung patients is an important factor in these
results. In order to further assess the limit of IGPT possibilities, we further looked at a liver
case for which the tumor and its surrounding tissue present very similar densities.

3.3.3

Liver patients - indirect tumor tracking

Tumor delineation is significantly more complex in liver patients than it is in some other sites
due to the close proximity in densities between the tumor (^1.04 g/cm 3) and its surrounding
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tissues (^1.06 g/cm 3). For this reason, it is common practice to surgically add fiducial markers
(gold seeds) in predefined locations around the tumor for delineation and setup purposes.
When visually resolvable, these markers can further be used for indirect tumor tracking in ion
therapy.
Figure 3.14 shows a side by side comparison between radiographic sequences generated
with a 330 MeV proton beam and a 500 MeV/nucleon carbon ion beam through a liver patient
4D CT. The fiducial markers were 1.2 mm in diameter and 5 mm in length. The 230 MeV
proton radiography sequence is not displayed here by lack of interest, as further discussed.
The CNR between the tumor and its surrounding tissue were evaluated at 0.06 dB, 0.09 dB,
and 0.44 dB for the 3 beams, respectively. These very low values further highlights the difficulty
in detecting the tumor’s edges.

Figure 3.14: Reconstructed 4D radiograph sequences through a liver tumor patient breathing cycle
using (a) a 230 MeV proton pencil beam, (b) a 330 MeV proton pencil beam, and (c) a 500 MeV/nucleon
carbon ion pencil beam. Please note: These sequences must be visualized using a PDF reader software
with sequence display capabilities such as Adobe Acrobat™ in order to fully appreciate the motion.

In the presented case, two fiducial markers were surgically inserted before CT. These markers
are not visible on a 230 MeV proton radiograph, which makes such beam irrelevant for liver
imaging. A 330 MeV radiograph, however, allows visualization of a single seed that is not
located in-line with the spine (large bony anatomy). On the other hand, both seeds are clearly
visible on the carbon ion radiograph. These markers have been contoured on the radiographs
in figure 3.14, with their amplitude of motion characterized between the lines. The difference
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in marker visibility followed the expectations based on the difference in MCS component be
tween these beams. Thus, a lower energy proton beam (< 250 MeV) would not be suitable
for liver patients setup and/or indirect tumor tracking. On the other hand, depending on the
location of the seeds, a higher energy beam (> 300 MeV) would be appropriate for marker
tracking. In such a case, the fiducial markers could specifically be surgically inserted away
from the spine. Nonetheless, image guided ion therapy using indirect tumor tracking would
only be feasible by using heavier ions, such as carbon. The intrinsically greater spatial reso
lution of heavy ions compared to protons, truly allows for a visualization of the gold seeds, as
well as accurate tracking of the tumor position.

3.3.4

Pediatric patients

An actual kV X-ray scout (120 kV - 10 mA - 0.597 mm x 0.545 mm voxel size), as well as a
reconstructed 230 MeV proton radiograph for the 3 l/2 year old pediatric patient are shown
in figure 3.15. Computed CNR for the scout and the radiograph were 4.2 dB and 2.0 dB,
respectively. As previously observed in the lung case, the X-ray scout results in a higher spatial
resolution than the proton radiograph. In spite of this quality difference, bony anatomy is still
clearly visible in the ion radiograph. Proton imaging could therefore allow for accurate daily
patient setup, along with a drastic diminution in imaging dose as previously discussed (order
of magnitude versus X-ray imaging). This is of particular importance in pediatric patients for
whom a small dose of radiation can lead to irreversible damages. Moreover, it is not believed
that significantly increasing the number of incident particles (hence the imaging dose), for ion
radiographs would result in a dramatic improvement in image quality.
Furthermore, the use of a single BEV for both imaging and therapeutic purpose would reduce
systematic shifts due to uncertainties in BEV positions. This is not necessarily relevant in
passive scattering irradiation for which the whole volume is treated at once given well-defined
aperture edges which can be visualized on prior setup X-ray radiography. Conversely, this
can be more problematic during PBS irradiation for which the dose is deposited one layer at
a time, with a beam position that potentially changes.
Similarly to the previously presented lung case , these findings can be extended to heavy ion
therapy, such as carbon ions, due to their intrinsically similar physical properties.
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Figure 3.15: (a) Actual kV X-ray scout, and (b) 230 MeV proton radiograph of a 3 x/2 year old pediatric
patient.

3.3.5

Study limitations

It is important to note that these patient studies suffer from a few limitations. Reconstructed
patient radiographs present an advantage over actual proton imaging system due to the cur
rent state-of-the-art in detector technology. In this sense, this work presents the best achiev
able results. On the other hand, the number of imaging particles could be increased in order to
improve the signal statistics in an actual detector. Of course, such tweak would come at the
cost of extra imaging dose, but, in that sense, the results presented in this work are clinically
viable.
Furthermore, the use of an actual X-ray CT scan vastly impacts the quality of the simulated ion
radiographs. Not only are there small uncertainties in the Hounsfield unit values obtained from
a CT scanner (^2%) as well as in the material conversion in the GEANT4 MC code (^2%),
but the CT produces a discrete data set, in this case 2.5 mm slices, which greatly impacts
the optimal output quality. An ion radiography system used on actual subjects could very well
yield different results than the ones observed in this work. This is of particular importance in
the liver cancer patient case for which the small fiducial markers might become visible at lower
proton energies, with potentially greater edge detection.
Concerning the 4D studies, the patient was considered instantaneously imaged through each
single phase of their breathing cycle. While this is believable from a technology stand point, as
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the delivery of a single high energy pencil beam layer is in the order of a ms (machine specific),
one can foresee interplay effects between the beam motion and the patient internal motion.
Nonetheless, these effects have yet to be characterized even from a therapeutic dose delivery
point of view, and were therefore ignored.
Some readers might also see a limitation in this work in regards to using higher energy proton
beams (> 250 MeV) compared to the commercial availability at the time of redaction. Never
theless, none of the current systems offer ion imaging capabilities; this work was based on the
prospective use of near-future systems that will offer both higher energy beams and imaging
capabilities , such as Protom™’s Radiance 330 system.

3.4

Conclusion

The emergence of proton and heavy ion therapy centers has spurred a renewed interest in ion
imaging. In this work, the imaging properties of proton radiography have been characterized
and compared against conventional kV and MV X-ray imaging through MC simulations using
a specific phantom. This study confirmed the known intrinsic limitations in spatial resolution
of proton radiography due to the large contribution of multiple Coulomb scattering. It was
shown in figure 3.9, however, that proton radiography offers significant improvement in density
resolution over X-ray imaging, giving the ability to detect inserts with densities closely related
to the density of their background (up to 0.02 g/cm 3 density difference).
Such theoretical results were further analyzed in a clinical framework by comparing actual
patient X-ray images with simulated ion radiographs. The large difference in density of the
tumor and its surrounding tissues in lung cancer patients proved to be of greatest interest for
proton imaging. Not only does the clear delineation of patient anatomy and tumor position
allow for accurate setup, but it also results in the possible use of image guided proton therapy
through direct tumor tracking. Furthermore, the use of a single beam for both imaging and
treatment significantly reduces the potential discrepancies in BEV position.
The use of ion imaging would also significantly reduce the amount of imaging dose. This is
of particular relevance for pediatric patients, as even a small amount of imaging dose can be
detrimental. As a rather low energy proton beam for imaging (230 MeV) already offers bony
anatomy detection, this modality would be suitable for patient setup.
Proton radiography somewhat finds its limitation in a more homogeneous tumor location, such
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as the liver. In such a case, the use of proton imaging for patient setup and/or tumor tracking
is questionable. Conversely, heavy ion beams present a lower MCS component resulting in
greater imaging quality. This further translates to the possible use of heavy ion radiography for
patient setup and IGRT with direct or indirect tumor tracking, even in homogeneous patient
anatomy such as the liver.
Additionally, it is believed that ion radiography, despite its unique projection angle, carries
range information that could be further used to reduce range uncertainties and treatment
margins. More investigative work, however, is needed to accurately answer this hypothesis.
Withal, such findings on ion imaging seem fruitless without an actual radiography detector. As
a consequence, the conception of a clinically viable proton imaging system was proposed.
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Chapter 4

Proton Radiography: experimental
realization
4.1

Introduction

Ion imaging could improve patient’s daily setup prior to proton therapy as well as potentially of
fer some IGPT properties, as previously demonstrated in chapter 3 . Based on those theoretical
results, the investigation of a clinical proton radiography system was initiated. As introduced in
section 2.3, prior experimental realizations of a proton radiography system have been carried
out using either (a) scintillating tiles (hodoscopes), (b) gas electron multipliers (GEM) detec
tors, or (c) silicon strip detectors (Schneider and Pedroni [18], Schneider and Pedroni [19],
Schneider et al. [3], Sauli [20], Pemleretal. [4], Johnson etal. [21], Talamonti et al. [22], Sipala
et al. [23]). A first breakthrough was performed in 2004 by Schneider et al. [3], in which the
world’s first actual proton radiograph of an animal patient was presented. In this experiment,
the detector consisted of hodoscopes and a range telescope to acquire the position and the
remaining energy. The system was so inefficient that it took hours to obtain the radiograph
(the dog was anesthetized), therefore resulting in a dramatically large amount of imaging dose
as compared to our theoretical results. Thus, this system was totally inviable for clinical use
with patients due to both its inefficiency and its bulkiness.
This work was intended to design a clinical proton imaging system that would present both a
small form factor and adequate accuracy in position and energy resolution. Three distinct ap
proaches were therefore considered in order to acquire both particle position and energy on a
particle-by-particle basis: photonic bandgap fibers (PBG fibers), complementary metal-oxide

4- Proton Radiography: experimental realization ~ N. Depauw, PhD thesis, 2014 - CMRP, UOW

52

semiconductors (CMOS), and scintillating fibers. 1

4.2

A novel approach

Current proton imaging systems are unable to acquire both positioning and energy informa
tion simultaneously, resulting in larger systems. The system could therefore be reduced by
acquiring particle-by-particle information in simple planes in front and beyond the patient. The
reconstruction of such radiographs would then be performed as described in section 3.2.2.
Such novel approach is represented in figure 4.1.

Figure 4.1: Depiction of a clinical proton radiography system, small and functioning on a particleby-particle basis. E0, (x0, y0, z0), and (u0, v0, w0) represent the initial particle’s energy, position, and
directions, respectively. Similarly, E1, (xx, y 1, z1), and (u1, v1, w1) represent the energy, position, and
directions of the exiting particle.

The main challenges of such a system are speed, efficiency, and resolution (both spatial and
energetic). In order to optimize the imaging system’s efficiency, the read-out system would
have to match the output current of the machine, thus operating on a particle-by-particle basis.
Unfortunately, the typical therapeutic output of a proton accelerator is in the order of thousands
of gigaprotons per seconds. For imaging purposes, this rate should be limited as much as
possible, but usually remains extremely high due to machine output capabilities. At MGH, for
1This work was published in Polf et al. [32] and Seco and Depauw [30], as well as presented at various con
ferences (Depauw and Seco [39], Depauw and Seco [40], Seco and Depauw [33], Goulet et al. [41], Koybasi
et al. [42]).
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instance, the lowest available beam rate would correspond to a couple of gigaprotons per
second. Given the cyclotron’s duty cycle (« 10 ns), this represents a couple of protons in
each cyclotron pulse (« 3 ns) every 10 ns. This further translates into the need for a read
out system presenting Gigahertz bandwidth and capable of Gigasamples/s sampling rate.
This is a major consideration for the system design since this type of electronics presents a
remarkable cost. Conversely, a synchrotron-based center could offer far smaller beam rates.
The efficiency of the system would therefore be largely based on its speed capabilities, and
dictate the improvement in imaging dose compared to current clinical systems.
The accuracy of the imaging system will be based on its spatial and energetic resolution.
Depending on the system’s design, these specifications could either be independent or closely
tied one to another. In this sense, protons’ intrinsic limited spatial resolution (due to MCS)
would actually be helpful since spatial resolution could be slightly compromised at the benefit
of a higher energetic resolution.
Based on these considerations, the three aforementioned routes were pursued. The following
section describes the detector technology as well as the necessary read-out electronics that
was utilized for experimental testing.

4.2.1

Photonic bandgap fibers

Extensive knowledge in fiber design and manufacturing exists at the Massachusetts Insti
tute of Technology (MIT), which resulted in their development of fibers that confine light into
a hollow core, the so-called Photonic Bandgap (PBG) fibers (Kuriki et al. [93]). These fibers
have previously been made from arrays of air holes in a solid dielectric, as well as from pairs
of solid materials forming multilayer structures (Yeh et al., Cregan et al., Allan et al., Eggleton
etal. [94, 95, 96, 97]). PBG fibers were then improved with the integration of distinct functional
elements and the development of intelligent self-monitoring optical fibers(Bayindir et al. [98]).
Metal-insulator-semiconductor photo-detecting fiber devices were further produced based
on these previous improvements. Such fiber consisted of an inner polymer tube made of
polyethersulfone (PES) or polycarbonate (PC), supporting a thin film of photo-conducting el
ement contacted with four metallic tin conduits. The inner tube is encapsulated by polymer
cladding which leaves its strength and flexibility to the fiber (Sorin et al. [99]). Figure 4.2 shows
a schematic drawing as well as a scanning electron microscope (SEM) micrograph of both
the cross and longitudinal sections of the PBG fiber.
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Figure 4.2: (a) Schematic cross-section of a thin-film fiber device showing the electrical connections
to an external circuit; SEM images of (b) cross section and (c) longitudinal section of the thin-film fiber
device (the thin film is not visible in the longitudinal section).

The original assumption behind the consideration of such fiber for proton imaging was that, by
irradiating the fibers, the creation of electron-pair holes in the electrodes would generate a local
current that could be recorded. Such scenario would then permit the acquisition of a signal for
individual protons crossing the fiber. After initial experiments and subsequent brainstorming, it
was decided that it would be more appropriate and effective to fill the fiber’s hollow-core with
signal-enhancing material (”dope”). It was therefore suggested to add scintillating material
inside the fiber. The photo-electrons would then generate a stronger signal in the electrodes
that would be readable with an appropriate electrometer. In this work, the scintillating materials
considered were cesium-iodine (CsI), an inorganic scintillator known for its relatively high light
yield (« 50,000 photons/MeV), and BC-517 (Saint-Gobain Crystals™), an organic scintillator
known for its extremely fast decay time (« 2 ns). Both these scintillating materials produce light
in the violet to green range, making the Ar40Se52Te8 model of the MIT PBG fibers highly suitable
for doping, as they are specifically tailored to transmitting visible light. Both the diameter of
the hollow core and the concentration of scintillating material were varied in order to assess
the optimal configuration. The manufacturing process for these doped fibers is described in
figure 4.3.
In parallel to experimenting with these scintillating PBG fibers, an attempt was made to replace
both the conductive glass and the scintillating material with layers of conductive material. Such
alternative design would result in a fiber operating in a similar way as an ionization chamber
(IC): protons interact in the medium and collide with electrons, with the ejected electron and
the residual positive ion constituting an ion pair. Each ion pair produced in air results in an
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Figure 4.3: Fabrication steps of a scintillating thin-film fiber device: a) production of the solid-core fiber
device; b) production of the thin-film fiber device; c) finalization of the scintillating fiber through doping.
In details, a chalcogenide rod (a2) is slid into a polymer tube where rectangular spaces have been cut
to place the tin (Sn) electrodes (a3); the structure is then encapsulated in a polymer cladding (a4) and
consolidated to obtain a macroscopic preform (a5); chalcogenide glass is then thermally evaporated
on a polymer sheet (b1) that is rolled and consolidated to obtain a polymer tube with an outer layer of
controlled thickness of glass (b2); the structure is then encapsulated in a polymer cladding (b4) and
consolidated to obtain a macroscopic preform (b5); afterward the macroscopic preform is thermally
drawn to yield a thin-film fiber device (c1) which is finally doped with the scintillating material (c2).

average expended energy of 33.85 eV, also known as the W -quantity.
The linear energy transfer (L E T x ) corresponds to the average loss in energy per unit length
of path of the incident radiation. L E T x can be obtained from the range-energy relationship
of the incident energy in the medium. The number of ion pairs produced in a given medium
per unit length of path of the incident radiation, called the specific ionization, can therefore be
obtained from equation 4.1.
SI =

W

R x W

(4.1)
[ 1

where, S I is the specific ionization, W the W -quantity, E the incident particle energy, and R
the corresponding incident particle range in the medium.
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The theoretical ion pair production for a 230 MeV proton was therefore evaluated for various
materials, based on equation 4.1, in order to produce the most theoretically efficient fiber
design. The choice of 230 MeV for the energy evaluation was based on MGH’s accelerator
capabilities, since proton radiography would be performed with the highest available energy.
Different ratios for the anode and cathodes radii were computed for aluminum, graphite, iron,
lead, tin, tungsten, and conductive polycarbonate (CPC), based on a 1 mm diameter fiber
design. Figure 4.4 presents the theoretical ion pair production from protons as a function of
energy, along with the optimal theoretical design for a PBG fiber using a CPC conductor, for
which the specific ionization is « 21.5 ion pairs/pm.
#IPn
P

: 6328

230MeV

(a)

10

10

10

log(E)

10

Rcore :0.19mm

(b)

Figure 4.4: (a) Number of ion pair produced in a 1 mm diameter IC-simile fiber as a function of proton
energy on a log-log scale; (b) Optimal theoretical anode and cathode radii for a fiber using a CPC
conductor, #IPp230MeVis the theoretical number of ion pairs collected using the given radii when a 230
MeV proton traverses the fiber.

In this work, regardless of the model of PBG fibers considered (scintillating thin-film device or
IC-simile device), the signal produced in a given fiber was acquired using a LeCroy™ elec
trometer with a very basic LabView (LabVIEW[100]) software. This software was provided by
the MIT team, hence not described here.

4.2.2

Scintillating fibers

Subsequent to the suggestion of scintillating PBG fibers, it was further proposed to consider
pure scintillating fibers. As individual protons traverse a fiber, they will lose energy based on
their initial energy and the effective path length. This energy deposition, dX, corresponds to
the L E T ^ previously introduced. The interactions of the protons inside the fiber result in the
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creation of photo-electrons, generating a luminescent signal throughout the fiber whose inte
gral is relative to the energy deposited, hence L E T ^ . The charge collected can therefore be
interpreted such that one can obtain the particle’s incident energy.
By perpendicularly aligning two sets of fibers in tight meshes, each particle would traverse
two fibers. Not only can the particle’s position be retrieved based on the coincident signals in
these two fibers, but the dual jEE readings would also result in a reduction of the uncertainties
in the interpretation of the particle’s incident energy. Additionally, the signal slowly attenuates
throughout the fiber as a function of distance between the interaction point and the read
out system location. The dE reading could therefore be corrected based on the interaction
position, thus further reducing the uncertainties in the interpreted incident energy. This coin
cidence mechanism is later depicted in the experiments section in figure 4.14.
As previously demonstrated in the Monte Carlo simulations (see chapter 3), the information
required for proton radiograph reconstruction solely consists of the energy and position of
individual particles before and after the patient. However, the difficulty resides in the fact that
energy and position information present competing requirements from a fiber design spec
ification point of view. A thicker scintillating fiber would result in a longer proton path and
therefore, greater energy deposition. This greater energy deposition further translates into a
brighter luminescent output signal from the fiber. This therefore results in a more accurate
jjE reading and better incident energy interpretation. Conversely, a thinner and narrower set
of fibers would result in smaller ”coincidence pixels” and thus, a more accurate acquisition
in position information. Due to the poor intrinsic resolution of proton radiography, as evalu
ated in section 3.2.4, and in order to optimize the compromise between energy and position
accuracy, this work considered 2 mm square scintillating fibers. These fibers’ square cross
section, as opposed to the more conventional circular cross-section (e.g. PBG fibers), allows
the design of gapless meshes of fibers. This improves both the accuracy (quasi constant 2
mm path length through the fiber would result in stable jjE readings) and efficiency of the sys
tem.
As previously discussed, the MGH cyclotron operation is such that an « 3 ns proton bunch
is emitted approximately every 10 ns. The intensity of the beam in the room, i.e. the number
of particles coming through in each bunch, is highly correlated to both the requested output
current at the exit of the accelerator and the requested proton energy. The higher the beam’s
energy, i.e. greater individual proton’s velocity, the smaller the spatial spread. A smaller spa
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tial spread further results in more particles able to exit the cyclotron. For particle radiography
purposes, it is ideal to minimize the number of particles through the system, yet using the
highest available energy which is the most efficient one. Thus, by reducing the output current
at the accelerator level, at MGH it is possible to produce, on average, 1 particle per 3 ns burst
at the nozzle exit, i.e. 1 particle in the room every 10 ns. Although this rate is extremely low
from a proton accelerator output point of view, this is an extremely high rate of signals from a
read-out system standpoint. Thus, this is an important consideration for the entire system’s
design and configuration.
Furthermore, due to read-out electronics availability and efficiency, it was preferable to con
sider scintillating fibers with output signals in the visible spectrum, especially blue or green.
Given these various considerations, it was decided to use BCF-20 plastic scintillating fibers
from Saint-Gobain Crystals™. BCF-20 fibers emit light in the green spectrum with a peak
at 492 nm and present a decay time of 2.7 ns. The decay time means that each particle
interaction would result in a 2.7 ns pulse which would match the speed requirements set by
the machine at MGH. The BCF-20 fibers’ characteristics are such that an average of 8,000
photo-electrons were expected per 1 MeV energy deposition. The fibers present an accep
tance angle o f « 21 ° which translates to « 10% efficiency of the system. These specifications
can be found on the manufacturers’ brochure (Saint-Gobain Crystals™ [101]). A few limita
tions in using these BCF-20 fibers were purposefully ignored during the initial phase of the
project: the crosstalk between adjacent fibers (clear adjacent fibers in meshes); a 50 % effi
ciency loss based on signal acquisition at only one end of the fiber; and a small residual signal
reflecting at the end of the fiber on the opposite side from the electronic read-out. A schematic
of a round BCF-20 fiber from Saint-Gobain Crystals™ is depicted in figure 4.5, along with an
actual photograph of the square fibers used in this work.
The read out process for signals coming from optical fibers is fairly well documented. The
most common approach is to use photomultiplier tubes (PMT). The mechanism of a PMT is
as follows: light photons are received on a thin photo cathode window and generate electrons
through photoelectric interactions; these electrons are accelerated to an electrode (first dynode) through a high voltage (-1000 V in our case) which generates more secondary electrons;
these secondary electrons are then accelerated to the next dynode which further generates
more electrons; this patterns continue until the last dynode (the anode) where the signal is
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Figure 4.5: (a) Schematic of a cylindrical BCF-20 fiber from Saint-Gobain Crystals™ depicting its main
physical properties; (b) actual photograph of the square BCF-20 fibers used in this work.

collected. This dynode cascade results in a tremendous signal gain (up to 100 millions times
the original signal). It is then possible to perform individual photon counting depending on the
setup and PMT specifications. The schematic of a PMT’s way of functioning is depicted in
figure 4.6.

Figure 4.6: Schematic of a photomultiplier tube (PMT). The light signal is received on the thin photo
cathode and multiplied through a dynode chain to the anode.

In order to match the speed requirements of the system, this work considered Hamamatsu™
8-channel PMT arrays, model H9530-01. These arrays present 8 distinct 2 mm x 2.5 mm
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sensitive areas allowing the light acquisition from 8 scintillating fibers side-by-side with a min
imal gap in between (< 1 mm). An interaction in any fiber would result in the generation of
a 3 ns output pulse with a ^ 3 5 0 ps rise time at the exit of the PMT. The charge (integral) of
the output pulse would then be relative to the amount of light transmitted from the interaction.
Additionally, the charge of that pulse would also be linked to the gain of the PMT channel.
This gain is directly related to both the channel's high voltage and the spectrum (energy) of
the light transmitted through the fiber. Thus, a -1000 V high voltage unit, model C4900-01
from Hamamatsu™, was chosen on the manufacturer’s recommendation to match the PMT
assembly. For the given -1000 V high voltage and the previously described fiber’s output
spectrum peak of 492 nm, the manufacturer quotes a 3 x106 gain and an « 12% quantum
efficiency. This H9530-01 PMT array further offers minimal crosstalk between its 8 channels
(< 0.1%) as well as minimal dark current. It should be noted that beyond the characteristics
of the PMT or fiber model, the quality of the output signal is highly correlated to the quality
of the fiber-PMT interface. Careful attention must be paid in smoothing the end of each fiber
in order to avoid air gaps that could result in the reflexion of the luminescent signal instead
of its absorption into the PMT. The fiber-PMT contact can also be improved through the use
of optical gel (cf. measurements section). Nevertheless, no matter what is chosen for the
final design, each individual fiber’s response must be carefully characterized. Once the entire
system has been fully calibrated, accurate data can be collected which can then be used for
proton radiography purpose.
It is also crucial to minimize the light contamination in the system. This contamination comes
from both stray light photons and cosmic rays, and is virtually impossible to completely sup
press it. A tight black enclosure is a minimal requirement to mitigate the issue of stray photons.
On the other hand, nothing can be done concerning cosmic rays which would result in false
positive signals in the system. The original solution to assemble PMT arrays and fibers is pre
sented in figure 4.7(a). The latter consisted of an in-house black acrylic holder allowing tight
fiber-PMT coupling. The holder was then wrapped in a light cardboard box (minimal beam per
turbation) and duck-taped over a couple of layers. Although rough on the edges, this solution
permitted initial data acquisition that served as a proof of principle. Subsequent to promising
initial results, a cleaner solution was sought. That solution, far more onerous, came directly
from Hamamatsu™. Hamamatsu™ terminated the scintillating fibers with F-connectors and
created a custom assembly that encapsulated the PMT array and matched our needs. This
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advanced solution is shown in figure 4.7(b).

Figure 4.7: (a) Original in-house fiber-PMT holder made of black Lucite, wrapped into light cardboard,
and sealed with duck tape; (b) schematic representation and actual photograph of the subsequent
onerous solution offered by Hamamatsu™.

In parallel to the PMT solution, silicon photomultiplier (SiPM) were purchased from Hama
matsu™ for investigation. Due to a lack of budget and resources, only the PMT-based design
could be pursued. The novelty of SiPM and their relatively unrecorded capabilities were in di
rect contrast with the well-documented PMT specifications and understanding. It is believed,
however, that the minimal cost, stability, and ease of replacement of the SiPM would present
an interesting alternative to the PMT-based system. It would thus be adequate to pursue such
route once SiPM have reached a higher level of maturity.
Two distinct data acquisition systems (DAQ) were necessary for these scintillating fiber de
vices: a powerful oscilloscope (limited number of channels) and a more substantial system
that would be scalable for clinical use. The oscilloscope could be used for proof of principle
measurements, energy-output relationship characterization, and accurate characterization of
single fibers. Conversely, the clinical system must be able to offer both coincidence (position)
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and charge (jE ) acquisition on numerous channels with a reasonable efficiency.
The oscilloscope used in this work was a WavePro 715Zi-A from LeCroy™ with the WPZiA-L-128 (extended memory) and WPZi-1.5GHz-4X20GS (advanced sampling rate) modules.
The impressive characteristics of the oscilloscope made it a perfect match for the designed
system. The 1.5 GHz bandwidth allowed the acquisition of an input signal approximately every
0.7 ns exceeding the requirements of 1 or 2 particles per 3 ns. Furthermore, in order to ob
tain an appropriate signal shape, i.e. accurately compute the signal’s charge (integral), it was
necessary to be able to acquire enough points along the signal curve. The WavePro 715Zi-A
offers 40 GS/s on a single channel resulting in over a hundred points on a given 3 ns pulse.
Such sampling speed is more than appropriate as highlighted in the measurements section.
Moreover, since the oscilloscope runs directly on a Windows™ operating system, it offers a
multitude of ultrafast signal processing analyses tool and export options. It also present the
capability to run automated scripts for data analysis. The latter would be particularly use
ful in the future process of individual fiber characterization. This oscilloscope model actually
presented far more advanced mathematical signal analysis options than that required by the
project. The WavePro 715Zi-A was therefore very adequate for single fiber signal analyses.
In the context of the clinic however, a 10 x 10 cm2 imaging panel size would represent a min
imum requirement. Such panel size corresponds to a couple of meshes made of 50 adjacent
scintillating fibers each based on the chosen design. The second DAQ system, intended for
clinical use, therefore presented different requirements. It had to offer an appropriate band
width for the evaluation of a 100 channels, while offering a sampling resolution sufficiently high
enough to accurately evaluate the timing (for coincidences) and charge of the signals coming
from various fibers simultaneously. Unfortunately, such system was not readily available at the
time of the work, nor was it feasible to build our own system due to a lack of resources. As a
consequence, two DAQ devices were considered in this work. Although these DAQ system
represented the state-of-the-art in acquisition systems, they did not meet the requirements
set by the designed system. The first system, the Pixie-16 from XiA™, presented 64 channels
split into 4 modules of 16 channels with 12-bit analog-to-digital converters (ADC) capable of a
data sampling rate of 100 MS/s. The Pixie-16 came with a generic software from XiA™ which,
for each channel, generated charge measurements as well as time stamps (75 MHz, 13 ns
resolution). The time stamps could be used for coincidences measurements (XiA™ [102]).
Alternatively, a more promising DAQ, the SIS3305 digitizer from Struck™, offered a 2 GHz
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bandwidth with a 1.25 GS/s sampling rate on 8 channels in parallel (Struck™ [103]). Although
the SIS3305 was a better fit given the design requirements of the proton radiography detector,
it was not fully released at the time of the work (2011); only a single 8-channel module was
available with no proprietary software. At the time of redaction, it is believed that the SIS3305
was successfully scaled to a 128 channel system and implemented off-site by Struck™.

4.2.3

CMOS APS

The use of CMOS technology for radiotherapy detection purposes has been previously inves
tigated for proton and photon beam visualization and dosimetry (Sipos etal., Sanchez-Crespo
etal. [104, 105]), as well as for imaging purposes in newer digital X-ray radiographic systems
(Yorkston [106]).
The investigation of CMOS detectors for proton radiographic imaging use was not part of
the initial project. Nevertheless, due to a collaborative project, we gained access to a CMOS
active pixel sensor (APS). This CMOS APS was developed as part of the MI3 Consortium at
the Science and Technology Facility Councils Rutherford Appleton Laboratory, UK (Allinson
et al., Turchetta et al. [107, 108]); it presented a 42 x 42 mm2 detection area made of of
40 x 40 p m2 pixels. The data acquisition was performed using the given read out system
which operated at a frame rate of 1-100 frame/s. Because our group was not involved in the
development process of this CMOS APS system, please refer to Osmond et al. [109] for more
details.

4.3

Experimental results

Rarely expressed in published work, it seemed important here to report inconclusive/poor
results obtained during our experimental process. Although these measurements mostly re
sulted in stopping points rather than advancements for the project, they must be described
in order to highlight the inadequacy of certain technologies for proton radiography purposes.

4.3.1

CMOS APS: inconclusive results

CMOS detectors could potentially be used for proton radiography purposes. The CMOS APS
system used in this work, however, did not present the required characteristics. Measure
ments were performed using the MGH proton beam line in double-scattering mode, with the
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first scatterer, range modulator wheel, and second scatterer set in such a way that the de
livered beam was monochromatic with an energy of 117 MeV. This energy is comparable to
the energy of particles that would be exiting a patient during actual proton radiography. The
CMOS APS, as well as commercial Gaphcromic™ EBT 2 films and Kodak™ X-Omat V films,
were alternately placed at isocenter using two different configurations: a ball point pen with
two metal screws (one in the beam direction, one perpendicular to it), and a phantom made
of 5 alternated slabs of water, lung and bone equivalent materials.
For both aforementioned commercial films, the configurations were placed at various dis
tances prior to the film, namely 0, 2, 5, and 10 cm. These measurements, displayed in figure
4.8 for the pen and screws configuration, were performed in order to assess the effect of
proton beam scatter on the image formation.
During the CMOS APS experiments, both configurations were located 5 cm antecedent to
the detector. The energy deposited by the protons (jE ) in the CMOS layer of the CMOS APS
detector was recorded as a voltage amplitude, with the corresponding residual energy of the
exiting protons computed. For comparison purpose, conventional photon X-ray radiographs
were also performed in similar conditions at 70 kVp using a Varian™ PaxScan flat panel de
tector. Figure 4.9 highlights the comparison between the film X-ray irradiations and the CMOS
APS proton irradiations.
The resemblance between the proton irradiated films at 5 cm (figure 4.8) and the CMOS APS
images (figure 4.9) highlights the imaging capabilities of the CMOS technology. Film is consid
ered a gold standard in the imaging practice regarding spatial resolution, which emphasizes
the high capabilities of this CMOS APS system.
As expected, X-ray irradiated films have an apparent higher spatial resolution than CMOS APS
acquired images (figure 4.9). The CMOS APS system, however, display higher density reso
lution as demonstrated by the visualization of the pen’s edges in the proton images.
Despite the fact that these proton images represent the best reconstruction that were ac
quired throughout the entire project, these are not proton radiographs per se. Indeed, due
to its integration time (10 ms), the system produces so-called scatter radiographs rather than
the desired range radiographs. As highlighted in figure 4.8, scatter imaging is highly depen
dent on the distance between the setup and the detector (focus). As such, there is clearly an
optimal distance (here 2 cm) which would depend on the proton beam energy as well as the
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Figure 4.8: 117 MeV proton beam irradiation of the pen and metal screws configuration (one screw
is in the beam direction while the other is perpendicular to it) using commercial Gafchromic™ EBT 2
and Kodak™ X-Omat V films placed at 0 cm, 2 cm, 5 cm, and 10 cm beyond the configuration. The
difference in contrast between images is explained by the difference in dynamic range between the
films, as well as the windowing and leveling used during the film scanning process.

Figure 4.9: 70 kVp X-ray radio
graphs of (a) the water, lung, and
bone phantom, and (b) the pen
and metal screws configuration
set-up using a Varian™ PaxScan
flat panel detector; proton radio
graphs of (c) the water, lung, and
bone phantom, and (d) the pen
and metal screws configuration
using the CMOS APS.

thickness/composition of the traversed subject due to the amount of scatter. This high scat
ter dependency of the presented CMOS APS system does not make it a good alternative to
conventional X-ray radiography. Conversely, should the system be rebuilt in such a way that
individual channels offer on-line data acquisition rather than an integrated signal, range maps
could be reconstructed. Such a system would present a true potential for proton imaging.
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Unfortunately, this route could not be pursued as part of this work due to a lack of resources.

4.3.2

PBG fibers: poor results

The initial concept of a small proton radiography detector for this work was based on the
PBG fibers. The experimental results obtained with such fibers, however, turned out to be
inconclusive.
First, the PBG fibers were characterized outside of the proton radiation field in order to assess
their stability. The characteristic curves, also known as intensity-voltage (IV) curves, corre
spond to the acquisition of output intensity (nA) as a function of input voltage (V) for a given
light stimuli. IV curves were therefore acquired for various light stimuli (absence of light, red
light, green light, ambient light) at different times (immediately after fiber drawing, and 2 to
4 weeks later), and at multiple voltages ranging from -100 V to 100 V These curves were
also acquired for different PBG fibers: with or without scintillating material; annealed or not
annealed. Due to the large amount of data and the relative lack of interest, these IV curves are
not shown here. The absence of change in IV curves versus time of acquisition highlighted
the initial stability of those PBG devices outside of the radiation field.
Thus, the various PBG fiber ’’models” were taken for irradiation at MGH with a monochro
matic beam which was produced with a double scattering field, similarly to the CMOS APS
experiments. The most significant results are shown in figure 4.10.
Surprisingly, the presence or absence of scintillating material in the hollow core of the fibers
had no visible effect (not displayed here). Furthermore, it appeared that the less conductive
the glass was, the better the signal. Additionally, a modification of the beam location along the
fiber resulted in different responses: the closer the beam was to the output contacts, the larger
the response. This unexpected behavior from the system uncovered the non homogeneity of
the electric field within the fibers which was believed to come from the manufacturing process.
As seen in figure 4.10(b), the input voltage applied to the fibers had surprisingly no effect on
the output response. In fact, only the dose rate dependency of these PBG fibers, illustrated
in figure 4.10(a), followed expectations: the higher the intensity of the beam, the larger the
response. The response of the fibers appeared to be quasi constant as a function of beam
energy, as depicted in figure 4.10(c). This result was almost at the opposite of the expected
behavior, the output signal should increase linearly versus the amount of energy deposited in
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Figure 4.10: Experimental results from proton irradiation of PBG fiber devices: (a) response curve
versus beam intensity (dose rate) with two irradiations for each intensity; (b) relative response versus
applied voltage as a function of dose rate; (c) response versus beam energy (signal corrected for dose
rate).

the fibers (dX), hence decrease as a function of beam energy.
These inconclusive results stressed the inadequacy of the PBG fibers in their current form for
proton radiography purposes, and therefore ended this approach.

4.3.3

Scintillating fibers: a novel path towards PR

The first measurements performed with the Saint-Gobain Crystals™ Bicron BCF-20 fibers
served as a simple proof of principle. Two scintillating fibers were placed inside a homemade
apparatus, as seen in figure 4.7(a). One fiber was set with optical grease at the PMT-fiber
interface, the other without. The apparatus was then irradiated in pencil beam scanning (PBS)
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mode using a 230 MeV beam. In order to optimize the chance of single event recordings,
the beam’s intensity was kept at a minimum, « 1 nA at accelerator exit, which on average
corresponds to a single proton p e r« 3 ns being delivered inside the treatment room. For these
experiments, the PMT array output channels for both fibers were connected to the LeCroy™
WavePro 715Zi-A oscilloscope. Figure 4.11 provides an example of an output trace obtained
in the aforementioned setup when a proton traversed the fiber. The second smaller peak in the
output trace was believe to come from ringing within the system. The ringing effect arose from
the relatively poor quality of the cables and connections which resulted in a slight mismatch
in impedance.
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Figure 4.11: Single event pulse produced by the PMT-BCF-20 scintillating fiber assembly and recorded
with a LeCroy™ WavePro 715Zi-A oscilloscope.

The output signals acquired in the aforementioned conditions, such as the trace shown in
4.11, proved the capabilities of the system to resolve individual interactions in the fibers. The
comparison between traces obtained with and without optical grease at the fiber-PMT inter
face showed no apparent difference. This lack of difference highlighted the lack of benefit from
using optical grease. Thus, the overall manufacturing requirements of a larger scale system
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were simplified.

4.3.3.1

dE/dX measurements

Based on the knowledge acquired from the oscilloscope measurements, the homemade ap
paratus was subsequently connected to the full XiA™ Pixie-16 DAQ system. The assembly
was then irradiated with a narrow proton beam using a 2 cm aperture. Measurements were
performed at multiple energies, namely 191, 177, 151, 131, 116, 103, 93, and 77 MeV. The
output spectra from these measurements were acquired with the Pixie-16 software. The out
put spectra corresponded to the raw light output from each fiber which could then be com 
pared to the expected energy deposition (dE) based on the incident proton beam energy.
Figure 4.12 shows an example of output spectra obtained with a 151 MeV beam.
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Figure 4.12: Output spectra obtained from the irradiation of two scintillating fibers with a narrow 151
MeV monoenergetic proton beam and recorded with the XiA™ Pixie-16 DAQ system.

The output spectra shown in figure 4.13 presented similar Gaussian profiles but with different
characteristics (center and standard deviation). The center of a Gaussian fit of these curves
corresponds to the relative signal, i.e. energy deposited (dE) in the given fiber, while the width
of the Gaussian (standard deviation) is representative of the noise. The discrepancy between
the two signals can be explained by multiple causes. The narrow proton beam might not have
been equally distributed over the 2 channels, resulting in more statistics/signal amplitude in
one of the channels. Additionally, the difference in the signal’s height could have risen from
a significant difference in gain between the 2 channels due to the quality of the fiber/PMT
interface. The shift in spectrum center, which translates to a discrepancy in energy deposited,
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could be due to many things within the system; this discrepancy, however, would not be an
issue as it would disappear once proper calibration of the individual fibers in the system has
been performed.
The response of each channel as a function of both incident energy and expected energy
deposited (jjE) is given in figure 4.13. The relationship used between incident energy and djE
was based on the PSTAR data (Berger [ 88]) (based on ICRU-49 report data (Allisyetal. [10])).

Figure 4.13: BCF-20 fiber response to proton beam interactions as a function of (a) expected energy
deposited (dE) and (b) incident beam energy. The relationship between dE and incident energy was
based on the ICRU-49 data (Allisy et al. [10]).

These results highlight the appropriate agreement between fiber response and expected dose
deposition. This further proves the possibilities of using a small factor detector made of scin
tillating fibers for proton imaging purpose. The relatively large error bars seen in 4.13 showed
the limitations of the system used for these experiments. This large noise is believed to be due
to the non-optimal connections throughout the system as well as the relatively low resolution
speed of the DAQ system. Thus, the noise of the system could have been reduced through
various improvements in the overall quality of the system.
It is noteworthy to point out that a 2 mm fiber design presents some limitations in accuracy.
In practice, the inherent fluctuation in dE from each particle would result in an uncertainty in
energy resolution. These fluctuations would translate into a spectral width in the acquired out
put signal, such as the one visualized in figure 4.12. These uncertainties in energy resolution

4- Proton Radiography: experimental realization ~ N. Depauw, PhD thesis, 2014 - CMRP, UOW

71

would grow larger with the incident beam’s energy due to the inversely exponential shape of
the dE curve as a function of energy. Although these uncertainties may be acceptable for
proton imaging purpose, they are also expected to be slightly larger than a system using a
range telescope, resulting in slightly poorer image quality. In figure 4.12, however, the large
width of the acquired output spectra (« 10 to 30 %) is mostly explained by the overall build
quality of the prototype.

4.3.3.2 Coincidence measurements
For these experiments, a second homemade apparatus (figure 4.7(a)) was used. The appa
ratus contained two fibers each, and were positioned perpendicularly one to another, leaving
the perpendicular fibers separated only by the slim encasing carton boxes and tape. Thus,
this setup represented X and Y axes of a grid through which each particle interaction’s po
sition could be resolved. This concept is illustrated in figure 4.14. The coincidence area of
two fibers (out of the four) was then irradiated with a narrow 151 MeV proton beam produced
through a 2 cm aperture, similarly to the dE experiments. The coincidence area of the two
other fibers, located outside yet at the edge of the irradiation field, could therefore be used to
assess the noise in the system. Such experiments required the system to have a ’’coincidence
window” . As a proton would ’ simultaneously” traverse two fibers at a given intersection, two
signals should be ’ simultaneously” acquired by the DAQ system. This is, in practice, not true,
as the fibers are not infinitesimally thin, and the interactions would occur at a slightly different
time. The system's coincidence window corresponds to how large this aforementioned time
difference is allowed to be in order for multiple signals to be considered as pertaining to the
same interaction. For these experiments, the coincidence window was set to 5 ns.

Figure 4.14: Coincidence measurement
concept: four fibers, perpendicularly po
sitioned in pairs, were irradiated with a
narrow proton beam; each coincidental
interaction then resulted in a signal in
both fibers which in turn gave the posi
tion of the interaction.

X1

Y1

Y2
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In order to ensure the functionality of the system, a first measurement was performed with
the Pixie-16 in spectral mode (similar to jE measurements) and was then repeated with the
coincidence mode enabled. An example of output spectra is given in figure 4.15. As expected
from the jE measurements, the characteristics (center and standard deviation) of the curves
differed. This discrepancy would not have shown should the calibration of the individual fibers
had been performed. Once enabled, the coincidence mode resulted in a duty cycle of «10
%. This means that 90 % of the interactions were not considered to be coincidental. Although
this was true for many of these interactions, many others were not ”caught” due to the large
internal dead-time of the Pixie-16. Once the number of channels increases this issue would
greatly worsen, for instance in a larger scale detector. This further highlights the need for a
faster system such as the SIS3305 digitizer from Struck™. Additionally, although the channels
outside the field resulted in counts without the coincidence mode enabled (mainly due to large
scatter nuclear interactions), there was no significant signal/noise once the coincidence mode
was enabled.
In a following experiment, various thicknesses of Lucite, namely 0, 1.25, 3.75, and 6.25 cm,
were placed atop the apparatuses. The aim of this experiment was to assess the effects
of scatter and small energy change. The coincidence spectra with and without the 6.25 cm
Lucite buildup are shown in figure 4.15. It is believed that the first low energy peak in the output
spectra corresponds to pile-up effects in the system. These pile-up effects could potentially
be mitigated through smarter hardware and software, but this solution could not be pursued at
the time of the project because of a limitation in available resources. As previously observed,
there is a difference in the Gaussian characteristics of the curves for a given irradiation due to
the lack of inter fiber calibration. The ratio of the centers from each channel, however, remain
constant as a function of Lucite thickness. This shows that, after proper calibration of the
individual channels in the system, both fibers in a coincidental interaction would yield similar
signals. This information could be helpful in order to reduce the uncertainties in the computed
jE value for the given interaction. Furthermore, the thicker the buildup was, the larger the
standard deviation of the spectral distribution was. This is due to the energy spread created
through the scattering process in the buildup material.
These experiments highlighted the position tracking capabilities of a scintillating fiber system
through on-line channel coincidence analysis. Since such a detector would be able to resolve
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Figure 4.15: Energy spectra from coincidence measurements of scintillating fibers irradiation with (a)
no buildup, (b) a 6.25 cm Lucite buildup.

both the position and energy information of each interaction on a particle-by-particle basis, a
larger scale model would be suitable for proton radiography purpose.

4.3.3.3 Individual fiber calibration
Following these preliminary results, a homemade larger scale system was assembled. The
final homemade assembly is shown in figure 4.16. The new system consisted of 64 BCF20 scintillating fibers split into two two sets of 32 parallel fibers with a negligible small gap.
The two sets of fibers were set perpendicular one to another, resulting in an X/Y mesh with a
total detecting area of approximately 6.4 x 6.4 cm2. The fibers’ holders were made of black
acrylic board in order to limit light contamination and cross talk between fibers. The scintillating
fibers were then connected eight at a time to PMT arrays using custom assemblies made by
Hamamatsu™, as previously described in figure 4.7(b). Note that additional light shielding
was provided using light tight radiographic film sleeves that enclosed the whole fibers/PMT
areas, this is not shown in figure 4.16. Printed circuit boards (PCB) were specifically designed
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to provide HV power to the PMT arrays as well as optimal quality of connections throughout
the system. For instance, each PMT array’s output was connected directly to the Pixie-16
DAQ system through large D-connectors and BNC cables. This ensured a drastically higher
quality of signals traveling throughout the system.

Figure 4.16: Final homemade assembly of a proton imaging detector using 64 BCF-20 scintillating
fibers set into an X/Y grid detecting area. The fibers were connected to PMT whose output was
recorded by the Pixie-16 DAQ system.

Individual pulses from each channel were first recorded using the LeCroy™ WavePro 715ZiA oscilloscope in order to ensure the overall well functioning of the newly designed detector.
The quality of the signals were far better than the ones previously acquired (figure PRPRtrace),
which is explained by the significantly greater quality of the connections throughout the system.
On the other hand, the new signals showed surprisingly lower gains compared to the original
curves acquired (« 30 % the size). After careful investigation, it was discovered that the
Hamamatsu™’s custom PMT assemblies largely reduced the cross section of the terminated
fibers (1 mm instead of 2 mm), resulting in a tremendous signal loss. This issue must be taken
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into consideration for the design of a finished product as the efficiency of the whole system
would greatly suffer.
Due to the small attenuation of the light transmitted through the scintillating fiber, it was first
necessary to perform a position calibration in each channel. For this measurement, a small
portion of the parallel fibers in a given set were simultaneously irradiated with a narrow beam
(1 cm). The signal Si collected at the PMT for a given fiber i was then given by equation 4.2
(Koybasi et al. [42]).
Si(x) = A i(x ) x Ci x $ x f (E)

(4.2)

where, x is the position within the fibers (cm) based on x 0 = 0 cm being the closest position to
the PMT within the sensitive area; A i(x ) is the unitless relative attenuation of the signal at the
distance x compared to x 0; Ci represents the coupling efficiency of the fiber-PMT interface
in %; $ is the fluence of incident particles (protons/m2); and f (E ) represents the relationship
between light output and proton energy.
Thus, for a given fiber i, the values of Ci and f (E) are constants which must be determined
as a function of incident beam energy. For a known beam intensity (particle fluence), the
position calibration could therefore be performed based on the ratio of signals

at different

positions x. Figure 4.17 shows the measured position calibration for two fibers. Note that
modifying a specific channel’s gain would not have helped harmonize the calibration between
fibers. Instead, the software would need to compensate the attenuation of the acquired signal
based on the estimated origin of the interaction. As previously discussed, the interaction’s
position would be obtained from the coincidental interaction that simultaneously occurred in
a perpendicular fiber.
In order to inter-calibrate the scintillating fibers, the narrow irradiation field was kept at a known
position, x 0, and a known energy, 151 MeV. The beam intensity (fluence rate) was modulated
and the response from the fibers were acquired two at a time with the WavePro 715Zi-A
oscilloscope. Figure 4.18 shows the responses for two fibers. The hardware gain for each
channel could then be individually adjusted based on one arbitrarily chosen channel. As a
consequence, similar absolute signal response can be acquired from any fiber subject to the
interaction of a proton with a given energy and position within the fiber.
Subsequent to the successful calibration of the whole system using the WavePro 715Zi-A os
cilloscope, the detector was connected to the Pixie-16 DAQ system and a broader irradiation
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Figure 4.17: Relative attenuation of the PMT output signal as a function of proton beam irradiation
position along the sensitive area measured for two BCF-20 scintillating fibers with the WavePro 715Zi-A
oscilloscope. The positive abscissa corresponds to an increasing distance from the PMT with x 0 = 0
cm being the closest position to the PMT within the system’s sensitive area (see figure 4.16).

of the sensitive area was performed. Unfortunately, neither the Pixie-16 was able to handle
the processing of so many input signals, nor could the beam intensity be further decreased.
The only solution would have been to move towards a significantly faster DAQ system such
as the SIS3305 digitizer from Struck™. However, this route could not be pursued due to a
lack of financial resources.
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Figure 4.18: PMT output signal as a function of incident proton beam fluence rate for two fibers,
measured with the WavePro 715Z-A oscilloscope. The proton beam energy and position were kept
constant, at 151 MeV and x0, respectively.

4.4

Conclusion

Three different routes were explored in order to create a novel proton radiography system
that would be reasonably compact for clinical use: photonic bandgap fibers, a CMOS active
pixel sensor, and Bicron BCF-20 scintillating fibers. Unfortunately, the PBG fibers appeared
to be fully inadequate for proton imaging purpose. Likewise, despite promising results from
the CMOS technology, the specific CMOS APS system used in this work did not present
capabilities for single event processing. Such a deficiency prevents the system from gener
ating viable proton radiographs that would carry proton range information, therefore making
the system unsuitable for the desired goals. Nevertheless, the redesign of a similar CMOS
APS system would be worth exploring as it is believed the system’s speed could greatly be
improved as needed. The use of scintillating fibers, on the other hand, proved to be very
fruitful. The acquisition of both a particle’s energy and position of interaction are retrievable
from the BCF-20 fibers. Each fiber could be calibrated in such a way that for a given position
and proton energy, any fiber would result in a similar signal. Additionally, the layout of two
sets of parallel fibers into a 2-dimensional X/Y mesh resulted in the capability to accurately
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resolve the position of an interaction based on coincidental signals in the system. Theoreti
cally, one could then reconstruct radiographs by recording both the positional and energetic
information behind a patient given a known incident proton beam. It would be more sensible,
however, to acquire this information twice, both upstream and downstream of the patient, in
order to additionally gather directional information. Based on this additional information, the
system could therefore benefit from better reconstruction algorithms using angular cuts (see
Chapter 2). Unfortunately, in order not to suffer from the high duty cycle of the proton ma
chine, yet preserve the theoretical dosimetric advantages of proton imaging, a considerably
faster data acquisition system than the one used in this work would be needed. At the time of
writing, such read-out electronics was not readily available, nor financially attainable. Based
on the seemingly never-ending Moore’s law (Schaller [110]), however, this type of electronics
should become increasingly accessible over the next few years, thus making proton imaging
a realistic project.

4- Proton Radiography: experimental realization ~ N. Depauw, PhD thesis, 2014 - CMRP, UOW

79

Chapter 5

Proton pencil beam scanning
planning
5.1

Introduction

Pencil beam scanning (PBS), also known as intensity modulated proton therapy (IMPT), is
a novel treatment technique for proton therapy. PBS refers to a narrow unscattered proton
beam whose properties are modified as needed in order to offer optimal tumor conformality
and organs at risk sparing. The beam properties mainly consist of beam position, energy
(depth), charge (intensity modulation), and size. The lateral position of the beam is controlled
through 'bending magnets' whose magnetic field is adjusted. The depth of the beam (third
positional dimension) is adjusted by the incident beam energy in a layering fashion (cf figure
2.8). The beam’s energy is governed by the output characteristics of the accelerator. The
size of the beam (spot sigma) is a fixed parameter as a function of beam energy (layer) and is
mainly determined by the quality of the beam transport line. At the present state of existing
accelerator/beam line controls, it is not possible to adjust the beam transport line parameters,
hence the beam size, on the fly. Nevertheless, the spot sigma could ultimately be adjusted
within the treatment volume for speed purpose. Although the intensity of the beam itself is
not modified on a per layer basis, the intensity modulation within the treatment volume comes
from the length of time that the beam lingers in a given spot. There are two common ways
to perform this intensity modulation: dose driven (spot scanning) or time driven (continuous
scanning). In spot scanning, the beam is turned off while its position is being adjusted, then
turned on for a defined period of time in order to obtain the desired dose in the target at
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that spot; this is the way the MGH’s system is configured. Conversely, in continuous scanning
mode the beam is never turned off, but the traveling speed is modulated throughout the target
to obtain the desired dose in a given spot.
The work presented here focuses on the treatment planning aspect of PBS and its current
limitations based on Astroid, the current treatment planning software (TPS) at MGH. Other
PBS considerations such as rescanning - the method for which each layer (depth) is being
delivered multiple times in order to mitigate tumor motion issues - were not evaluated here
because they are not currently implemented at MGH. 1

5.2

PBS TPS beam model

Conventionally, the commissioning process of the TPS requires the acquisition of a large
amount of data, the so-called ”beam model” , in order to ensure the accuracy of dose cal
culations (Das et al. [111]). For PBS planning, however, the amount of required data is quite
manageable from the TPS point of view. Information such as magnet speeds, deliverable
charges, etc, are not required for computations; they are subsequently applied to a com 
puted plan in order to obtain a deliverable plan on a given accelerator. Thus, this simplistic
PBS beam data set consists of measured Bragg peak curves in water as well as measured
beam size at isocenter in air, both as a function of deliverable energy. All other parameters,
such as source-to-axis distance (SAD) effects or off-axis ratio, are directly taken into account
within the pencil beam algorithm’s (PBA) computational model.
In order to further simplify this work, a set of a priori information named the Golden beam data
set was compiled. The latter quantifies a set of absolute pristine Bragg peak depth-dose dis
tribution in terms of multiple Coulomb scattering (primary) and nuclear scattering (secondary).
A combination of this Golden beam data set and minimal measurements then suffices to de
scribe the entire TPS beam data.
The Golden beam data set was generated using the Monte Carlo toolkit GEANT4 version
8.1.p01 (Agostinellietal. [82]) with the physics settings described by Jarlskog andPaganetti[87].
Protons, electrons, neutrons, and photons were tracked with a cut off value of 0.05 mm. This
set was comprised of Bragg peaks computed in water in a 300 x 300 x 0.2 mm3 geome
1Co-authored work has been published in Depauw et al. [44], Kooy et al. [45], Clasie et al. [11], Dowdell
et al. [46], Carabe et al. [47], and Butterworth et al. [48], as well as presented at various conferences (Clasie
et al. [49], Clasie et al. [50], Dowdell et al. [51], Rochet et al. [52], Carabe-Fernandez et al. [53], McGarry et al. [54]).
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try for ranges every 5 mm between 2 cm and 35 cm. The peaks were generated with zero
AE = 0) and zero emittance. These peaks were expressed in unit
incident energy spread (E
E
of Gy(RBE).mm2.Gp_1 in accordance with the convention set by Pedroni et al. [112](Gp =
gigaprotons = 109 protons). The peaks were then normalized based on actual measurements
of similar peaks acquired at a few specific energies. The normalization was performed at a
combination of a 1 cm depth and Rso/2 due to the fact that the small energy spread of the
actual beam presented a negligible effect at these points. The final Golden beam data set is
presented in figure 5.1. The latter is considered universal as it represents the physical charac
teristics of a proton beam; any institution could therefore use this data in order to further limit
the amount of measurements required to implement their TPS beam data.

Figure 5.1: Golden Bragg peaks data set generated in Monte Carlo and corrected through actual
measurement. This Golden data set can simplify any institution’s process to generate their TPS beam
model for PBS planning.

Once the Golden beam data set is acquired, only the range of deliverable energies with their
corresponding energy spread (AEE) and beam size are needed to fully specify the delivery
system. There are two approaches in order to obtain the AEE, either from theoretical models
for a given accelerator, such as in the work by Cascio et al. [113], or through measurements.
At MGH, the measurement’s approach was chosen for its higher accuracy. Thus, a few Bragg
peak curves were measured with a PTW™ Bragg peak chamber ranging from the lowest (93
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MeV) to the highest (225 MeV) available energies. Based on Monte Carlo calculations, it was
shown that the diameter of the PTW™Bragg peak chamber (8 cm) was not large enough to
fully characterize a Bragg peak curve. This is due to the small but non-negligible contribution
of nuclear interactions (halo effect). The setup for the Monte Carlo comparison is highlighted in
figure 5.2. The measurements therefore had to be corrected accordingly using the Benhananik
formula displayed in equation 5.1.
Cx

= 110 x max(0,p35X85 + p4X4 + p3X3 + p2X2 + p0)

Gy(RBE).mm2.Gp_1

(5.1)

Where CX is the correction factor, X = R_ the relative depth along the Bragg peak, R80 the
physical range of the given peak in cm, and p35, p4, p3, p2, p0 are factors given by:
p35(Rso) = min(0,1.585 x
p4(Rso) =

0.002133R2o

p3(Rso) =

-0 .00 3 3 6 3R 2 o

p2(Rso) =

0.001297R2o

p0(Rso) = 10~6 x

-

-

1 0~5R 2o

- 0.004559Rso + 0.04214)

0.04721Rso

+

0.0668Rso

0.0174Rso

(0.4087R3o

-

+ 0.195
- 0.3058

+ 0.08441

21.25R2o

+

326Rso

+ 215.6)

Figure 5.2: GEANT4 Monte Carlo phantom geom
etry used for verification of the PTW™ Bragg peak
chamber measurements. The energy deposited
was recorded in a 8 cm diameter cylinder corre
sponding to the detector, as well as a 30 cm diam
eter cylinder which captured the full extent of the
beam.

The corresponding peaks from the Golden peak set at the measured energies were subse
quently convolved using a Gaussian function. The Gaussian function parameters consisted of
R 80 and E

which were adjusted until the peak matched the corresponding corrected PTW™

Bragg peak chamber measurement. A fit of the energy spread as a function of the beam en
ergy could then be derived. This process is shown in figure 5.3.
The full set of the MGH depth dose curves were finally created by convolving the entire Golden
data set with the E

fit.

In addition to the Bragg peak set, the spot size as a function of beam energy was needed to
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Figure 5.3: (a) Fitting of a Bragg peak from the Golden data set to its corresponding measured peak.
The measured peak was first corrected for the Halo effect component. The energy spread for that
specific peak could then be determined. (b) Derived fit of E as a function of beam range (energy)
which can be used to conveniently generate the TPS beam model’s depth dose curves. Modified from
Clasie et al. [11].

complete the TPS beam model. The spot size data was acquired as straightforward measure
ments using the Beam Imaging Device (BIS) from IBA™. The BIS consists of a high resolution
scintillating screen and a readout CCD camera system. A single irradiation was performed
with a single central spot at 26 distinct energies (layers). The energies ranged from the lowest
to the highest available. The BIS was placed in air at the isocenter and a single snapshot was
acquired for each layer. A simple Matlab™ routine was utilized to fit each spot with a Gaussian
function from which the spot size value (Gaussian’s a parameter) could be obtained. A fit of
the spot size as a function of beam energy was then derived. Figure 5.4 shows a single spot
analysis with its Gaussian fit as well as the derived fit of spot sigma as a function of beam
energy.
Once the entire beam model was acquired, Astroid was able to compute dose using a pencil
beam algorithm (PBA). Thus, treatment plans could be generated following a defined pre
scription. A single or multiple beam approach may be utilized. Either way, each beam used
in a plan presents a specific target that is segmented into a fixed-size grid on which spots
are placed (e.g. figure 5.5). The dose delivered to this target by the given beam is then com 
puted in water using a nominal 1 Gp fluence per spot. The contribution to each voxel j, from
each spot i, gets recorded as bixels in a D j matrix, or bixel. The fluence in each of these
bixels is then optimized by the system in order to meet a set of user-defined constraints. The
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multi-criteria optimization process then results in the generation of anchor plans located on
a Pareto-optimal surface based on objectives set by the user. These anchor plans are sub
sequently navigated by the user in order to obtain a desired treatment plan. This navigation
process and the limitations of the specified constraints and objectives are further discussed
below.
Solely these succinct descriptions of the PBA model and the optimization/navigation algorithm
are provided here because original work was not performed on either of them. Instead, for
further information the reader is invited to refer to the work by Hong et al. [81] concerning the
PBA model, and the work by Craft et al. [114], Craft et al. [115], and Chen et al. [116] con
cerning the generation and navigation processes of Pareto-optimal surfaces for multi-criteria
optimization purposes.
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Figure 5.4: a) Fitting of a single spot size using Gaussian approximations in X and Y directions; b) spot
size as a function of energy for the cardinal gantry angles along with the final fit.
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5.3
5.3.1

Challenges in PBS planning
Spot placement

A scanning target volume (STV) is defined as a uniform 6 to 10 mm expansion of a dosimetric
target volume (GTV, CTV, or PTV based on physician guidelines). The aforementioned STV is
used by the system to geometrically place spots around the target. The spots are placed on
a fixed-size grid determined laterally by the spot size (a) at a given depth, and in depth as a
function of the width W 80 of the distal Bragg peak. The width W 80 corresponds to the width
of the distal 80 % point minus the proximal 80 % point along the Bragg peak curve. These
parameters are set by the user, with typically 1 a between the spots laterally, and 0.8 x the
distal W8o in depth. This spot placement methodology is appropriate within the target volume
as it results in an adequately homogeneous dose. On the other hand, this approach presents
heavy limitations at the edge of the tumor which can potentially result in non-optimal treatment
plans. This is true when high density variations are present at the tumor/tissue interface or
when organs at risk (OAR) are directly adjacent to the tumor.
A tumor located at the edge of the lungs, for instance, will result in spots which are placed
geometrically close to the tumor (« 1.05 g/cm 3 density) but within the lungs (« 0.4 g/cm 3 den
sity). The large density difference will translate dosimetrically to spots with drastic overshoot
in the low density region. This phenomena is illustrated in figure 5.5 where spots within the
lungs, such as spot (A), will result in large overshoot and poor contribution to the actual target
volume. It then becomes difficult to provide adequate coverage at the tumor interface without
allowing unnecessary hot spots inside or outside of the target volume. This issue could be and will be - solved by considering a spot placement based on water equivalent path length
rather than a purely geometrical expansion. The STV would then correspond to a non-uniform
expansion of the dosimetric target.
Spots are sometimes non-optimally placed around the tumor edges which is due to the fixedsize grid placement approach. In such instances, the closest spot to a given target’s edge
might already be far from that edge. Thus, the optimizer will have to put extra dose either
inside the target along the edge or in that spot outside the target. The close proximity of an
OAR can then be problematic as the OAR sparing could be compromised due to hot spots.
One solution to mitigate this issue is to give the user the possibility to manually adjust the
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spot placement around the dosimetric target. The optimizer would then be able to produce
increased tumor coverage with greater OAR sparing. This solution, however, is not optimal
as it would require a more iterative planning process with added computation time in order
to optimally adjust the position of the spots. Another solution to this problem has been sug
gested by van de Water et al. [117] using an automated ’ resampling” process. In their own
words, ’’resampling consisted of repeatedly performing: (1) random selection of candidate
pencil beams from a very fine grid, (2) inverse multi-criteria optimization, and (3) exclusion
of low-weight pencil beams” . At the time of redaction, neither of these solutions has been
investigated for Astroid.

Figure 5.5: Fictive spot placement
along a fixed-size grid based on the
geometrical STV expansion. Such
fixed-size grid might result in poor op
timization capabilities along the edge
of the dosimetric target due to large
density variations, such as in spot (A).

5.3.2

Multi criteria optimization

Astroid uses only convex mathematical functions. Thus, the quality of the user-defined MCO
parameters is critical as it can significantly affect the quality of the final plan. It is generally
admitted that a minimal set of hard constraints should be specified in the MCO as it defines the
boundaries of the optimization (hard constraints in convex mathematical functions cannot be
violated). Thus, constraints are only specified for ’’appropriate” target coverage and a few OAR
based on the prescription given by the physician. Pareto-optimal plans are then generated
based on a more extensive set of objectives. These objectives thus define the optimization
space that can be navigated by the user. The number and quality of these Pareto-optimal
plans vary greatly as a function of the maximum number of iterations the optimizer is allowed
to run (specified by the user). This may further affect the quality of the final plan. These effects
are limited in simple cases due to the fact that the optimization is mathematically simple and
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every solution is ’’acceptable” . This is true, for instance, when the target is clearly defined within
homogeneous tissue with critical OAR located further away from the tumor’s edges. In most
cases, however, critical OAR abut the target and/or the prescription is specified at multiple
dose levels which tremendously increases the mathematical complexity of the optimization.
In such cases, the more iterations the optimizer is allowed to run for, the better the balance
between OAR sparring and target coverage. The obvious drawback is the drastic difference
in computation speed.
In order to obtain better plans, it is also possible to go through a more iterative process using a
smaller number of maximum iterations. The plan can quickly be run multiple times using a set
of hard constraints which can be adjusted after each iteration, hence using the previous end
point as the starting point. In larger problems, however, a set of constraints might become
’ infeasible” while in reality it is achievable through the multi-criteria optimization process. It is
therefore useful to run a final computation with a ’ feasible” set of constraints for a large number
of iterations allowed for the optimizer. This methodology is efficient and permits the user to
achieve the most optimal treatment plans. Unfortunately, it comes at a high cost of resources
which are limited by the time and computation power available at the time of planning.

5.3.3

Machine related limitations

As previously suggested, the PBS machine parameters are very limited: a set of available
energies along with their respective energy spread and beam size at isocenter. Neverthe
less, these few parameters have a dramatic influence on the quality of the plan that may be
achieved.
The range of available energies determines the range of treatable depths as well as the possi
ble need for range shifters. The use of a range shifter not only reduces the deepest reachable
distance within the patient, but it also affects the size of the beam at isocenter due to multiple
scattering. Furthermore, its use may be impractical due to the weight and time required for
installation. An extensive air gap might also be required in order to avoid collision issues. The
air gap will further emphasize the beam size increase due to geometrical considerations. Al
though the effect of the beam size increase is negligible for a machine with a large spot size (>
10 mm), it results in a poorer plan quality for a machine presenting a small spot size (« 5 mm).
Additional considerations on the use of a range shifter are the large reduction in the quality
of beamline X-ray imaging as well as the potential safety concerns in case of it falling on the
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p a tie n t d u rin g tre a tm e n t.

The energy spread dictated by the beam transport line affects the width W 80 of each Bragg
peak. A larger energy spread results in slightly poorer homogeneity control between layers,
but this issue is negligible as the spread is, by definition, minimal when using the PBS delivery
mode.
As already suggested by the issues raised by the use of a range shifter, the beam a repre
sents the main machine related limitation. The beam size changes as a function of energy
because more energetic protons spread significantly less while traveling through the beamline
due to their higher velocity. A more energetic beam therefore results in a drastically small a
at isocenter. A smaller beam size results in a greatly improved target conformality and OAR
sparing compared to a larger beam a (van de Water et al. [118]). Thus, there has been a
race to the smallest proton PBS beam size in order to offer the optimal proton treatment.
The question thus becomes: how small is ”small”? This is a complicated question to answer.
The real issue linked to the beam size arises due the proximity of critical OAR to the target
volume. A smaller spot size will result, by definition, in both sharper penumbras and added
spot positions along the fixed-size grid. The MGH’s spot size, at the time of writing, is quite
large (k 8 to 16 mm). This results in extraneous dose outside of the target volume. The future
machine at MGH will present a significantly smaller spot size (expected k 2 to 5 mm), thus
offer a much greater control of the dose conformality. At the presently available sizes, a small
improvement in the current spot size would result in clinically significant changes in the treat
ment plan’s quality. Conversely, a small increase in the expected future a would only slightly
worsen the quality of the plan as the beam itself is smaller than the MCS spread through the
patient. An alternative to improve a treatment plan using a large spot size is to utilize hardware
- apertures and range compensators - which then limits the dose distally and laterally, hence
improving the dose conformality (Dowdell et al. [51]). It should be noted that despite the fact
that a smaller spot results in significantly better plans, it also requires drastically more time
and computing power to optimize due to the higher problem complexity (many more spots to
optimize). There are also a few practical implications from a treatment delivery point of view.
Not only do the large number of spots result in a significantly increased treatment time, but the
absolute delivery constraints must be significantly tighter in order to ensure the safety of the
treatment. In this case, the plan robustness might be more easily affected. Although not yet
available, one solution to these issues would be to consider an on-line modulation of the spot
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size. Large spots could be delivered within the target while small spots could be delivered
around the edges of the tumor. Such a system would ensure optimal quality for the treatment
plan (target homogeneity and OAR sparing) as well as optimal treatment delivery speed and
convenience.

5.3.4

Treatment robustness

Passively scattered proton fields, or homogeneous PBS fields, deliver a homogeneous dose
within the whole target volume; at the exception of patch fields. A perturbation in any direction
will result in small variations and is thus mitigated with the use of geometrical margins (beam
specific PTV). When considering intensity modulated PBS fields, however, it gets a bit more
complicated as beam perturbations will result in local disruptions of the dose homogeneity.
The beam perturbations arise from multiple sources such as range uncertainties, setup shifts,
and patient motion (especially breathing motion). Setup shifts, for instance, might displace the
beam along heterogeneities where a large water equivalent path length difference might occur.
This discrepancy could then result in a significant under/overshoot of single pencil beams.
Range uncertainties represent the main limitation of proton therapy and many research studies
aim at improving this issue. These range uncertainties occur due to setup quality, quality of
the CT units’ conversion to relative stopping powers, beam degradation, etc.
As a consequence, the ”robustness” of each field as well as the overall plan is an important
factor which should be taken into consideration for PBS treatment planning. At the time
of redaction, however, there has not been an exact set of guidelines or methodologies to
ensure the robustness of the treatment. Solutions such as geometrical margins, inter-pencil
smearing, or large hot spots within the target volumes have been suggested but not yet fully
assessed. For the time being, one can only infer on the treatment’s robustness a posteriori
through recomputations of the nominal plan under different scenarios. An example of this
robustness analysis is presented below in a practical case. Such analysis only permits the
ability to judge the quality of the plan’s robustness but not to improve it. Thus, a plan that is
shown not to be robust within clinically acceptable margins will have to be regenerated from
the beginning, with its robustness re-assessed.
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5.4

A practical example: PMRT

Radiation therapy has been an effective tool in the management of patients with breast can
cer. The radio therapeutic treatment has been shown to improve local tumor control and
potential survival benefits (Ragaz et al. [119]). Over the years, numerous improvements such
as heart blocks, CT-based planning, intensity modulation, or breath holding (Krueger etal., Lu
et al., Remouchamps etal. [120, 121, 122]) have been implemented. These ameliorations
have permitted a greater tumor coverage as well as a reduction in the dose to the lung and
cardiac structures. Despite these efforts, the heart dose remains an issue for many patients
(Gyenes et al., Darby et al. [123, 124]). This is true for patients undergoing mastectomy,
in which post-mastectomy radiation therapy (PMRT) targets the whole chest wall as well as
the potentially involved lymph nodes (axillary, supraclavicular, internal mammary) after mas
tectomy. Thus, it is necessary to balance tumor coverage and the risks of cardiac failure.
Several treatment planning studies have demonstrated significant dosimetric advantages of
the use of proton therapy in reducing cardiac and lung doses while improving target coverage
(Ares etal., MacDonald et al. [125, 126]).
While double-scattering proton therapy achieves these primary goals, certain aspects are less
than ideal. The limitation in field size imposes the use of multiple fields which results in hot
and cold spots along the matchline. Furthermore, the fixed modulation drives the skin to re
ceive the full prescription dose. As a consequence, the use of PBS for PMRT treatment has
been investigated at MGH (Jimenez et al. [127]). Two of the most distinctive features of PBS,
intensity modulation and larger treatment field size, are critical elements for improving proton
PMRT. In this section, we therefore present the treatment planning techniques employed in
order to obtain optimal PBS PMRT treatment. It should be noted that only post-mastectomy
patient, with or without breast reconstruction with implants, are considered for proton therapy.
Indeed, the mobility of an intact breast or of a breast reconstructed with tissue, makes them
poor candidates for proton therapy for which position reproducibility is key.
As previously discussed, although the quality of the treatment depends on the planning pro
cess, it is also largely affected by the practical considerations of the machine. For this reason,
this work also highlights the efforts realized in patient setup and treatment delivery in order to
further improve the use of PBS for PMRT treatment. The robustness of the treatment plan
was also evaluated a posteriori.
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5.4.1

Patient setup

PMRT patients are setup on a breast board used for conventional photon/electron treatment.
The angle of the breast board is raised at the highest angle possible, limited only by the bore
size of the CT scanner. The angle helps the surface imaging system used during patient setup.
Various additional steps have been taken in order to improve the patient position reproducibil
ity: the original breast board head rest has been replaced by a head cup generally used for
head and neck treatment to better control the neck position; a chin strap and hand grips are
provided to further remind the patient of their chin and arm positions. Historically, the patient’s
arms are generally raised above their head. This is due to the collision issue during treatments
with conventional photon tangent fields. Such consideration is not necessary for PBS treat
ment due to the use of en-face fields. Thus, a new akimbo-like position with the arms down
has been evaluated for PBS treatment. Figure 5.6 shows both setup positions for the same
patient at the time of CT scan.

This novel akimbo position presents several advantages for PBS treatment:

• Comfort: PMRT patients usually come in for radiation therapy shortly after their mas
tectomy surgery which leaves them with painful scars around the breast tissue. This
makes it particularly difficult, and sometimes unbearable, for them to keep their arms
raised above their head.
• Accuracy: as the patient gets tired and/or relaxed during the course of a treatment ses
sion, their arms tend to move downwards relative to their bust. This potentially changes
both the position and shape of their axillary and suprclavicular nodes which could result
in an inaccurate treatment.
• Practicality: not only is the raised-arm position difficult to reproduce, but the elbows and
the breast board’s arm cups are generally located outside of the CT’s reconstruction field
of view. This results in potential collision and reproducibility issues of the snout during
treatment.

One drawback of using an akimbo-like position is the hardening of the beam through the
arms’ bony structure, creating artifacts in the CT. However, the conversion curve between CT
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Figure 5.6: PMRTpatient setup at the time ofCT scan: (a) conventional arms up setup position, (b)
novel arms down setup position; in both cases, a chin strap and hand grips are used to ensure better
reproducibility of the setup position.

HU and the proton relative stopping power ratios (RSP) is adjusted on a patient/scan specific
basis. The beam hardening therefore does not affect the quality of the plan nor the dose
calculation.
In the case of a larger patient, unwanted underarm skin flaps might be in the beam path. These
skin flaps could affect the treatment reproducibility and create areas of hot spots on the skin.
For such a patient, the conventional arms-up setup position would be used for treatment.

5.4.2

Treatment planning

The target for PMRT is usually composed of the whole chest wall (CW) and the potentially
involved lymph nodes (axillary, supraclavicular, internal mammary).
Planning objectives are generally defined as follow:
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• 45 Gy(RBE) to the chest wall and all nodes, followed by a 5.4 Gy(RBE) boost to the chest wall(s)
and the internal mammary nodes (IMN) for a total dose of 50.4 Gy(RBE)
• 48 Gy(RBE) max dose to the chest wall’s skin (« 3 superficial mm)
• 3 Gy(RBE) max dose to the left anterior descending coronary artery (LAD)
• 5 Gy(RBE) max dose to the heart ventricles
• < 1 Gy(RBE) max mean dose to the heart
• V20 < 15 % for each lung
• 42 Gy(RBE) max dose to the thyroid
• 40 Gy(RBE) max dose to the esophagus

Range uncertainties are primordial in proton therapy as they can rapidly result in an under
dosing of the target and/or over dosing of the OAR.
For patients without a breast implant, the chestwall target volumes are usually very shallow
with a required beam range of 3 cm or less. The associated uncertainty is thus only around a
millimeter and can be practically ignored, being comparable to uncertainties in CT scanning,
contouring, etc.
For patients that undergo reconstructive surgery, however, the implant will result in a deeper
treatment range, hence larger range uncertainties. Measurements were thus performed in
order to accurately assess the relative proton stopping power ratio (RSP) of the material inside
breast implants. Specifically, a Bragg peak of a known energy/range was irradiated through
a water phantom with and without a box containing the material found in breast implants.
The range degradation was then evaluated. Based on the conversion curve used for dose
computations[70], the Hounsfield units found in breast implants correspond to RSP of 1.02 on
average, as evaluated on 10 patients. The range pullback observed during the experiments,
on the other hand, yielded a value consistent with a material of 0.92 RSP. During the planning
process, the breast implants are therefore contoured and their RSP values homogeneously
overridden to 0.92. The omission of this correction would result in Astroid computing each
pencil beam with a 10 % pullback error, translating to a 10 % overshoot during treatment
delivery. With the contribution from the breast implants entirely eliminated, the resultant range
uncertainties consist only of those found in the real chestwall tissue, and can therefore be
practically ignored.
PMRT plans are generated with a single geometric en-face field 30° from vertical. This field is
first assigned to the 45 Gy(RBE) volume (CW + involved nodes) for 25 fractions, then to the
50.4 Gy(RBE) volume (CW+IMN) for 3 fractions. Pareto-optimal plans are generated through
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the optimization of the proton fluence in the individual spots based on the abovementioned
set of constraints and objectives. The set of Pareto-optimal plans are then navigated to a
desired state. The target coverage and dose to the cardiac structures can then be optimally
balanced through intensity modulation. Likewise, it is possible to reduce the skin dose to an
acceptable level, especially in the supraclavicular nodal region which is located deeper within
the body. Figure 5.7 shows a nominal PBS PMRT plan generated for clinical use at MGH.

Dose (Gy (RBE))

Figure 5.7: A proton PBS PMRT plan and its associated dose-volume histograms (DVH), as intended
for treatment at MGH.
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The treatment plan shown in figure 5.7 was also regenerated using a fictitious machine with
a much smaller spot size (2 to 5 mm instead of 9 to 16 mm, as a function of energy). This
machine corresponds more or less to a future proton machine that will be installed at MGH.
The new plan was optimized and navigated with the exact same set of constraints as the plan
intended for treatment. This fictive plan is presented in figure 5.8.
This fictive plan highlights the dramatic effect of the machine parameters on the plan’s quality.
There is a clear advantage of using a smaller spot size; the IMN coverage is optimal and the
only loss in target coverage is fortuitous, due to superficial skin sparing. The drastic reduction
in beam penumbra results in higher tumor conformality and far greater OAR sparing with vir
tually no dose given to the contra-lateral lung.
The PBS PMRT plans generated for clinical treatment at MGH are already considered to rep
resent a great improvement over conventional photon/electron therapy (Depauw et al. [44]).
The use of a better/newer proton accelerator would therefore help reach the optimal treatment
plan.
On the down side, the computation of this plan with such a smaller spot size took approxi
mately five times longer than the clinical plan intended for treatment. The implementation of a
much faster dose computation algorithm and/or cloud computing is therefore needed to fully
take benefit of the better machine. Additionally, such a treatment plan results in a drastically
more complicated treatment delivery. The dramatic increase in the number of spots to be
delivered would translate to a significantly longer treatment time. Moreover, the thresholds
associated with beam delivery safety would be much tighter due to the smaller spot size,
making the delivery much more strenuous on the system.

5.4.3

Plan robustness

As previously discussed, for the moment the robustness of a plan can only be assessed a
posteriori, and thus only be performed through recomputations of the nominal plan under dif
ferent scenarios. The robustness of both presented nominal plans (figures 5.7 and 5.8) have
then been evaluated against breathing motion and setup shift uncertainties.
The analysis of the setup shift uncertainties was performed as a recomputation of the nominal
plans with the introduction of geometrical perturbations. The perturbations were as follow: ±
3 mm along each translation axis (lateral, longitudinal, vertical), ± 2 ° along each rotation axis
(yaw, pitch, roll), and a combination of all aforementioned ± shifts in all 6 directions simulta-
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Figure 5.8: A proton PBS PMRT plan based on the use of a fictitious machine with a small spot size
(2-5 mm) and its associated DVH.

neously. DVH data were then generated for each scenario. The composite dose distribution
based on the average of the individual shifts was also computed and its DVH generated. This
average dose distribution corresponds to the expected treatment over the course of treatment
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due to the statistical randomness of the shifts based on a large fractionation scheme. The
result of this analysis is presented in figure 5.9 as DVH envelopes which correspond to the
maximum amplitude of the resultant perturbations in the original plan.

Figure 5.9: DVH envelopes based on the robustness analysis of the setup shifts (± 3 mm, ± 2 ◦)
performed on previously presented PMRT patient plans (solid line); (a) MGH clinical plan, (b) small spot
plan. The thick dotted lines correspond to the composite dose distribution based on the average of
the individual shifts’ doses.
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The setup robustness analysis considered individual systematic shifts as well as a combination
of all these shifts. The combination of all of the shifts is considered a worst case scenario.
In reality the worst disturbance would arise from a distinct patient-specific combination of
the individual perturbations. This, however, cannot be easily quantified, and the proposed
methodology is believed to be a fair representation of the worst case scenario. Consequently,
it is admitted that any combination of those shifts (< ± 3 mm, < ± 2 °) will be contained
within those DVH boundaries.
The analysis of the robustness of the setup shifts resulted in appropriate stability of the tumor
coverage, hence showing the adequate robustness of such plans. Although the effect on
most OAR is small, the IMN, thyroid, and esophagus (which are dosimetricly linked) suffer
significantly more from these setup shifts. Nevertheless, the IMN coverage remains higher
than with conventional photon/electron therapy.
As expected, these perturbations have a larger effect on a plan based on a smaller spot
machine as compared to the current MGH machine. This is explained by the fact that the
amplitude of the shifts is comparable to the size of the beam. The nominal dose distribution
with the smaller spot size, however, is far better than the intended clinical plan, and the worst
case scenario remains similar to the treatment deliverable currently.
In both cases, the composite dose distributions based on the average of the individual shifts’
doses are remarkably close to the intended treatment. These DVH deviations are therefore
considered clinically acceptable, and the plans reasonably robust. A more consistent set of
analyses based on a large cohort of patients will be performed in the future to actually quantify
the robustness of the offered PBS PMRT treatment.
For the breathing motion study, a 4D-CT scan of the patient was acquired in addition to the
regular planning CT scan performed at quiet respiration. The PBS fields created for the nominal
plans were then transferred to each phase of the 4D CT scan and the dose distributions were
recomputed. DVH were generated for each of the 10 phases as well as for the total composite
dose accumulated through deformable registration, mimicking the actual treatment. Figure
5.10 shows the result of the breathing motion analysis on both the clinical and fictive PBS
plans.
The recomputations of the dose distributions onto the 10 phases of the patient’s 4D CT scan
resulted in little difference for both machine. These deviations, drastically smaller than the
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Dose (Gy (RBE))

Figure 5.10: DVH envelopes based on the breathing motion analysis performed on the previously
presented PMRT patient plans (solid line); (a) MGH clinical plan, (b) small spot plan. The thick dotted
lines correspond to the composite dose distribution based on the average of the 10 breathing phases’
doses.
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ones observed in the robustness analysis, are thus believed to be of no clinical concern. Fur
thermore, the composite dose distribution based on the average of the 10 breathing phases’
doses, which statistically correspond to the actual treatment, are remarkably similar to the
intended plans.
Ideally, these treatment plan robustness analyses should be performed on every single PBS
plan, and should result in specific guidelines for each treatment site at a given institution. Fur
thermore, being able to predict a priori the robustness, or non-robustness, of a given plan,
would be of great advantage for PBS treatment planning and delivery. Unfortunately, the cur
rent technology does not allow for such heavy recomputations due to limited resources and
computing power. The implementation of a much faster dose computation algorithm and/or
cloud computing, would once again prove to be very useful in the execution of such a task.

5.4.4

Treatment delivery

The conventional setup process for most proton centers relies on orthogonal X-ray. First, the
patient is positioned based on tattoos priorly inked at the time of CT-sim, afterwards orthogonal
X-rays are taken at a specified cardinal angle and the patient precisely placed at isocenter;
finally, a beamline X-ray is performed at the treatment gantry angle to finalize the setup position.
This modality was deemed suboptimal for PMRT patients as it considers bony anatomy as a
surrogate for the chest wall position (Fayad et al. [128]). Instead, surface imaging is used as
the primary tool for patient setup as the target volume is both shallow and superficial (Gierga
etal., Cervino etal. [129, 130]). The use of surface imaging results in afasteryet more accurate
patient positioning along with minimal imaging dose (only the final beamline X-ray is required).
An example of a setup surface image is presented in figure 5.11.
Figure 5.12 shows the residual setup errors for 4 patients in all 6 degrees of freedom, based
on the use of surface imaging. The boundaries of the aforementioned robustness analysis
are highlighted as red dashed lines on these graphs. This emphasizes that the use of sur
face imaging for patient setup results in treatment position errors largely within the robustness
analysis limits. Surface imaging is therefore an appropriate tool for patient positioning. Further
more, these residual shifts are a combination of both specific positional shifts and breathing
motion which, statistically, will average out over the duration of treatment and eliminate most
of the undesired dosimetric perturbations.
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Figure 5.11: PMRT patient setup at the time of treatment using surface imaging; the finely dotted pink
mesh represents the skin contour based on the planning CT while the green area represents a daily
setup image that was evaluated for setup registration. The patient could therefore be accurately setup
based on the shallow target, virtually represented by the cyan contour, using the skin surface rather
than bony anatomy.

The accuracy of the skin dose calculated by Astroid was also evaluated for PMRT patients due
to the shallowness of the target. Two fictional plans were generated in a solid water phantom,
one mimicking a non-reconstructed chest wall patient (3 cm Range, full modulation), the other
mimicking a patient with a breast implant (11 cm range, full modulation). Measurements were
subsequently performed using thermoluminescent dosimeters (TLD) at 0, 1, 3, 5, and 7 mm
depth as well as in the center of the fields. Additional measurements were performed at the
same positions using a Markus ionization chamber for absolute dosimetry. The results are
presented in table 5.1
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Figure 5.12: Residual patient setup errors along the 6 degrees of freedom for 4 PMRT patients based
on the use of surface imaging. The red dashed lines correspond to the perturbations used in the
robustness analysis of the setup shifts.
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(a) 3 cm range, full m odulation

Depth
mm
0
1
3.3
5.4
7.6
13

Markus chamber
cGy(RBE)
87.6
91.0
99.2
101.0
97.5
101.5

TLD
cGy(RBE)
86.2
87.5
97.4
98.0
95.8
97.6

TLD error
%
-1.5
-3.9
-1.9
-2.9
-1.7
-3.9

Astroid
cGy(RBE)
93
97
102
102
100
102

Astroid
error %
6.2
6.7
2.8
1.0
2.6
0.4

Depth
mm
0
1
3.3
5.4
7.6
43

(b) 11 cm range, full modulation
Markus chamber
TLD
TLD error
cGy(RBE)
cGy(RBE)
%
88.1
85.6
-2.9
-4.4
90.4
86.5
92.1
94.5
-2.6
95.4
89.2
-6.5
91.2
93.8
-2.8
97.2
-2.1
99.3

Astroid
cGy(RBE)
94
97
97
98
96
100

Astroid
error %
6.6
7.3
2.7
2.8
2.3
0.7

Table 5.1: Comparison of the skin dose for PBS PMRT treatment between Astroid’s predictions, TLD
measurements, and Markus chamber measurements for (a) a field mimicking a PMRT treatment without
a breast implant (3 cm range, full modulation), and (b) a field mimicking a PMRT treatment with a breast
implant (11 cm range, full modulation).

The TLD and Markus Chamber measurements agree within 5 % of each other, matching
expectations {Zullo et al. [131]). Those measurements are also in good agreement with the
TPS values for depths of 5 mm and beyond. The closer the measurements were from the
skin, the larger the TPS’s discrepancy, reaching 7 % at the superficial skin. This shows that
Astroid slightly overestimates the superficial skin dose for PBS treatments. Although this result
is similar to computations performed by photon TPS (Qi et al. [132]), the reasons are quite
different. In the current version of Astroid, this discrepancy is explained due to the omission
of the proton build-up when a range shifter is used, in its current version {Clasie et al. [ 1 1 ]).
In order to confirm this hypothesis, the two aforementioned plans were re-generated using a
fake range shifter burned directly into the CT scan rather than using Astroid’s internal range
shifter model. These new plans agreed within 2.5 % of the Markus chamber measurements
at any depth, as illustrated in figure 5.13.
The current discrepancy introduced by Astroid, however, is not considered an issue from a
clinical point of view as it provides further skin sparing, which is desirable. Tangential photon
fields commonly deliver« 43-45 Gy(RBE) to the superficial skin through the use of bolus. PBS,
on the other hand, is planned with « 48 Gy(RBE) which then translates to « 45.5 Gy(RBE)
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Figure 5.13: Comparison of the skin dose for PBS PMRT treatment between Markus parallel plate ion
chamber measurements and Astroid’s prediction based on the use of a fake range shifter rather than
the system’s internal range shifter algorithm.

actual dose after a 5 % correction.

5.5

Conclusion

The current treatment planning methodologies for PBS at MGH have been described in this
work. Although Astroid’s MCO capabilities greatly improve the planning experience and the
quality of the treatment plans, it suffers from multiple limitations. From a treatment point of
view, the main limitation resides in the machine parameters themselves, especially the size of
the beam. It was highlighted that a machine with a smaller spot size results in better tumor
coverage along with better OAR sparing. From a technical point of view, however, a smaller
spot size results in a significantly longer computation time and computing power needs. The
issue of spot placements, due to the fixed-grid size approach, also translates into the need for
stronger computing power. With faster computation algorithms, the spot placements could
be optimized internally by the system through an iterative process. The robustness of a PBS
PMRT plan was evaluated on a single plan only due to the large resource requirements to
perform a more systematic study. An institution would greatly benefit from the capability to
perform a priori robustness analyses for any plan. This, again, translates into the need for a
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faster computation algorithm and extended computing power.
Additionally, it was discussed in section 2.4.2 that the pencil beam algorithm commonly used
for proton treatment planning was lacking in accuracy in the presence of large heterogeneities.
Although, these inaccuracies are generally within the clinically acceptable range (2 %), they
can sometimes be far greater for patients with unfavorable geometry, such as in lung cancer
patients [24]. In such cases, one must turn toward Monte Carlo dose calculation algorithms
which offer single particle tracking models. Thus, these MC algorithms result in appropriate
estimations of the dose along large heterogeneities.
With these current limitations in mind, an extremely simplified Monte Carlo algorithm was
developed within the Astroid framework. This Monte Carlo engine offers greater accuracy
than PBA algorithms as well as faster, more parallelizable computations, which can be used
to overcome some of these computing speed needs.
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Chapter 6

Fast MC dose algorithm
6.1

Introduction

As previously discussed, proton therapy treatment planning systems (TPS) are currently rely
ing on a pencil peam plgorithm (PBA) for dose computations in patient (Hong etal. [81]). PBA,
while relatively fast, fails to fully model the effects of heterogeneities which can be critical dur
ing delivery, e.g. for lung tumor treatment. It is therefore necessary to turn towards full Monte
Carlo (MC) systems such as GEANT4 in order to obtain the most accurate dose represen
tation in patients. However, these systems have a large overhead and generally comes at a
high time and resources consumption. For this reason, full MC dose computations are usually
reserved as an independent dosimetry check, rather than for actual treatment planning. Thus,
there is a real necessity for an improved dose calculation engine in radiation therapy.
We propose a simplified MC algorithm for proton dose calculation. The latter, known as GMC
['gImIk] (A unique or quirky special feature that makes something ”stand out” from its con
temporaries.), was intended to be extremely fast yet accurate against tissue inhomogeneities.
GMC’s implementation is intended to be at the lowest level of the MGH proton TPS, Astroid,
hence simply replacing the current clinical PBA engine. 1

1This work was partially presented at the International Conference on the Use of Computers in Radiation Therapy(Depauw et al. [55]), and published in their proceedings(Depauw et al. [56]).
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Figure 6.1: GMCs particle transport model at the voxel level.

6.2
6.2.1

Algorithm implementation
Specifications

Figure 6.1 shows a representation of the particle transport in GMC at the voxel level. A par
ticle enters a voxel (volume V, density p) with certain input parameters: current energy (Ei),
relative position (xi,yi,zi) and direction cosines (ui,vi,wi) within the voxel, and initial energy
(E0) (energy at the entrance of the phantom/patient). A cord length (L) is computed from a
non-scattered transport of the particle (straight line) through the voxel. For Coulomb scat
tering, the mean radial scattering angle is subsequently computed from the scattering power
described by Gottschalk [133], as shown in equation 6.1, and applied midway through the
cord (L ).
{e2} = f TdMdx « TdMi
J0

x

L

(rad2),

(6.1)

with,
TdM = fdM(Ei,Eo) X (

X X-,
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where,
fdM =

0.5244

+

0.1975 x log10(1 -

E■
a 2320 x logio(M e v )

-

(

)

+

( )2
E■
/e A
0.0098 x logio(Mew) x logio(1 - (
)

(6.3)
(MeV)>

0 is the average radial scattering angle, x the distance already traveled by the particle along
its track in cm, Es = 15.0 MeV, and X s = 46.88 cm.
The azimuthal scattering angle is a random variable between 0 and 2n.
The Halo effect, due to the protons’ nuclear interactions (inelastic), is evaluated based on
a particle’s remaining energy E i. The nuclear interaction probability as a function of particle
range in water is described in Paganetti [12]. GMC relies on a fit of the probability of interaction
per centimeter. This fit, as seen in equation 6.4, is a function of energy based on Janni’s
energy-range power-law relationship in water (Janni [ 66]). The resulting nuclear interaction
probability per centimeter as a function of energy can be seen in figure 6.2. Upon nuclear
interaction, the proton will undergo large angle scattering while releasing, on average, half of
its kinetic energy to another proton that will scatter with a similarly large angle (see section
2.2.1). For simplicity and computational speed purposes, GMC only halves the energy but
doubles the weight of the primary particle deflecting it with a large radial scattering angle
only (0.2 radians); the secondary particle itself is not tracked. It is believed that the statistical
nature of these nuclear interactions will naturally compensate for the imbalance created by
only tracking the primary proton with the additional weight. Similarly to Coulomb scattering
processes, the azimuthal angle remains variable between 0 and 2n.
dP
— = 9.297
dR

x

E ~ 0-509

(%.cm-1 )

(6.4)

where, jR is the particle’s probability of nuclear interaction per centimeter of range (based on
E 0), and E i the remaining particle energy in MeV.
The mean energy loss A E is based on the initial proton energy E 0 and the trapezoidal ap
proximation of the integral under the curve of its corresponding Bragg Peak. The set of Bragg
peaks for all energies is given by Astroid’s PBS beam data based on Clasie et al. [11], as
described in Chapter 5. The local dose deposited A D is then computed from equation 6.5,
assuming a relative mass stopping power ratio equal to unity. This process is highlighted in
figure 6.3 for a 150-MeV proton.

6- Fast MC dose algorithm ~ N. Depauw, PhD thesis, 2014 - CMRP, UOW

110

3

O'----------------------1
----------------------1
----------------------1
----------------------1
----------------------1

0

50

100

150

200

250

E (M eV)

Figure 6.2: n't of the nuclear reaction probability per centimeter as a function of remaining energy,
based on the data from Paganetti [12].

AD ——
pV

(Gy),

(6.5)

where,
A E — smaeUm x L x ( d E )
— [ X2 f ( X )d X
V dx J water
J Xi

(MeV),

(6.6)

and,

[ X2 f ( X )d X « p L f (X2) + f ( X l)
2

(6.7)

Jx 1

where, s md iUm is the relative mass stopping power ratio (unitless), and f X f ( X )d X the
integral below the Bragg peak curve in which X 1 and X 2 are based on the current particle
energy E i in MeV; f ( X ) is given in units of Gy.mm2, and X 1 and X 2 in g/cm 2.
At the TPS level, spot positions for a particular beam are internally selected based on the
requested target. The relative dose contribution from each spot j to point i, also known as the
D ij matrix, is then computed based on one gigaproton delivered per spot. One D ij matrix is
computed per beam. The subsequent optimization/navigation process modulates the number
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Figure 6.3: Dose deposition model based on Astroid’s PBS beam data(Clasie et al. [11]).

of protons per spot in each field as a whole in order to attempt to obtain the best compromise
between the objectives specified by the user.
GMC is implemented at the lowest level of Astroid within the D j matrices computation, in lieu
of the former PBA engine. It operates at the bixel level, that is, the computation of the dose
contribution in patient from each spot based on one gigaproton. This calculation takes into
account the machine parameters such as SAD, in order to obtain accurate beam transport,
and the initial spread information (beam sigma in air as a function of initial energy). For more
details about the higher level hierarchy of Astroid, please refer to Kooy et al. [45].

6.2.2

Double-Scattering algorithm

GMC can also be adapted for proton double-scattering dose computations because a SpreadOut Brag Peak (SOBP) is the combination of multiple pristine Bragg Peaks, as shown in figure
6.4. As such, the initial energy E 0 of the beam could be evaluated from the SOBP range from
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Figure 6.4: A Spread-Out Bragg Peak (SOBP) based on individual pristine Bragg peaks; this is part of
Astroid’s DS beam data.

Janni’s energy-range power-law relationship in water as described in equation 6.8 (Janni[ 66]).
Eo « 30.486 x R 0-576

(MeV)

(6.8)

where, R is the SOBP range in cm, and E 0 the corresponding incident energy of the beam.
Furthermore, in DS mode the dose deposition in the TPS is in relative units only. The field
could therefore be computed based on an arbitrarily chosen scale, such as 100 cGy, and
then be appropriately normalized according to the plan’s prescription.
The energy deposited could be derived from the trapezoidal approximation of the integral un
der the SOBP curve, similarly to the PBS mode. The remaining energy after each interaction
would be based on a fraction of the initial energy E 0.
The scattering power could be computed based on E 0 and the remaining energy, using equa
tion 6.1.
A different approach might have to be implemented concerning nuclear interactions. Some
additional specific measurements as a function of equivalent field size would probably be
needed.
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6.2.3

Portage to GPU

The use of a Graphical Processing Unit (GPU) can drastically improve the performance of any
parallelizable algorithm.
For GMC, there is an obvious gain to be performed as each spot is individually computed.
There are pitfalls associated with the GPU architecture, such as difficulty of code debugging
and non trivial memory considerations. For this work, a so-called ”pseudo-code” - a version
of the algorithm that is first implemented on a CPU architecture - was generated in order to
validate and easily debug the various processes of the algorithm.

6.3

Validation of GMC’s algorithm

GMC’s dose computation algorithm was tweaked and verified based on the evaluation of the
physical observables.

6.3.1

Absolute depth dose distribution

Computation were first performed in a virtual water phantom using a single monochromatic
point source. The machine SAD was considered infinite and the incident beam did not present
any angular spread in order to match the generation parameters of Astroid’s input beam model.
The overall depth dose curve was visually inspected and the integral as well as range R80 were
computed. These depth dose distributions were then compared to the input data from MGH’s
beam model for all 129 available energies.
The input beam model is expressed in absolute units of Gy(RBE).mm2.Gp_1 in accordance
with the convention set by Pedroni et al. [112]. These peaks correspond to the integrated
depth dose along the beam path. A small discrepancy in range R 80 was therefore expected
in GMC since the cumulative track length of each particle through the phantom would appear
slightly shortened due to the added small scattering angles. In order to compensate for this
effect, it was necessary to virtually scale the curves from the input model. The range analysis
based on the first set of simulated depth dose curves could thus be used to evaluate the
correction needed. Rather than stretching the actual input data, GMC slightly decreases the
apparent cumulative distance traveled after each interaction/dose deposition. This correction
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is performed based on the formula described in equation 6.9.
RtweakE = 0.9991 —0.000004 x E 0

(6.9)

where Rtweak is a unitless scaling factor, and E 0 the incident energy of the particle in MeV.
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Figure 6.5: Depth dose comparisons between GMC simulations and Astroid’s beam model data for
(a) a 91.015 MeV beam, (b) a 175.82 MeV beam, and (c) a 223.25 MeV beam. The simulations were
performed in a 2 x 2 x 2 mm voxel geometry with infinite SAD and no initial spread (point source at
surface) after path length correction, per equation 6.9; (d) remaining range discrepancy between GMC
simulations and Astroid’s beam model data after path length correction.

Figure 6.5(a-c) shows the matching depth dose distributions between the input beam model
and GMC’s computations for three beam ranges after the range correction. Figure 6.5(d)
shows the remaining error in range as a function of beam energy. The curves show ex
tremely good agreement in absolute dose highlighting the proper dose deposition mechanism
of GMC’s algorithm. The remaining range discrepancy after path length correction is close to
null with an average of -0.03 ± 0.02 mm, well beyond clinical expectations.
The proton stopping power ratio (i.e. density) of the virtual water phantom was then altered in
order to check that GMC adequately deposits dose as a function of medium stopping power.
Figure 6.6 presents three peaks of similar energy but computed with different water densities,
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namely 1.0, 1.5, and 0.75. As expected, the height of the peak in absolute dose remains
constant as a function of medium density but the range R 80 is shifted inversely proportional
to the medium density.
400
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Figure 6.6: GMC simulations in a water phantom made of three different proton stopping power ratios,
namely 1.0 (blue), 1.5 (green), and 0.75 (orange). The height of the curve remains constant while the
range is inversely shifted due to the density difference. Astroid’s beam model data in water (RSP = 1)
is shown for comparison purpose (dashed magenta line).

6.3.2

Scattering power

The same set of computations could also be analyzed for angular scattering as a function
of range. The scattering power, derived from Gottschalk’s formula (see equation 6.1, could
therefore be evaluated. The sigma of the beam was thus automatically computed along the
depth dose curve at every ^ 90/20 increments. The average relative angular spread as well as its
standard deviation based on all 129 energies are shown in figure 6.7, alongside the theoretical
data from Hong et al. [81]. The small bump in the entrance region for GMC’s computations
was believed to arise from the initial absence of spread.This absence of spread resulted in
dose deposition in a single voxel laterally, thus affecting the Gaussian fit.
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This hypothesis was validated by running the same simulations with a much higher lateral res
olution (0.2 mm versus 2 mm) for only a few energies. These results were in perfect agreement
with the Hong model, as shown in figure 6.7.
This result highlight the correctness of GMC's scattering power along the depth dose curve
as a function of energy.

depth / Rg0
Figure 6.7: Comparison of the behavior of lateral spread as a function of depth over range for GMC
(blue line) versus the Hong model (red line). The inital discrepancy is explained by the coarse simulation
resolution in GMC (2 mm cross-section voxels), as proven by the high resolution data (0.2 mm cross
section voxels - green line) based on a few peaks.

6.3.3

Machine parameters

Subsequent computations were performed with a 6-spot map in order to evaluate the cor
rectness of the machine’s geometrical parameters. The geometrical considerations for dose
computation are beam size in air at isocenter and SAD. The positions of the six spots at
isocenter are known from the input map file (these parameters can be found in table 6.1 as
the ’’expected” values). Thus, these tests further ensured the correctness of the map read-in
feature of the code as well as the algorithm’s appropriate spot placement. It should be noted
that the input map file considered for these analyses is the same map file used clinically to
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validate Astroid’s proper implementation of new machines.
Figure 6.8 shows the 6-spot map at the surface of the virtual water phantom for three different
isocenter positions. The adjusted spot position and size can be appreciated, as well as the
different spot size from the distinct incident energies.

Figure 6.8: Entrance lateral dose distribution of a 6-spot map simulated in GMC with difference SSD:
(a) isocenter at 200 mm depth - SSD o f « 1,940 mm; (b) isocenter at the surface - SSD = SAD «
2,140 mm; (c) isocenter 200 mm before the surface - SSD of « 2,340 mm. The initial correction for
position and beam size are appreciable.

Figure 6.9 illustrates the analysis for the machine SAD evaluation, and table 6.1 summarize
the overall results of the analyses. The values obtained for SAD as well as spots’ sizes and
positions agreed well with the expected values, especially given uncertainties in the analysis
due to the 2 mm cross-section voxels.

Figure 6.9: SAD analysis based on the 6-spot map simulations at different SSD. The PBS machine at
MGH is a dual SAD system; each SAD corresponds to the center of a bending magnets (X or Y) that
are used to steer the pencil beam.

These results are well within MGH ’s clinical requirements, and GMC gave slightly better results
than the current clinical pencil beam algorithm. This highlights the accuracy of the modeling
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(a) Position

Spot En#
ergy
(MeV)
1
2
3
4
5
6

145.22
91.015
223.58
206.59
223.58
181.97

Expected X
position
(mm)

Computed
X position
(mm)

Difference
(mm)

Expected Y
position
(mm)

Computed
Y position
(mm)

Difference
(mm)

-90
-90
90
90
-110
0

-90.05
-89.78
-90.07
89.70
-110.01
0.27

0.05
0.22
0.07
0.3
0.01
0.27

-90
90
-90
90
0
0

-90.01
89.82
-90.22
89.96
0.10
0.16

0.01
0.18
0.22
0.04
0.10
0.16

(b) SAD

Orientation

Expected SAD(mm)

Computed SAD (mm)

Difference (%)

X
Y

2340
1940

2342
1945

0.1
0.3

(c) Sigma

Spot En#
ergy
(MeV)
1
2
3
4
5
6

145.22
91.015
223.58
206.59
223.58
181.97

Expected
ax (mm)

Computed
ax (mm)

Difference
(%)

Expected
aY (mm)

Computed
aY (mm)

Difference
(%)

10.36
14.82
7.70
8.25
7.70
8.86

10.56
14.73
7.72
8.35
7.71
8.55

1.9
0.6
0.3
1.2
0.1
3.5

10.36
14.68
7.99
8.97
7.99
9.75

10.77
14.89
8.03
8.99
7.8
10.09

3.9
1.4
0.5
0.2
2.4
3.5

Table 6.1: Summary of the machine parameter analyses based on the 6-spot map simulation with
isocenter at the surface, hence corresponding to beam parameters in air at isocenter: (a) position
accuracy analysis, (b) SAD results as presented in figure 6.9, (c) in air spot sigma at isocenter. These
highlight the excellent overall agreement between GMC and Astroid’s beam model data.

of machine parameters in GMC. This also shows GMC’s proper handling of the input map
reading.

6.3.4

Heterogeneities

A simulation was performed using a virtual a water phantom (p=1.0 kg.m3) in which 4 inserts of
lung (p=0.1 kg.m3) and bony tissue (p=2.0 kg.m3) material were added.Three spots of equal in
tensity and a of 10 mm were placed such that: one spot would go through no heterogeneities,
one spot would first travel through the edge of a lung insert then through the edge of a bony
tissue insert, one spot would first travel through the edge of a bony tissue insert then through
the edge of a lung insert. This setup, as well as the result of the simulation, are illustrated in
figure 6.10. The black overlaying box in the figure represents the lung inserts while the bony
tissue inserts are represented as white overlaying box. All 4 inserts in this simulation were 6
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Figure 6.10: GMC simulation of three 10 mm a spots in a water phantom with heterogeneities: 4
inserts with either lung tissue (black - RSP =0.1) or bony tissue (white - RSP = 2.0). One spot does not
go through any heterogeneities, while the two other spots travel along the edges of the heterogeneous
inserts in reverse order. A clear difference in scattering can be observed, as well as tails of protons that
interacted more with the lung insert than with the bony tissue insert.

centimeters thick.
There is an appreciable difference in dose distributions between the two spots traveling along
the edges of the heterogeneities in reverse order. This is expected due to the difference in
scattering power as a function of remaining energy between the two different inserts. Such
a difference in dose distribution would not appear in PBA dose computations. In such an
instance, all three spots would look similar as the scattering process is only based on the
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equivalent path length along the axis of the spot through ray tracing. This is an important re
sult as it highlights GMC’s ability to handle large heterogeneities. This is in direct comparison
to Astroid’s current PBA.
Although this result corresponds to the theoretical expectations, it is difficult to experimentally
demonstrate it. The subsequent dose computations and comparisons in patients (see sec
tion 6.4) are considered an appropriate validation step, as data has been clinically approved
through QA measurements of the individual patient fields.
A tail of protons can be observed in figure 6.10 beyond the two spots traveling through het
erogeneities. These tails correspond to protons which either interacted through lung tissue
and scattered off to the side (avoiding the following bone tissue insert), or did not interact
much through the bony tissue insert and then scattered inside the lung insert. Such behavior
then results in particles with an apparent deeper range. Even though the spots interacted with
their respective heterogeneous inserts mirrored one to another, the tails are oriented toward
the same direction. This is due to the order of the interactions and the scattering through the
inserts. This, in fact, further emphasizes the accuracy of GMC’s algorithm to model compu
tations through heterogeneities.
A subsequent setup was simulated with two 2 cm thick inserts of cortical bone (p=1.8 g . c ir r 3)
for comparison purposes against the literature. This setup mimics the work performed by
Schaffner et al. [13](see Figure 9) in which a 177 MeV beam was simulated with Monte Carlo
at the edge of a 2 cm thick cortical bone insert. The insert was then placed at different po
sitions along the beam. The beam parameters were kept similar, i.e. a 177 MeV beam first
traversing a 6.8 cm range shifter with a 10 cm air gap. Both the location of the isocenter
and the initial spread of the beam were unknown and thus, had to be arbitrarily chosen. The
isocenter was placed at the surface of the phantom with the spot size given by MGH’s ma
chine parameters, that is « 9.0 mm in X and 9.9 mm in Y. Figure 6.11 illustrates the setup as
well as the obtained dose distributions.
The range pullback in the region traversing the bone insert is clearly visible. Additionally, a
difference in lateral spread can be observed between the two spots as well as the expected
small hot and cold areas at the end of range. These results are similar but not identical to the
work by Schaffner et al. [13]. The overall features are closely related, but their work showed
slightly smoother distributions in the pullback region at the end of range. This is believed to
have risen from the difference in MC code, the unknown parameters (spot size and isocenter
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position), and the lack of advanced validation of the air gap handling in GMC. This result once
more illustrates GMC’s ability to properly handle heterogeneous media.
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Figure 6.11: GMC simulation of two 177 MeV spots in a water phantom with 2 cm cortical bone inserts
(p=1.8 g.cm-3); one insert is located 2 cm from the entrance of the phantom, the other 10 cm. A 6.8
cm range shifter was used with an 8 cm airgap. This setup mimics the work performed by Schaffner
etal. [13].

6.3.5

Halo component

The halo component of a proton beam greatly varies with the equivalent field size of the ir
radiation. An irradiation larger than 12 cm diameter will result in no discernible effect on the
dose distribution due to lateral compensation among the beamlets. For larger cases, it is thus
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possible to forgo the halo effect in dose computations altogether. This is the current state
of Astroid, in which compensating for the halo effect in the PBA would result in a dramatic
reduction of speed performance.
On the other hand, fields smaller than 12 cm may suffer from dose underestimations by a
few percents due to the halo effect (Clasie et al. [11]). Because of this, it is important to con
sider these effects at the macro level within GMC to ensure optimal accuracy. Moreover, the
addition of the nuclear interactions’ modeling presents a highly negligible impact on the per
formance of a particle-by-particle tracking algorithm such as the one used in GMC.
The intent was for GMC to reproduce our semi-theoretical work described in Clasie etal. [11].
As such, the depth dose curves of the beam model were readjusted inside GMC in order to
obtain the core of the beam (beam without the halo component). This was performed using
equations 5 and 6 from Clasie et al. [11] with the given parameters. Figure 6.12 shows the
generated core component of a 205.37 MeV beam along with its corresponding Bragg peak
from the input beam model. This illustrate the correctness of this work. The core compo
nent closely matches the expected core depth dose distribution proposed in Clasie etal. [11],
showing the expected dose discrepancy as a function of depth.
The aforementioned methodology for halo handling was employed, halving the primary parti
cle’s energy, doubling its weight for dose deposition, and scattering it with a large angle (0.2
rad). Unfortunately, this did not provide the expected result. The amount of energy lost and
the amount of weight gained were thus optimized such that the final depth dose curve would
match the input beam model. Figure 6.13 presents the status of GMC’s halo handling at the
time of writing for a 205.37 MeV beam. Although the curve somewhat follows the expected
trend, unacceptable over and under-dosing occurs. This result suggests that the use of a
mean 0.2-radian scattering angle, along with the semi-theoretical values given in our previous
work Clasie et al. [11 ] , are not accurate enough to describe the halo effect from dose compu
tations. The tweaking of the different halo component parameters will be performed in future
work.
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Figure 6.12: Core component of a 205.37 MeV beam along with its whole depth dose curve from
Astroid’s beam model. The core component was generated using the equations provided in our work
described in Clasie et al. [11].
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Figure 6.13: Depth dose curve computed with GMC for a 205.37 MeV beam including the halo com
ponent. This represents the status of the halo component in GMC at the time of writing. This shows
that it is necessary to tweak the parameters from our previous work (Clasie et al. [11]).
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6.4
6.4.1

Patient calculations and comparisons
Cases

Three distinct patients were considered for validation due to their interesting geometry: one
spine sarcoma case with a small homogeneous field, one pericardia & lung sarcoma case pre
senting large heterogeneities, and one head & neck patient presenting large heterogeneities
and planned with two small intensity modulated fields. The CT and delineated contours for
these patients are shown in figures 6.14, 6.15, and 6.16, respectively.
The patient ’s fields were first recomputed in a virtual water phantom, similarly to the process
performed at the time of pre-treatment QA. Thus, these computations could be directly com 
pared to the QA data generated prior to patient treatment:

• 3D

y -index

evaluations were performed against the QA dose recomputation which was

generated using the PBA in water.
• 2D/3D

y -index

evaluations were performed against MatriXX™ measurements that were

acquired at the time of pre-treatment QA.

Lastly, dose recomputations were performed with GMC in the actual patient ’s geometry and
compared to both the original dose computation from Astroid and a full Monte Carlo dose re
computation (Jan Schuemann, private communication) performed with TOPAS, a framework
based on the GEANT4 toolkit [134].
These GMC recomputations were mostly performed with what is considered to be full statis
tics, that is, 1,000,000 protons generated per requested gigaproton. The grid size was either
matching the submillimeter CT grid size (patient dependent), or consisted of a 40 cm3 cube
with 1 m m 3 voxels for the virtual water phantom recomputations. Some discussion on these
parameters is provided in section 6.5.
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6.4.1.1

Spine sarcoma

Figure 6.14 shows the spine sarcoma patient geometry. This case is of interest due to the
small size of the target, approximately 5 x 5 x 7 cm. The small size of the target, along
with the highly homogeneous planned dose distribution, represent an optimal configuration
to appreciate the full extent of the halo effect. As later illustrated in table 6.3, this hypothesis
was further confirmed during patient QA.
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Figure 6.14: Spine sarcoma patient considered for GMC’s computation quality assessment. The
target (CTV - magenta contour) is very small, approximately 5 x 5 x 7 cm, for which the PBA dose
calculation would suffer from halo effects.
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6.4.1.2 Pericardia & lung sarcoma
Figure 6.15 shows the pericardia & lung sarcoma patient geometry. The large tissue hetero
geneities present in this patient push the limit of PBA dose calculations; up to 10 % underdose
could have been expected as shown by the work by Grassberger et al. [24].

Figure 6.15: Pericardia & lung sarcoma patient considered for GMC’s computation quality assessment.
The target (CTV - magenta contour) presents a very irregular shape with large tissue heterogeneities
for which the PBA dose calculation would suffer from poor heterogeneity handling.

6.4.1.3 Head & neck
Figure 6.16 shows the head & neck patient geometry. This case combined all of the worst
possible scenarios for PBA dose calculations: small target (« 6 cm3) with large tissue het-
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erogeneities, and planned with two intensity modulated beams. As previously discussed, un
derdosage would be expected from the halo effect as well as from the large inhomogeneities.
Additionally, the use of two overlapping IMPT fields can result in serious robustness concerns
versus range and geometrical uncertainties. This represents a worst case scenario for PBS
in the current clinical context. In fact, these fields were considered inappropriate, and PBS
treatment deemed unacceptable for this patient.

Figure 6.16: Head & neck patient considered for GMC’s computation quality assessment. The target
(CTV - magenta contour) is very small (& 6 cm3) and presents large tissue heterogeneities; this is an
excellent example of a great combination of feature that reach the limitations of PBA dose calculations.

6.4.2

Dose recomputations in water

Each of the aforementioned patient ’s fields, 4 in total, were recomputed in a virtual water phan
tom corresponding to the dose calculation performed for pre-treatment QA measurements.
These dose recomputations were then evaluated against the QA dose computation through
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3D y-analyses based on the work by Clasie etal. [135]. Figure 6.17 shows the resulting y-map
for one of these analyses for a 1 mm / 1 % Y-criterion. The overall results of these analyses
are presented in table 6 .2 .

Figure 6.17: 3D Y-map based on a 1 mm / 1 % Y-criterion as evaluated between GMC’s water dose
recomputation and the original QA dose computation for the pericardia & lung sarcoma field.

“ Field
Spine sarcoma
pericardia & lung sarcoma
Head & neck field 1
Head & neck field 2

1 m m / 0.5%

Y-criterion
1 mm / 1 % 2 m m / 0 . 1 %

2 m m / 0.5%

92.9
92.7
93.3
92.9

Passing rate %
93.7
94.9
93.6
95.2
94.4
95.1
94.2
94.0

96.9
97.3
97.0
96.7

Table 6.2: 3D Y-analyses results between GMC’s water dose recomputation and the original QA dose
computations. Numerous Y-criteria were used.

At first glance, the results of the 3D y -analyses, with an average of 94.7 ± 1.6 %, were slightly
less than expected. A passing rate of 90 % is generally considered acceptable, which is
sensible here given the relative tight y -criteria used. Nevertheless, one would expect better
agreement between computer generated dose distributions in water, due to the absence of
heterogeneities and measurement uncertainties. One hypothesis was that the QA dose cube,
generated with 3 m m 3 voxels, might have degraded the calculation accuracy as compared to
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GMC’s simulations, which used 1 m m 3 voxels. QA dose cubes were therefore regenerated
using a grid with 1 m m 3 voxels for comparison. A 3D 7 -analysis using these higher definition
cubes yielded very similar results like the one observed in table 6 .2 , within ± 1 %.
The subsequent step consisted of 2D/3D 7 -analyses between GMC’s recomputations in water
and actual 2D MatriXX™ measurements that were acquired at the time of pre-treatment QA.
Figure 6.18 shows the 7 -analysis for the pericardia & lung sarcoma field at a given depth
for a 1 mm / 1 % 7 -criterion. The head & neck case fields had been considered so small
and heterogeneous that treatment was deemed unacceptable using pencil beam scanning.
Consequently, no QA measurements were acquired and it was therefore impossible to perform
the 7 -analysis for those fields.

Figure 6.18: 2D/3D j-analysis result based on a 1 mm / 1 % j-criterion as evaluated between GMC’s
water dose recomputation and actual QA MatriXX™ measurement for the pericardia & lung sarcoma
field at a depth of 105 mm.

The results of the 2D/3D 7 -analyses for the two other patient cases are presented in table
6.3. It should be noted that in order to obtain the best possible result, the position of the
measurement was slightly adjusted (± 1 mm) due to slight position uncertainties during the
QA acquisition process. This was an appropriate step, as it was not intended to check the
delivery but rather the dose computation accuracy. Nevertheless, the 2D/3D 7 -analyses for
the treated fields - this does not include the non-halo corrected spine fields - all yielded ex
ceptional passing rates, over 95 % for a 1 mm / 1% 7 -criterion. This agreement is extremely
high, far beyond current clinical expectations. All fields, including the non-halo corrected ones,
passed the 3 mm / 3% 7 -criterion analysis at 100 %, except for one at 98 %. Conversely,
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the actual QA Y-analysis using the current QA dose computations in water resulted in good or
acceptable passing rates, except for one field at 76 %. As a comparison point, the Y-analysis
for the pericardia & lung sarcoma field at 155 mm depth yielded a passing rate of 69.6 % with
a 1 mm / 1% Y-criterion for the current clinical QA dose computation. This is far less than the
99.1 % passing rate obtained using the GMC’s dose recalculation.
This is an extremely important result. Not only does it explain the acceptable yet not great
results observed in table 6.2, but it also shows the excellent accuracy of GMC’s dose compu
tation in water. Conversely, this further highlights the limitations of PBA dose computations,
even when performed in a uniform medium.

Field
Spine sarcoma
Spine sarcoma
Spine sarcoma (halo corrected)
Spine sarcoma (halo corrected)
pericardia & lung sarcoma
pericardia & lung sarcoma

Depth (mm)
105
155
105
155
54
155

Y-criterion
1 mm / 1 % 3 m m / 3 %

QA measurement
3m m /3%

Passing rate %
75.9
100.0
62.1
98.3
96.6
100.0
98.6
100.0
95.1
100.0
99.1
100.0

Passing rate %
91.9
76.0
99.6
99.6
99.8
94.7

Table 6.3: 2D/3D Y-analyses results between GMC’s water dose recomputation and the actual QA
MatriXX™ measurements. Y-criteria of 1 m m /1% and 3 mm / 3% were used. The results of the 2D/3D
Y-analyses observed during pre-treatment patient QA are given for informational purposes.

In order to further assess the quality of GMC’s dose recomputations in water, similar simula
tions were performed in a far less statistically optimal situation. The number of particles was
decreased by an order of magnitude (100,000 particles simulated per gigaproton requested),
and the voxel size increased from 1 mm 3 to 2 mm3. The speed considerations associated
with such parameters are further discussed in section 6.5.
Table 6.4 gives the results of the 2D/3D

y -analyses

between these coarse simulations and

actual QA measurements. Although the passing rates of 1 mm /1 % y -criterion analyses de
creased at the limit of acceptability, the 3 mm / 3 % Y-criterion analyses yielded perfect 100 %
passing rates. In fact, similar simulations of the spine sarcoma field using 4 mm 3 voxels re
sulted in similar passing rates for a 1 mm / 1 % Y-criterion. These results further emphasize
the accuracy of GMC’s algorithm for dose computations in water, even with far from optimal
statistics. This makes GMC very attractive from a clinical use point of view.
It should be noted that the results presented in tables 6.3 and 6.4 are based on
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Y-criterion
1 mm / 1 % 3 mm / 3 %

Field
Spine sarcoma (halo corrected)
Spine sarcoma (halo corrected)
pericardia & lung sarcoma
pericardia & lung sarcoma

Depth (mm)
105
155
54
155

Passing rate %
92.1
100.0
95.2
100.0
86.8
100.0
96.1
100.0

Table 6.4: 2D/3D Y-analyses results between coarse GMC’s water dose recomputation (100,000
histories per Gp with 3 mm3 voxel size) and the actual QA MatriXX™ measurements.

using spline evaluations. It was discussed in Clasie etal. [135] that such evaluations presents
limitations when performing Y-analyses on noisy data set. Both the measurements and MC
recomputations are, by definition, relatively noisy. The effect is such that an overestimation of
the

y -results

could occur. The y -analyses were therefore re-run using a 3 x 3 median filter on

the MC dose distribution along with a simple interpolation evaluation of the Y-indices which,
on the other hand, could result in an underestimatation of the Y-results. As expected, the
passing rates were reduced but remained superior as compared to the current QA PBA dose
calculations for a 3 mm / 3 % Y-criterion, and were mostly acceptable for a 1 mm / 1 % Ycriterion. This, once again, emphasizes the accuracy of GMC’s dose recomputation algorithm
in water.

6.4.3

Patient dose recomputations

Figure 6.19 shows a comparison of the dose and DVH data for the spine sarcoma case be
tween Astroid’s planned dose and GMC’s recomputation. Due to a lack of resource, no full
MC calculation could be performed. The dose distributions from Astroid’s PBA computation
and GMC’s recalculation appear visually alike, however, GMC’s is noisier, as one would expect
from a MC simulation. This is also highlighted through the fine agreement in the DVH data,
with virtually no tumor coverage difference at V95, and a mean OAR dose discrepancy of 3.5
± 2.5 % (driven by the liver and kidneys which received a very low dose). The slight round
up in the tumor coverage in GMC’s recomputation is explained by the proper handling of lat
eral scattering. Overall, such a result meets the predicted expectation given the uniformity of
the treatment region and the dose, and the fact that the halo component was lacking in this
computation. The proper handling of that halo component would be expected to result in an
overall uniform drop of the dose within the target volume.
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Figures 6.20 and 6.22 show three-way comparisons between the current clinical PBA dose
computation (Astroid), GMC’s dose recomputation (GMC), and a full MC dose recomputation
(TOPAS) for the pericardia & lung sarcoma patient, as well as the head & neck patient. All
three of these dose calculations are reasonable, with the TOPAS dose recomputation appear
ing colder in both cases. The general features, such as penumbra size and slight over or
undershooting of the beam, are highly similar between GMC and TOPAS when compared to
Astroid. These features arise from the large heterogeneities present in the patient’s geometry.
Thus, based on these three rather extreme cases, GMC’s transport through patient geome
tries appear accurate. It should be noted that the slight discrepancies in dose level between
GMC and TOPAS may be due to the lack of halo component in GMC. This will be evaluated
at a later time once the halo component correction has been correctly implemented as dis
cussed in section 6.3.5. Furthermore, it should be noted that TOPAS relies on many tweaks
and tricks in order to appropriately match the beam data present in Astroid. As such, there
is no true gold standard for dose computations in patients. Only in-vivo measurements can
truly assess the dose accuracy.
The DVH comparisons between the current clinical PBA dose computation (Astroid), GMC’s
dose recomputation (GMC), and a full MC dose recomputation (TOPAS) for the pericardia &
lung sarcoma patient and the head & neck patient are presented in figures 6.21 and 6.23.
The DVH data confirms the results previously observed in the dose distribution comparisons.
TOPAS’s recomputations present large target underdosing (3.5 ± 1.1 Gy(RBE) for V95) and
differences in OAR dose (11.3 ± 6.7 % mean dose) as compared to Astroid’s planned dose.
GMC, sensitive to the heterogeneities, presents features similar to that of TOPAS but the ef
fects are not quite as dramatic: target underdosage of 2.1 ± 1.9 Gy(RBE) for V 95 and OAR
mean dose discrepancy of 6.7 ± 5.1 %.
As previously stated, despite the fact that both MC algorithms present similar characteristics
against the inhomogeneities, it is difficult to judge their absolute accuracy. It should be noted,
however, that GMC relies only on the TPS’s beam model with a simple calibration to adjust
the range discrepancy due to the scattered nature of the individual proton tracks through in
teractions. Conversely, systems like TOPAS or any other full MC algorithms must generate
their own beam model from square one. This beam model must then be adjusted through
numerous tweaks and tricks in order to match the TPS's beam model. This represents a large
overhead, and could easily introduce systematic discrepancies in the resulting dose calcula
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tions.
In order to further assess the statistical effects on GMC’s dose recomputations, these three
patient cases were generated in the low statistical mode (100,000 per Gp requested). An ex
emplary comparison between the full statistical mode and the low statistical mode for GMC’s
dose recomputation of the head & neck patient’s plan is given in figure 6.24. The dose dis
tribution with low statistics clearly shows a higher noise level than the one with full statistics;
this was emphasized in figure 6.24 by using one of the noisiest image slices. On the other
hand, the DVH comparison shows very little difference, which fits well within the clinical ex
pectations. Although it is not illustrated here, the two other patient’s recomputations yielded
similar results. These preliminary examples highlight the possibility to use lower statistics yet
obtain appropriate dose computation accuracy, thus highly reduce the required computing
power and time.
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Figure 6.20: 3 way dose comparison for the pericardia & lung sarcoma patient between the current clinical PBA dose computation (Astroid), GMC’s dose
reocmputation (GMC), and a full MC dose recomputation (TOPAS).
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Figure 6.21: DVH comparison for the pericardia & lung sarcoma patient between the current clinical PBA dose computation (Astroid), GMC’s dose
recomputation (GMC), and a full MC dose recomputation (TOPAS).
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Figure 6.22: 3 way dose comparison for the head & neck patient between the current clinical PBA dose computation (Astroid), GMC’s dose recomputation
(GMC), and a full MC dose recomputation (TOPAS).
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Figure 6.23: DVH comparison for the head & neck patient between the current clinical PBA dose computation (Astroid), GM C’s dose recomputation
(GMC), and a full M C dose recomputation (TOPAS).
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Figure 6.24: Dose and DVH comparison of GMC’s dose recomputations for the head & neck patient with full statistics (1,000,000 particles simulated per
requested Gp) versus low statistics (100,000 particles simulated per requested Gp). Although noisier, the low statistics remains accurate from a clinical
stand point.
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6.5

Speed considerations

The version of GMC presented in this work was only evaluated for accuracy; the source code
was not optimized for speed. Thus, there are multiple opportunities that could help speed up
the computation process.
The first aspect consists of the statistics, i.e. how many histories should be simulated and how
coarse the dose grid could be in order to ensure acceptable dose computations accuracy.
The simulations performed for section 6.4.2 perfectly illustrate these considerations. The ”full
statistical” computations, considering 1 ,000,000 histories per gigaproton requested, using a
1 mm 3 voxel geometry, took approximately 315 minutes for the spine sarcoma field and 574
minute for the pericardia & lung field. These numbers are extremely high and unacceptable in
clinical practice. On the other hand, the simulations with reduced statistics, 100,000 histories
per gigaproton requested, using a 2 mm 3 voxel geometry, took approximately 13 and 26 min
utes, respectively. This represents over a 2000 % speedup factor. Albeit the accuracy was
diminished when using reduced statistics, it was well within clinical acceptability. Such con
siderations would need to be taken into account for a finalized algorithm. A more quantitative
analysis, however, must be performed in order to optimally balance speed and accuracy.
It is worth noting that GMC’s code, in its current form, presents countless mathematical oper
ations and for loops. An appropriate profiling of the source code could be performed in order
to ensure optimal execution speed throughout the algorithm.
Furthermore, GMC is a perfect candidate for multi-threading. GMC, in its current state, per
forms dose computations using a single CPU thread. Multiple threads could easily be used for
parallel particle tracking, either at the particle or the spot level. The use of ”mutex” (locks de
signed to enforce mutual exclusion for parallel memory access) could easily be implemented
on a per dose voxel basis. Such multi-threading implementation would be highly efficient in
GMC’s algorithm given that two particles are statistically unlikely to have an interaction with
the same given voxel at the same time. Currently, a basic desktop computer would offer over

8 threads, while a dedicated workstation could easily offer over 30 threads. Despite the fact
that, depending on the code’s scalability, the runtime speedup might not linearly increase as
a function of available threads, a large speedup should be expected in such environment.
Since the simulation of a single particle in GMC currently takes on the order of 3 seconds,
such setup should permit us to bring the computation times discussed in section 6.4.2 to
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under a minute.
Such speed improvements, however, will not be implemented in the current version of GMC.
Only the source code profiling should be performed in order to assess and optimize the func
tions affecting the computational speed the most. The ”pseudo-code” presented in this work
was intended for modeling and accuracy validation only. As previously suggested, this algo
rithm is extremely parallelizable, thus highly suitable for GPU use. The next step will consist
of the portage of the source code to the GPU architecture. The simulation of a single parti
cle currently takes about 3 seconds on a ’’regular” computer. This time is mainly driven by
the program’s initialization (CT and fluence loading) and finalization (dose cube write-out), as
confirmed through the simulation of 1000 particles which occurs in about 4 seconds. In the
final layout, these initialization and finalization steps would be independent of GMC, thus the
simulation of 1,000 particles would be performed under a second. Once ported to the GPU
architecture, one could therefore expect to decrease the computation time for an entire field
to the level of a second.

6.6

Conclusion

GMC ['gImIk], an extremely simplified MC algorithm for proton dose calculations has been im
plemented on a CPU architecture. Its basic physics’ properties have been validated against
the physical observables of a proton beam at the macro level. GMC’s dose computation accu
racy was then assessed against measurements, with results surpassing clinical expectations.
Dose computations in patients were also performed and compared to the current clinical PBA
calculation for three patients that presented challenging geometry. These simulations further
highlighted the limitations of the current pencil beam algorithm's dose computations.
The current version of the algorithm, running on a single CPU thread, is arguably fast from
a Monte Carlo stand point, but undoubtedly slow from a clinical point of view. Although the
source code could easily be optimized for computational speed, resulting in a similar calcu
lation time as the current PBA system in place, the aim is to port the algorithm to a GPU
architecture. The loading of the patient information, spot placement, etc, will be performed at
a higher level by Astroid. GMC’s GPU implementation will only perform the dose computation
itself based on the provided input. Computation time at the level of a second can then be
expected. At such speed, the dose computation is considered ”online”, and any changes to
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the input data, such as range shifter thickness, spots’ position and energy, etc, would auto
matically result in an updated dose distribution.
Online dose calculations open the door to adaptive recomputation. With the proper imaging
system, expected daily fractional doses could be instantaneously computed. The position of
the spots could further be automatically adapted with the dose instantly recomputed.

6- Fast MC dose algorithm ~ N. Depauw, PhD thesis, 2014 - CMRP, UOW

1 43

Chapter 7

Conclusions and future work
Proton pencil beam scanning radiotherapy is currently at the forefront of the treatment of
cancer with a promising future of continuous improvement. For example, the use of proton
imaging along with a fast dose computation engine could result in a daily adaptation of the
patient’s treatment plan based on tumor position. This work has laid a solid foundation to
achieving adaptive radiotherapy for PBS. The characteristics and limitations of proton radio
graphy imaging have been evaluated and the design and preliminary experimental work of
a small form factor proton radiography system have also been performed. Furthermore, the
requisites and limitations of PBS treatment planning were assessed, and a simplified Monte
Carlo dose algorithm was implemented.

7.1

Proton imaging

The imaging characteristics and limitations of proton radiography have been evaluated through
the use of GEANT4 simulations. These imaging properties were also compared against con
ventional kV and MV X-ray imaging. In spite of proton radiography’s limited spatial resolution
(due to multiple Coulomb scattering), it was found that its density resolution was far greater
than conventional X-ray radiography. In fact, it was shown that an ROI with a density closely
related to the density of its background (up to 0.02 g/cm 3 density difference) could be re
solved. This density resolution may be beneficial for certain tumor sites, such as lung cancer.
Moreover, the use of the plateau region of the beam’s Bragg peak results in a very low imaging
dose. The reduced imaging dose is especially attractive for pediatric patients, because even
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the smallest dose may be detrimental to the patient. Most importantly, the use of a single
beam for both imaging and therapy would ensure a higher treatment accuracy, especially as
the technology advances and permits the use of proton imaging for online tumor tracking.
The current design of proton radiography detectors are clinically impracticable. A small form
factor proton radiography detector, suitable for clinical use, was therefore designed. Multiple
technologies were evaluated: photonic bandgap fibers, a CMOS active pixel sensor, and Bi
cron scintillating fibers. PBG fibers proved to be unsuitable for proton imaging use as they did
not properly react with the beam. Although the CMOS APS yielded inconclusive results due
to its integration time, it presented promising aspects which showed the potential for proton
imaging. The redesign of a similar CMOS APS system specifically for proton imaging purposes
would therefore be worth exploring. It was highlighted that Bicron scintillating fibers were a
viable option to be considered for proton radiography purposes. The basic function of the
fibers, i.e. acquisition of position and energy information on a particle-by-particle basis, was
demonstrated. After calibration, the energy information can be acquired from the amount
of signal generated in the fiber through the particle’s interaction. The position information
can be reconstructed from the coincidental interactions in two sets of parallel fibers set in a
2-dimensional X/Y mesh. This information should be acquired both in front and behind the pa
tient, twice, allowing for the reconstruction of directional information on a particle-by-particle
basis through coincidence measurements. This information can then be used to generate
radiographs with more advanced image reconstruction algorithms. Nevertheless, a full scale
functional system could not be implemented, partly due to the high cost of read-out electronic
systems.

7.2

Fast dose computation algorithm

The requisites and limitations of current treatment planning for proton PBS were assessed.
The acquisition of the beam model required by the TPS was described. The main limitation
of the treatment’s quality lies in the machine’s spot size. Although the dosimetric benefits of a
smaller spot size were highlighted, the downfalls were unfortunately highlighted as well, due
to the strict requirements for delivery tolerances and the need for higher computing power.
From a TPS point of view, the issues linked to spot placement have been described. Solutions
to spot placement issues necessitate heavy computing power, but should be expected to be

7- Conclusions and future work ~ N. Depauw, PhD thesis, 2014 - CMRP, UOW

1 45

performed quickly. The robustness of PBS treatment planning was also discussed through
an exemplary case. This type of robustness analysis could be performed routinely in the clinic
if the dose computing engine was faster. Lastly, the relative accuracy of the current pencil
beam algorithm for dose computation was discussed, as well as the need for more accurate
engines, such as Monte Carlo algorithms.
The simplicity of the beam model for PBS facilitates the design of a simplified Monte Carlo
algorithm. Thus, GMC, an accurate MC proton dose computation engine, was implemented
on the CPU architecture. GMC was then validated against physical observables. The range
of the Bragg peak first had to be calibrated in order to match the beam model due to the
scattering of the particles. This results in a tortuous path which projects shallower than a
straight path. Subsequently, the accuracy of the input position, beam size, and machine
SAD was verified. The correctness of the scattering in water was also compared to the the
oretical model. The implementation of the halo effect was also evaluated, but it uncovered
issues with the theoretical model. Lastly, GMC’s behavior against heterogeneities was as
sessed. Once the implementation was validated, three patient cases were considered for
comparisons. GMC’s dose recomputations of the patient fields in water were compared to
pre-treatment QA dose computation and measurements. The agreement between the QA
dose computation and GMC’s recomputations was merely acceptable. On the other hand,
the comparisons against measurements yielded excellent results. This highlighted the excep
tional accuracy of the algorithm used in GMC. The recomputations were ultimately performed
in the patient’s geometry and compared to both the original Astroid pencil beam algorithm
dose computation and the recomputations performed with TOPAS, a full Monte Carlo engine.
The general features matched the expectations but, overall, GMC’s recomputations displayed
a milder discrepancy than TOPAS when compared to Astroid. The evaluation of the accuracy
of such computations is difficult however, as there is no ground truth. As GMC is currently
implemented on the CPU architecture only, there are numerous opportunities for large speed
improvements which are believed to reduce the computational time to a negligible level.

7.3

Future work

The work presented in this thesis lays the foundation for adaptive replanning, which will require
both proton imaging and fast dose calculation capabilities in the future. Nevertheless, many
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aspects require further investigation and action. These includes:

• Optimize the image reconstruction algorithm for proton radiography based on the pa
tient’s diagnostic images.
• Apply the methods learned for proton radiography to a more complex proton CT system.
• Determine proton radiography’s capabilities for generating proton range information.
• Assess the real possibilities for a CMOS APS based proton radiography system.
• Build a fully functional prototype of a scintillating fiber device for proton imaging pur
poses.
• Correct the halo component of GMC’s dose computation algorithm.
• Port GMC to the GPU architecture.
• Optimize the accuracy/statistics trade-off for optimal speed performances in GMC.
• Validate GMC against in-vivo measurements.
• Implement a double scattering version of GMC’s algorithm.
• Implement relative biological effectiveness (RBE) considerations in GMC.
• Generate a framework combining proton imaging, GMC, and a reoptimization routine.

The immediate future work will specifically focus on GMC’s finalization. The parameters of the
halo component will first be adjusted so that the core of the depth dose curve is appropriately
complimented by the halo component in order to recover the entire pristine peaks of the
beam model. Once validated, GMC will be ported from the CPU architecture to the GPU
architecture. The computational time on the GPU is expected to be negligible, thus opening
the way to online dose recomputations. In parallel, efforts should be put into the design of a full
scale proton imaging system. The synergy of the imaging system and GMC’s fast algorithm
will then pave the way to proton pencil beam scanning adaptive radiation therapy.
The addition of the relative biological effectiveness of protons into GMC’s algorithm is another
improvement that could be made in the future. Since GMC is implemented based on particleby-particle tracking, the LET^ information is readily available on a voxel basis. Thus, the
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implementation of proton RBE weighted dose computations is not a complicated issue in itself.
Proton RBE models, however, present very large uncertainties [136]. Large improvements in
RBE models is therefore necessary before such feature could be considered in the clinic.
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